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Brain  tissue,  both  grey  and  white  matter  from  the  cerebral  parietal  region  and 
the  cerebellum,  was  obtained  from  66  infants  dying  of  sudden  infant  death 
syndrome.  The  fatty  acid  composition  was  analysed  in  these  tissues  by  gas 
liquid  chromatography  after  extraction  and  derivatisation.  The  subjects  were 
divided  according  to  their  dietary  history,  either  breast  or  formula  feeding. 
Formula-fed  infants  were  further  subdivided  according  to  the  content  of  (x- 
linolenic  acid  in  the  formula  milk.  At  the  time  of  this  study  no  formula  milks 
analysed  contained  long  chain  polyunsaturated  fatty  acids. 
Dietary  related  differences  were  found  in  the  accretion  of  polyunsaturated  fatty 
acids  into  neural  membranes.  Docosahexaenoic  acid  concentrations  were 
higher  and  conversely  n-6  series  fatty  acids  lower  in  breast-fed  than  formula- 
fed  infants.  In  cerebral  white  matter,  nervonic  acid,  the  long-chain  fatty  acid 
associated  with  myelination,  appeared  in  breast-fed  in  advance  of  fonnula-fed 
infants.  Similar  dietary  related  differences  in  polyunsaturated  fatty  acid 
compositions  were  found  in  the  cerebellar  cortex  and  the  cerebellar  white 
matter  was  associated  with  an  earlier  accretion  of  nervonic  and  lignoceric 
acids  when  compared  to  the  cerebrum.  Analysis  of  the  phospholipid  and 
glycolipid  composition  of  the  cerebral  and  cerebellar  white  matter  tissues  was 
achieved  by  means  of  separation  by  high  performance  thin  layer 
chromatography  followed  by  scanning  densitometry. 
The  results  of  this  study  support  the  need  for  breast  feeding  for  a  minimum  of 
four  months.  Formulation  of  manufactured  milks  should  include  long  chain 
polyunsaturated  fatty  acids  and  nervonic  acid  at  concentrations  similar  to  those 
of  breast  milk. DECLARATION 
I  certify  that  this  thesis  does  not  contain  material  previously  published  by 
any  other  person,  except  where  referred  to  in  the  text,  and  that  the  results 
in  this  thesis  have  not  been  submitted  for  any  other  degree  or  diploma. 
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SPH  sphingomyelin 
SU  sulphatides 
TLC  thin  layer  chromatography 
ul  microlitres 
umol  micromoles 
UV  ultraviolet 
VLCFA  very  long  chain  fatty  acids 
WISC-R  Weschler  intelligence  scale  for  children 
viii Acknowledgements 
I  would  like  to  thank  the  following  for  their  assistance  during  the  course  of  this 
project:  - 
My  joint  supervisors,  Professor  Forrester  Cockburn  and  Dr  Robert  Logan  for 
providing  me  with  the  opportunity  to  carry  out  this  research  project  and  for 
their  guidance  and  encouragement  during  the  period  of  my  research. 
Dr  Ainslie  Patrick  and  Dr  Allan  Howatson,  Department  of  Pathology,  for  the 
provision  of  the  tissue  specimens  for  this  study. 
Dr  Angus  Gibson  and  Mrs  Hazel  Brooke,  Scottish  Cot  Death  Trust,  for  the 
provision  of  infonnation  regarding  dietary  history. 
My  colleagues  in  the  Departments  of  Biochemistry,  Child  Health  and  Human 
Nutrition  for  their  assistance  and  many  words  of  encouragement. 
Dr  James  Farquharson  who  has  been  of  invaluable  help  not  only  with  advice 
about  experimental  procedures  but  also  with  the  correction  of  the  manuscript. 
Mrs  Myra  Fergusson  who  introduced  me  to  the  world  of  word  processing. 
Miss  Jean  Hyslop,  Medical  Artist  for  the  preparation  of  illustrations. 
Dr.  Douglas  Watt,  Department  of  Mathematics  and  Statistics  for  advice  on  the 
data  handling. 
Dr  Ray  Noble  and  Dr  Brian  Speake,  Scottish  Agricultural  College, 
Auchincruive,  for  the  use  of  the  scanning  densitometry  equipment. 
Milupa  Ltd.,  Hillingdon,  Essex  for  financial  assistance  with  the  research 
project. 
All  my  friends  who  have  been  incredibly  patient  and  supportive  during  the  past 
five  years. 
Les  Smart  who  provided  a  great  deal  of  positive  encouragement,  constructive 
criticism  of  the  manuscript  and  most  importantly  varied  diversions  from 
playing  keyboard  duets  to  building  conservatories  until  his  untimely  death. 
Finally  my  mother  for  her  unfailing  support  throughout  the  period  of  my 
studies  and  my  late  father  whose  belief  in  continuing  self-challenge  has 
inspired  me  to  undertake  this  project. 
ix Summary 
This  work  examines  the  hypothesis  that  the  fatty  acid  composition  of  milks  fed 
to  infants  during  the  first  months  of  life  significantly  affects  the  fatty  acid 
composition  of  the  human  infant  brain. 
Breast  milk  is  the  human  infant's  natural  food  and  for  the  first  four  to  six 
months  of  life  meets  his  or  her  total  nutrient  requirements.  In  Britain  although 
more  than  80%  of  mothers  breast  feed  their  babies  for  the  first  week  of  life 
fewer  than  35%  continue  for  four  months.  In  the  Greater  Glasgow  Health 
Board  Area,  which  is  renowned  for  its  bad  health  record,  fewer  than  one  third 
of  mothers  breast  feed  their  infant  for  even  one  week.  In  the  last  one  hundred 
years  mothers  have  increasingly  relied  on  manufacturers'  milks  to  feed  both 
term  and  preterm  infants. 
This  thesis  examines  the  fatty  acid  components  of  human  milk  and 
manufactured  formula  milks  in  relation  to  the  phospholipid  and 
glycosphingolipid  fatty  acid  components  in  the  brains  of  infants  fed  different 
milks. 
During  the  first  year  of  life  the  infant  brain  weight  increases  threefold;  50  -  60 
%  of  this  increase  is  due  to  structural  membrane  lipid  deposition  required  for 
the  increase  in  neuronal  cell  size,  the  formation  of  synaptic  connections  and 
the  deposition  of  white  matter  (myelination).  It  is  known  that  linoleic  acid  and 
cc-linolenic  acid  are  essential  fatty  acids  (EFA)  and  these  two  fatty  acids  are 
present  in  most  formula  milks  although  not  generally  in  the  proportions  present 
in  breast  milk.  There  is  increasing  evidence  that  the  longer  chain 
polyunsaturated  fatty  acids  (LCPUFA),  docosahexaenoic  acid  and  arachidonic 
acid,  which  are  both  minor  constituents  of  breast  milk  are  also  essential  fatty 
acids  for  infants. 
x Cerebral  cortex  grey,  cerebral  parietal  white,  cerebellar  grey  and  cerebellar 
white  matter  from  brains  of  both  term  (57)  and  preterm  (9)  infants  dying  from 
sudden  infant  death  syndrome  (SIDS)  were  studied.  Once  other  causes  of 
death  had  been  eliminated  after  post-mortem  by  an  experienced  paediatric 
pathologist,  a  full  dietary  history  and  birth  details  were  obtained  for  the  infants. 
Total  tissue  lipid  was  extracted  by  the  method  of  Folch.  Grey  and  white  matter 
fatty  acids  were  transesterified  with  boron  trifluoride  in  methanol  or 
methanolic  HCI  respectively.  Selected  cerebral  cortex  lipid  samples  were 
ftirther  separated  into  individual  phospholipids  by  two-dimensional 
chromatography  followed  by  esterification.  Fatty  acids  were  separated  by  gas 
liquid  chromatography  (GLC)  or  gas  chromatography-mass  spectrometry 
(GCMS),  identified  by  retention  times  with  respect  to  known  standards  and  the 
weight  percentage  of  each  fatty  acid  calculated. 
Infants  were  assigned  to  feeding  groups  as  described.  The  breast  fed  group 
received  exclusively  their  mothers'  milk.  The  SMA  group  received  either 
SMA  Gold  Cap  or  White  Cap  formula  milks  and  the  CGOST  group  were  given 
either  Farley's  Ostermilk  (pre  1996  formulation)  or  Cow  &  Gate  Premium  (pre 
1990  formulation).  The  essential  fatty  acid,  a-linolenic  acid,  was  present  at  a 
concentration  of  1.5%  of  total  fatty  acids  in  the  SMA  group  but  at  a  low  level 
of  <0.5%  in  the  CGOST  group.  A  ftuther  smaller  group  (C&G)  was  fed  Cow 
&  Gate  Premium  or  Cow  &  Gate  Plus  (post  1990  formulation)  with  an  a- 
linolenic  acid  concentration  of  2.2%  of  total  fatty  acids.  At  the  time  of  the 
study  none  of  the  manufacturers'  milks  contained  docosahexaenoic  (DHA; 
C22:  6n-3),  arachidonic  acid  (AA;  C20:  4n-6)  or  nervonic  acid  (C24:  I  n-9). 
Examination  of  cerebral  cortex  total  phospholipid  showed  that  breast  fed 
infants  had  significantly  greater  concentrations  of  DHA  than  both  formula  fed 
groups.  The  corollary  of  this  was  an  increased  incorporation  of  n-6  series 
xi LCPUFA,  namely  amchidonic,  docosatetraenoic  and  docosapentaenoic  acids. 
Examination  of  individual  phospholipids  of  the  cerebral  cortex  demonstrated 
similar  significant  differences  in  fatty  acid  compositions  between  feeding 
groups  which  were  most  marked  in  phosphatidylethanolamine  and 
phosphatidylserine  fractions  as  these  neuronal  membrane  phospholipids 
contain  the  greatest  percentages  of  these  LCPUFA. 
High  performance  thin  layer  chromatography  (HPTLC)  was  employed  to 
separate  lipid  classes  in  cerebral  and  cerebellar  white  tissues. 
Galactocerebrosides  and  sulphatides  were  absent  at  birth  in  cerebral  white 
matter  in  comparison  to  cerebellar  white  matter  in  which  both  lipids  were 
present  in  significant  concentrations  fi7om  birth.  Individual  phospholipid 
compositions  did  not  vary  markedly  with  age  in  either  tissue. 
Most  of  the  fatty  acid  compositions  of  cerebral  white  matter  were  found  to 
vary  with  age.  There  was  a  universal  reduction  in  DHA  concentrations  in  all 
feeding  groups  during  the  first  year,  being  more  marked  in  the  formula  fed 
infants  and  initially  more  rapid  in  the  preterm  infants.  In  the  breast-fed  group, 
concentrations  of  the  major  fatty  acid  of  myelin,  nervonic  acid,  increased 
logarithmically  in  the  third  month,  from  undetectable  at  birth  to  about  4%  of 
total  fatty  acids  at  the  end  of  the  first  year.  This  increase  was  not  generally 
evident  in  the  formula  fed  groups  until  the  fourth  month  in  both  term  and 
preterm.  infants. 
Dietary  related  differences  in  DHA  and  the  n-6  series  LCPUFA  in  both 
cerebellar  grey  and  white  matter  were  similar  to  those  found  in  cerebral  cortex 
and  cerebral  white  matter  respectively.  Cerebellar  white  matter,  however, 
differed  from  cerebral  white  in  that  lignoceric  (C24:  0)  and  nervonic  acid 
concentrations  were  present  at  about  1%  at  birth. 
xii There  may  be  long  term  health  implications  from  lack  of  supply  of  DHA  in  the 
infant  diet.  The  cerebral  white  matter  results  also  point  to  the  probable 
essentiality  of  nervonic  acid,  present  in  human  milk  but  not  in  formula  milks, 
especially  as  it  is  a  major  constituent  of  cerebrosides  important  in  the 
formation  of  myelin. 
Further  studies  are  needed  into  the  long-term  effects  of  deficiency  in  DHA 
and  nervonic  acid  in  the  diet  of  formula  fed  infants.  The  short  term  effect  on 
efficiency  of  synaptic  transmission  and  longer  term  effects  on  neuronal 
membrane  integrity  caused  by  these  neuronal  membrane  fatty  acid  changes 
require  investigation. 
These  results  support  both  the  hypothesis  and  maintenance  of  breast  feeding 
for  human  infants. 
xiii CHAPTER  I 
INTRODUCTION 1.1.  History  of  infant  feeding 
The  female  of  the  human  species  evolved  with  the  capacity  to  feed  her  infant. 
Breast  feeding  by  either  the  infant's  mother  or  by  a  "wet  nurse"  was  nature's 
way  of  providing  the  infant  with  the  all  the  nutrients  required  for  development. 
Breast  milk  on  its  own,  tended  to  be  the  infant's  diet  for  9-  12  months  but  in 
some  cases  this  could  extend  for  up  to  3  years. 
There  are  references  to  the  artificial  feeding  of  babies  as  far  back  as  ancient 
Roman  times  when  animals'  milk,  particularly  sheep  or  goats,  with  honey  or 
sugar  and  bread  added,  was  given  as  a  substitute.  However,  this  practice  was 
thought  to  be  dangerous. 
A  combination  of  factors  brought  about  by  the  industrial  revolution  contributed 
to  the  mounting  popularity  of  artificial  feeding.  For  example,  women  began  to 
take  up  employment,  and  families  moved  away  from  their  traditional  fanning 
communities  to  an  urban  way  of  life.  Also,  glass  bottles  became  available  along 
with  the  first  rubber  teats  and  more  importantly  the  development  of  the 
pasteurisation  process  made  milk  preparation  much  safer.  Milk  substitutes, 
manufactured  from  wheat  flour,  cow's  milk,  malt  flour  and  potassium 
bicarbonate  were  developed  during  the  latter  part  of  the  19  th  Century.  Most  of 
these  new  formulas,  however,  were  totally  inadequate  as  a  sole  source  of 
nourishment,  and,  infant  death,  due  to  contaminated  artificial  feeds,  was  a 
recognised  problem. 
By  the  beginning  of  the  20th  Century,  an  estimated  80%  of  mothers  were  breast 
feeding  at  birth  and  approximately  50%  of  them  continued  to  do  so  for  at  least 
three  months  (Fildes,  1988).  The  introduction  of  roller-dried  milk  powders 
significantly  reduced  mortality  amongst  artificially  fed  infants.  New  formulae 
with  an  altered  protein  and  mineral  composition  and  with  added  Vitamin  D 
I and  carbohydrate  were  developed  in  response  to  more  sophisticated  analyses  of 
dietary  needs  and  understanding  of  the  physiological  processes. 
The  introduction  of  the  Welfare  Food  Scheme  in  1940  resulted  in  free  or  cheap 
National  Dried  Milk  for  children  and  consequently  an  increase  in  the  number 
of  formula  milks  on  the  market.  This  convenient  and  safe  way  of  feeding  the 
baby  was  popular  because  it  allowed  young  mothers  to  go  on  working  and  let 
fathers  and  other  family  members  become  involved  in  the  feeding  of  their 
young  children. 
By  the  mid-  I  960s  only  25%  of  mothers  were  breast  feeding  as  artificial  feeds 
became  more  convenient  and  refrigerators  were  available  for  storing  pre- 
prepared  feeds.  Doctors  were  influenced  by  commercial  claims  of  the 
increased  nutritional  value  of  fbrrnula  feeds  and  recommended  their  use.  Thus 
by  1970  the  number  of  breast-feeding  mothers  reached  a  low  of  less  than  20%. 
However,  problems  such  as  hypernatraemia,  hypocalcaemia  and 
hyperphosphataemia  due  to  differences  in  the  composition  of  human  and 
cow's  milk,  and  the  ever  present  risk  of  infection  in  bottle-fed  infants  still 
remained  to  be  resolved.  After  investigation  revealed  the  presence  of  specific 
antibodies  and  growth  factors  in  breast  milk  which  could  not  be  replicated  in 
formula  milks,  doctors  returned  to  recommending  mothers'  milk  as  the 
preferred  method  of  infant  feeding.  Consequently  the  number  of  women  breast 
feeding  at  birth  rose  to  over  60%,  with  most  continuing  to  breast  feed  for 
longer  periods.  However,  when  breast  feeding  was  not  possible  there  was  a 
need  for  a  safe,  highly  nutritious  artificial  substitute.  Manufacturers  have 
continued  to  develop  formulas  with  biochemical  compositions  closer  to 
mothers'  milk  using  new  food  processing  technology,  for  example  the  addition 
of  the  amino  acid  taurine.  Nevertheless,  in  1983,  all  manufacturers  agreed  a 
code  of  practice  which  ensured  that  breast  feeding  was  promoted,  on  all  their 
product  labels,  as  the  best  form  of  infant  feeding. 
2 More  recently,  attention  has  focused  on  the  fatty  acid  content  of  formula  milks: 
not  just  because  of  their  caloric  content  but  more  importantly,  because  it  has 
been  shown  that  certain  fatty  acids  are  essential  components  of  neural 
membranes  at  this  time  of  maximal  growth  and  development  of  the  human 
brain  (Martinez,  1989). 
1.2  The  human  brain 
The  human  brain  (Fig  1.1)  is  the  most  complex  organ  in  the  body,  a  product  of 
evolution  and  of  its  host's  environment.  It  is  unique  to  the  individual  and  its 
development  depends  on  external  stimuli  to  that  individual.  Yet,  it  is  unable  to 
function  without  support  from  the  other  organs  in  the  body. 
1.2.1.  Brain  anatomy 
The  human  brain  can  be  divided  into  three  main  parts,  namely  the  cerebral 
hemispheres,  the  cerebellum  and  the  brain-stem.  The  two  cerebral  hemispheres 
comprise  85%  of  the  brain  (by  weight).  They  are  highly  convoluted,  consisting 
of  ridges  known  as  gyri  and  valleys  called  sulci.  The  surface  layer  of  the 
hemispheres  is  known  as  the  cerebral  cortex.  The  cortex  is  about  2.5  mm  thick 
with  an  approximate  area  of  2400CM2  (adult  brain)  and  consists  of  neuronal 
cell  bodies,  their  dendrites  and  glial  cells.  The  cortex  is  also  referred  to  as  grey 
matter.  Axons  entering  the  cortex  as  well  as  those  leaving  it  form  the  white 
matter,  which  constitutes  the  major  part  of  the  sub-cortical  tissue  of  the 
hemispheres. 
Each  hemisphere  can  be  divided  into  four  lobes,  namely  the  frontal,  parietal, 
temporal  and  occipital.  The  frontal  lobe  constitutes  about  one  third  of  the 
hemispheric  surface  and  is  concerned  with  planning  ahead,  prediction,  and 
programming  for  an  individual's  needs.  The  part  of  the  hemisphere  below  the 
lateral  fissure  is  the  temporal  lobe,  the  uppermost  part  of  which  is  involved  in 
the  sense  of  hearing.  Much  of  the  remaining  lobe  may  be  involved  with  the 
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Figure  1.1  -  Main  structures  of  the  human  brain 
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forebrain  nuclei integration  of  multiple  sensory  functions  such  as  hearing,  sight  and  touch.  The 
parietal  lobe  lies  behind  the  central  sulcus.  Afferent  nerve  impulses 
propagated  in  response  to  the  sensations  of  pain,  temperature,  touch  and 
pressure  are  received  in  this  area  of  the  brain.  The  occipital  lobe  is  behind  the 
parietal  and  temporal  lobes.  Visual  information  is  processed  here  and  thus 
damage  to  this  area  results  in  partial  or  complete  blindness. 
In  humans,  sited  posterior  to  the  occipital  lobe,  the  cerebellum  at  10%  by 
weight  is  the  second  largest  portion  of  the  brain.  The  cerebellum  controls 
proprioreception  by  relaying  impulses  for  movement  from  the  motor  area  of 
the  cerebral  cortex  to  the  spinal  cord.  It  receives  impulses  from  the  muscles 
and  joints  that  are  being  activated  and  compares  them  with  the  instructions 
issued  from  the  motor  cortex,  so  that  adjustments  can  be  made.  The 
cerebellum  thus  is  neither  the  sole  initiator  of  movement  nor  a  simple  link  in 
the  chain  of  nerve  impulses,  but  a  site  for  re-routing  and  in  some  cases  refining 
instructions  for  movement.  There  is  evidence  that  the  cerebellum  can  store  a 
sequence  of  instructions  for  frequently  performed  movements  and  for  skilled 
repetitive  movements. 
1.2.2.  Brain  morphology 
Postnatal  growth  of  human  brain  is  rapid  with  a  threefold  increase  in  size  in 
the  first  year  of  life  from  an  average  weight  of  350g  at  birth  in  a  term  infant  to 
10OOg  by  the  end  of  the  first  year  of  life.  At  birth,  the  human  infant  has  its  full 
complement  of  nerve  cells  or  neurons  (100  billion).  The  growth  of  the  infant 
brain  is,  therefore,  a  result  of  growth  of  pre-existing  neurons  proliferation  of 
neuroglial  cells  and  the  process  of  myelination. 
A  neuron  has  a  cell  body  containing  a  nucleus,  endoplasmic  reticulum, 
mitochondria,  Golgi  body,  and  ribosomes.  Neurons  differ  from  other  cells  in 
the  body  by  having  axons  and  areas  of  dendritic  branching  protruding  from  the 
0. 
4 cell  body  which  enable  electrical  (or  electrochemical)  conduction. 
Myelination  is  the  "insulation"  of  these  axons  with  a  fatty  sheath.  Dendrites 
act  as  sites  for  synaptic  connections  with  other  nerve  cells  and  other  body  cells 
such  as  muscles. 
The  other  main  group  of  cells  present  in  the  brain  are  known  as  neuroglial  cells 
or  glia.  These  cells  differ  from  neurons  in  that  they  do  not  participate  in 
electrical  signalling.,  Glial  cells  outnumber  neurons  threefold  and  do  not  have 
axons  or  dendrites.  In  the  developing  brain  these  cells  are  thought  to  provide  a 
support  structure  for  the  migrating  neurons.  There  are  three  types  of  glial  cells 
in  the  central  nervous  system.  Astrocytes  are  characterised  by  a  star-like 
appearance  and  maintain  an  appropriate  chemical  environment  for  neuronal 
signalling.  Oligodendrocytes  are  the  cells  responsible  for  myelination  of 
axons.  Microglial-cells  are  smaller  and  are  thought  to  be  a  type  of  macrophage 
because  they  have  been  shown  to  proliferate  after  injury  to  the  nervous  system. 
The  entire  neuron  including  all  its  processes  is  bound  by  a  thin  plasma 
membrane  which  is  selectively  permeable  to  different  chemical  substances. 
This  is  important  in  the  maintenance  of  the  resting  electrical  potential  of  the 
neuron. 
1.2.3.  Brain  composition 
The  chemical  composition  of  the  brain  reflects  the  composition  of  its  cellular 
components.  At  birth,  approximately  90%  of  the  whole  brain  is  composed  of 
water.  The  remaining  ten  percent,  which  represents  the  so  called  dry  weight, 
is  mainly  lipid  and  protein  with  smaller  amounts  of  carbohydrate,  nucleic  acids 
and  hormones.  The  lipid  is  located  in  the  cell  membrane  structures  along  with 
proteins  which  are  also  found  in  the  membranes  of  intracellular  organelles. 
S 1.3.1.  Brain  lipids 
The  brain  has  the  second  highest  concentration  of  lipid  after  adipose  tissue  in 
the  human  body,  (60%  of  the  dry  weight)  which  is  important  in  the  structure 
and  function  of  brain  cell  membranes  (Stubbs  and  Smith,  1984).  There  are 
three  main  classes  of  lipids  present  in  brain  tissue  -  phospholipids,  glycolipids 
and  neutral  lipids. 
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Figure  1.2  Lipid  chemical  structures 
Phospholipids  are  the  main  constituents  of  membranes  and  are  found  in  large 
quantities  in  the  brain.  These  compounds  have  a  glycerol  backbone,  two  fatty 
acids  esterified  at  positions  I  and  2,  position  3  being  occupied  by  phosphoric 
6 acid  esterified  to  the  hydroxyl  group  and  an  alcohol  base  attached  to  the 
phosphate.  The  three  which  predominate  in  mammalian  neuronal  membranes 
are  phosphatidy1choline  (PC),  phosphatidylethanolamine  (PE)  and 
phosphatidylserine  (PS)  (Fig  1.2).  Others  found  in  lesser  amounts  but  which 
have  important  roles  include  phosphatidylinositol  (PI),  cardiolipin  and 
phosphatidylglycerol.  Sphingomyelin  (SPH)  (Fig  1.2),  generally  classified  as 
a  phospholipid,  contains  both  phosphoric  acid  and  a  ceramide;  a  combination 
of  the  amino  alcohol  sphingosine  and  a  fatty  acid. 
I 
Glycolipid  are  widely  distributed  in  all  tissues  including  nervous  tissue.  They 
are  the  combination  of  a  ceramide  and  carbohydrate.  The  most  important 
glycolipid  in  brain  is  galactocerebroside  (GalCer).  The  fatty  acid  composition 
of  cerebrosides  in  glial  cells  differs  from  that  found  in  neuronal  cells  (Abe  and 
Norton,  1974).  Neuronal  cerebrosides  contain  more  unsaturated  and  shorter 
chain  fatty  acids.  Sulphation  of  the  galactose  moiety  of  galactocerebroside 
produces  sulphatides  (SU)  which  are  also  present  in  myelin. 
Neutral  lipids  which  do  not  have  a  charge  property,  are  acylglycerols, 
cholesterol  and  cholesterol  esters.  Acylglycerols  (Fig  1.2)  are  esters  of 
glycerol  and  fatty  acids  and  are  named  according  to  the  number  of  fatty  acids 
esterified  to  the  glycerol  e.  g.  tripalmitin  has  three  palmtic  acid  molecules 
attached  to  the  glycerol  backbone.  While  nervous  tissue  contains  little 
triacylglycerol  or  cholesterol  esters  (McMurray,  1983),  cholesterol  is  a  major 
and  important  constituent  of  brain  membranes  and  plays  an  important  role  as  a 
metabolic  intermediate.  It  has  a  polycyclic  ring  structure  and  acts  as  a 
precursor  for  steroid  hormones  and  bile  acids. 
1.3.2.  Lipid  cOmPosition  of  brain 
Analysis  of  brain  lipids  in  rats  (Cuzner  and  Davison,  1968),  in  pigs 
(Dickerson  and  Dobbing,  1966)  and  in  several  vertebrate  species  (Rouser, 
7 1971)  showed  that  brain  lipid  composition  changes  significantly  with  the 
stage  of  development.  Lipid  composition  of  normal  human  brain  was 
analysed  by  O'Brien  and  Sampson  (1965)  who  demonstrated  that  absolute 
concentrations  of  all  phospholipids  increase  during  development. 
Svennerholin  and  Vanier  (1972)  studied  the  lipid  composition  of  cerebral  grey 
and  white  matter  of  fetal  and  infant  brains  up  to  two  years  of  age.  Absolute 
concentrations  of  cholesterol  and  total  phospholipids  increased  rapidly  in  white 
matter  after  birth.  In  grey  matter  total  phospholipids  also  increased  with  age 
but  less  dramatically,  whereas  cholesterol  concentration  was  unchanged. 
Similarly  they  found  that  the  concentrations  of  cerebrosides  and  sulphatides  to 
increase  in  both  grey  and  white  matter.  These  glycolipids  however  were  at 
much  higher  concentrations  in  the  white  matter  than  the  grey  at  two  years  of 
age.  Within  the  phospholipids,  PC  concentrations  decreased  in  both  grey  and 
white  matter  during  the  first  year  of  life.  Conversely  sphingomyelin  increased 
and  PE  and  PS  concentrations  remained  constant  over  the  time  period. 
1.3.3.  Synthesis  of  brain  lipids 
Cholesterol  is  synthesised  by  brain  tissue  during  development  and  myelination 
(Cuzner  and  Davison,  1968).  Edmond  et  aL  (1991)  also  using  the  rat  model 
and  exogenous  deuterated  cholesterol  demonstrated  that  all  cholesterol 
required  by  the  developing  brain  is  synthesised  de  novo  in  the  brain. 
The  major  pathways  for  the  biosynthesis  of  phospholipids  are  illustrated  in  Fig 
1.3.  In  the  brain,  the  major  route  for  PC  synthesis  is  via  the  CDP-choline 
pathway.  This  is  favoured  over  the  alternative  base-exchange  conversion  of  PE 
to  PC.  Similarly,  although  four  different  pathways  exist  for  the  synthesis  of 
PE,  again  the  primary  pathway  is  by  de  novo  synthesis.  The  sole  pathway  for 
PS  production  in  the  brain  is  via  base  exchange  with  PE  (Yavin  and  Zeigler, 
1977).  Porcellati  demonstrated  that  in  nervous  tissue,  membrane-bound  base 
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Figure  1.3  -  Pathways  of  phospholipid  synthesis. 
exchange  enzymes  were  responsible  for  the  formation  of  the  three  main 
phospholipids  by  the  energy  independent  incorporation  of  the  appropriate 
alcohols.  (Porcellati  et  al,  1971).  PE  plasmalogens  are  also  a  major 
component  of  nervous  tissue  phospholipids.  They  differ  from  other 
phosphoglycerides  in  that  the  C,  fatty  acid  esterified  to  glycerol  is  in  the  form 
of  an  alkyl  chain  with  an  ether  linkage.  The  pathwhy  of  formation  of  the  ether 
linkage  in  plasmalogens  is  not  certain.  It  is  thought  that  the  most  likely 
mechanism  is  for  the  fatty  acid  to  be  incorporated  as  an  ester  linkage  which  is 
then  reduced  to  an  ether  group.  The  incorporation  of  the  ethanolamine  head 
group  has  been  shown  to  proceed  in  a  reaction  similar  to  that  already  described 
for  PE,  namely  the  transfer  from  the  CDP  derivative  (Ansell  and  Metcalfe, 
1971). 
9 Figure  1.4  summarises  the  pathways  for  synthesis  of  cerebrosides  and 
sulphatides.  Synthesis  of  these  compounds  occurs  by  sequential  addition  of 
glycosyl  monomers  transferred  from  sugar-nucleotide  donors  to  the  acceptor 
molecule.  A  sulphate  group  is  then  added  to  a  galactocerebroside  by  transfer 
from  the  sulphate  carrier,  3'-phosphoadenosine-5'-phosphosulphate  (PAPS)  to 
the  Y-hydroxyl  group  of  the  galactose. 
Ac3i  CoA  CoA  CDP-choline  CMP 
Sphingo.....,  --:  ý-,  -">Cemmide  Sphingomyelin 
UDP-galactose  (UDP 
if  PAPS 
Galactocerebroside  >  Sulphatide 
Figure  1.4  -  Synthesis  of  cerebrosides  and  sulphatides. 
1.3.4.  Catabolism  of  brain  lipids 
Phospholipids  present  in  cell  membranes  are  not  readily  hydrolysed  to  release 
fi7ee  fatty  acids.  However  they  can  be  catabolised  in  other  tissues  to  provide 
energy  in  extreme  circumstances.  The  breakdown  of  phospholipids  involves  a 
group  of  enzymes  known  as  phospholipases  which  are  widely  distributed  in 
animal  tissues  and  each  one  acts  at  a  specific  site  on  the  substrate  molecule. 
The  fatty  acid  -composition  of  intact  lipids  can  however  be  modified  by  a 
process  known  as  acyl  exchange.  Enzymes  can  exchange  existing  fatty  acyl 
groups  in  phospholipids  with  free  fatty  acyl  CoA  derivatives.  This  method 
can  enable  the  cell  to  adapt  to  different  conditions.  Fatty  acids  can  also  be 
released  from  triacylglycerols  or  phospholipids  by  positional  specific  lipases  or 
phospholipases  and  then  other  esterifying  enzymes  can  substitute  a  different 
fatty  acid.  Phospholipase  A  hydrolyses  diacylphospholipids  to  give  a  free  fatty 
acid  and  a  monoacylphospholipid.  The  enzymes  are  further  subdivided  into  A, 
10 and  A2  depending  on  whether  they  attack  the  fatty  acid  attached  to  the  C,  orC2 
glycerol  carbon  atom.  All  these  reactions  combine  to  determine  the  widely 
varying  compositions  of  the  various  phospholipids  in  the  cell  membranes  of 
different  tissues. 
1.4.1.  Fatty  acids 
Fatty  acids  are  major  components  in  brain  lipids.  They  consist  of  hydrocarbon 
chains  of  different  length  terminating  in  a  methyl  group  at  one  end  and  a 
carboxyl  group  at  the  other.  Most  naturally  occurring  fatty  acids  consist  of  an 
even  number  of  carbon  atoms.  The  number  of  intermediate  carbon  atoms  vary 
and  accordingly  they  can  be  classified  as  short,  medium  or  long  chain  fatty 
acids,  with  2  to  4,6  to  10  and  greater  than  10  carbon  atoms  respectively. 
Saturated  fatty  acids  have  no  double  bonds,  mono-unsaturated  one  double 
bond  and  polyunsaturated  two  or  more. 
In  general  polyunsaturated  fatty  acids  have  a  cis  configuration  at  each  double 
bond  which  produces  "coiling"  of  the  hydrocarbon  backbone  and  resultant 
reduction  in  fatty  acid  length  (Fig  1.5).  Incorporation  of  trans  double  bonds 
establishes  a  linear  structure  of  the  fatty  acid  and  endows  it  with  properties 
similar  to  the  corresponding  saturated  fatty  acid.  The  most  important 
unsaturated  fatty  acids  can  be  categorised  into  three  main  families,  namely  n-3, 
n-6  and  n-9.  The  number  represents  the  position  of  the  first  double  bond  from 
the  methyl  end  of  the  molecule.  Double  bonds  are  formed  in  desaturation 
reactions  catalysed  by  a  site  specific  enzyme,  represented  by  the  Greek  letter 
delta  (A).  The  numbering  for  the  site  of  action  of  these  enzymes  is  taken  from 
the  position  of  the  double  bond  in  relation  to  the  carboxyl  end  of  the  molecule 
(Fig  1.6). 
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Figure  1.5  -  Proposed  molecular  structure  of  a  typical  cerebral 
phospholipid n69 
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Figure  1.6  -  Nomenclature  of  fatty  acids. 
Oleic  acid  (C18:  ln-9),  linoleic  acid  (C18:  2n-6)  and  (x-linolenic  acid 
(C18:  3n-3)  are  considered  to  be  the  parent  molecules  for  the  three  different 
families.  Oleic  acid,  however,  is  not  an  essential  fatty  acid  as  animals, 
including  humans,  can  introduce  a  double  bond,  or  desaturate  at  the  A9 
position  in  saturated  stearic  acid  (C18:  0).  Animals,  unlike  plants,  however  are 
unable  to  desaturate  beyond  the  A9  atom  towards  the  methyl  end  (Rivers  et  aL, 
1975).  Linoleic  acid  and  cc-linolenic  acid  (Fig  1.7)  are  considered  to  be 
essential  in  humans  and  therefore  must  be  provided  in  the  diet.  The  fatty 
acids  of  each  family  are  not  inter-convertible,  and  synthesis  of  the  longer  chain 
polyunsaturates  is  directly  dependent  on  the  supply  of  the  respective 
precursors. 
CH3(CH2)4CH=CHCH2CH=CH(CH2)7COOH 
Linoleic  acid 
CH3CH2CH=CHCH2CH=CHCH2CH=CH(CH2)7COOH 
ct-linolenic  acid 
Figure  1.7  -  Chemical  structures  of  the  essential  fatty  acids. 
1.4.2.  Dietary  sources  of  fatty  acids 
Linoleic  acid  and  a-linolcnic  acid  are  synthesised  in  plants,  fungi  and  bacteria. 
They  are  both  found  in  abundance  in  plant  leaves  and  seeds  (Hitchcock  and 
Nichols,  1971).  Table  1.1  illustrates  linoleic  acid  and  cE-linolenic  acid 
12 concentrations  in  various  terrestrial  and  marine  plants  along  with  some  fish. 
Also  shown  in  the  table  are  arachidonic  acid  and  docosahexaenoic  acid 
concentrations,  the  latter  being  especially  rich  in  marine  plants  and  animals 
(Cunnane  et  aL,  1993). 
Table  1.1  -  Polyunsaturated  fatty  acid  composition  (weight  %  of  total 
fatty  acids)  of  terrestrial  plants,  seed  oils,  marine  plants  and  fish. 
Linoleic  Arachidonic  a-finolenic  Docosahmenoic 
Terrestrial  Plants 
Leaves 
Rye  Grass  14.3  33.8 
Oak  12.2  -  57.1 
Beech  15.9  -  51.9 
Seeds 
Grass  49.0  -  0.4 
Oak  52.7  -  11.6 
Beech  54.4  -  1.9 
Flax  15.0  -  58.2 
Seed  Oils 
Com  50.0  -  2.0 
Olive  11.5  -  0.8 
Soyabean  52.0  -  7.0 
Sunflower  52.0  -  0.2 
Marine  Plants 
Phytoplankton  0.8  0.7  0.3  10.5 
Algae  1.2  12.4  2.6  0.8 
Fish 
Mollusc  0.9  2.3  1.3  22.0 
Squid  0.5  5.8  0.8  21.3 
Herring  0.2  0.6  0.1  23.0 
13 1.4.3.  Dietary  sources  of  fatty  acids  for  the  infant 
In  1982,  the  European  Society  of  Pediatric  Gastroenterology  and  Nutrition 
(ESPGAN)  committee  report  on  guidelines  for  infant  nutrition  stated  that 
"human  milk  is  assumed  to  be  the  ideal  food  for  the  infant  at  least  up  to  the  age 
of  5  or  6  months,  ensuring  optimal  growth  and  development.  "  The  composition 
of  breast  milk  is  unique  in  that  it  varies  from  day  to  day,  with  the  time  of  day 
and  with  maternal  diet  as  well  as  length  of  gestation.  The  infant's  energy 
requirements  must  sustain  adequate  growth  and  optimal  body  composition. 
The  average  calorific  content  of  human  milk  has  been  used  in  this  assessment. 
These  measurements  have  been  determined  using  expressed  breast  milk, 
however  Lucas  et  al.  (I  990a)  reported  that  there  may  be  an  overestimation  as 
the  fat  content  may  be  greater  in  expressed  milk  than  in  suckled  milk.  Since 
milk  manufacturers  take  account  of  expressed  milk  values  when  producing 
formula  milks,  this  may  explain  why  breast  fed  infants  grow  less  rapidly  than 
formula  fed  infants  despite  their  lower  total  daily  energy  expenditure  (Butte  et 
aL,  1990;  Heinig  et  aL,  1993). 
The  fat  content  of  human  milk  is  important  not  only  because  it  provides  more 
than  50%  of  the  energy  requirements  and  is  the  vehicle  for  fat  soluble 
vitamins,  but  also  because  lipids  are  precursors  of  prostaglandins  and 
hormones,  and  are  essential  constituents  of  all  cell  membranes.  Lipids  are  the 
most  variable  component  of  human  milk.  Total  lipid  is  present  in  lower 
concentration  in  colostrum  than  in  mature  milk  (Bitman  et  al.,  1983)  as  well  as 
within  an  individual  feed  (low  in  fore  milk  and  high  in  hind  milk). 
Conversely,  cholesterol  and  phospholipids  are  high  in  colostrum  and  both 
decrease  to  lower  levels  in  mature  milk. 
Fat  in  milk  is  contained  within  membrane-enclosed  milk  fat  globules.  The  core 
of  the  globules  consists  of  triacylglycerols  (98  -  99%  of  total  milk  fat),  whereas 
the  globule  membrane  is  composed  mainly  of  phospholipids,  cholesterol  and 
14 proteins.  The  major  constituents  of  triacylglycerols  are  long  chain  fatty  acids 
derived  from  the  circulation.  Short  and  medium  chain  fatty  acids  are 
synthesised  by  the  fatty  acid  synthetase  complex.  Phospholipids  are 
synthesised  de  novo  within  the  mammary  gland  and  cholesterol  originates  from 
both  de  novo  synthesis  and  from  the  circulation.  The  amount  and  composition 
of  fatty  acids  in  milk  fat  is  the  final  product  of  the  processes  of  fat  digestion, 
absorption,  transport  in  the  circulation,  release  from  adipose  tissue  storage  and 
uptake  into  the  lactating  mammary  gland. 
Fatty  acids  in  breast  milk  triacylglycerols  have  a  highly  specific  positional 
distribution  (Martin  et  aL,  1993).  Seventy  to  seventy-five  percent  of  palmitic 
acid  is  esterified  at  the  sn-2  position  of  the  triacylglycerol  whereas  in  infant 
formulas,  palmitic  acid  derived  from  vegetable  oils  is  esterified  at  the  sn-I  and 
sn-3  positions  (Tomarelli  et  aL,  1968).  Stearic  and  oleic  acids  are  mainly 
located  at  the  sn-I  position  in  breast  milk  triacylglycerols,  whereas  linoleic 
acid  is  found  at  sn-I  and  sn-3.  LCPUFA  are  found  primarily  at  the  sn-2  and 
sn-3  positions  (Martin  et  al.,  1993).  The  result  of  these  stereospecific 
differences  is  that  triacylglycerols  derived  from  human  milk  are  assimilated 
more  readily  than  those  from  manufactured  sources. 
1.4.4.  Fatty  acid  digestion  and  absorption 
Dietary  fat  whether  that  from  breast  milk  or  formula  milk  is  mostly  in  the  form 
of  triacylglycerol.  The  digestion  and  absorption  of  fat  can  be  broken  down  into 
three  steps.  The  luminal  phase  where  triacylglycerols  are  hydrolysed  into  free 
fatty  acids,  monoacylglycerols  and  glycerol,  before  they  are  transferred  to  the 
intestinal  mucosa  :  this  involves  solubilisation  with  bile  salts.  The  mucosal 
phase  involves  the  re-esterification  of  the  free  fatty  acids  in  the  enterocytes. 
Here  they  are  combined  with  chylomicrons  and  very  low  density  lipoproteins 
before  release  into  the  blood  stream.  In  the  transport  and  delivery  phases,  the 
11poproteins  are  taken  up  selectively  by  individual  tissues  (Fig  1.8). 
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Figure  1.8  -  Digestion  and  absorption  of  fatty  acids The  hydrolysis  of  triacylglycerols  in  the  luminal  phase  depends  on  a  series  of 
lipases.  The  first,  lingual  lipase,  is  secreted  by  the  serous  glands  of  the  tongue 
(Hamosh  and  Bums,  1977).  This  enzyme  degrades  medium  and  short  chain 
triacylglycerols  in  the  stomach.  Gastric  lipase  is  also  found  in  the  stomach  and 
acts  similarly  on  medium  and  short  chain  triacylglycerols.  Further  digestion 
then  takes  place  in  the  small  intestine  through  the  action  of  pancreatic  lipase. 
This  enzyme  is  relatively  inactive  in  the  new-bom,  especially  in  pretenn 
infants  (Thomson  et  aL,  1989).  In  addition,  infants  have  reduced 
concentrations  of  bile  salts  necessary  for  emulsification  of  the  digested  fat 
(Watkins,  1975). 
Breast-fed  infants  are  uniquely  provided  with  an  additional  digestive  enzyme 
known  as  bile-salt  stimulated  lipase  (BSSL)  which  hydrolysed  triacylglycerols 
at  all  three  fatty  acid  positions.  Chen  et  aL  (1994)  demonstrated  that  without 
this  enzyme  there  was  incomplete  hydrolysis  of  triacylglycerols  containing 
arachidonic  acid  or  DHA.  All  four  lipases  are  necessary  for  complete 
digestion  of  milk  triacylglycerols  in  infants  (Berriback  et  aL,  1990). 
In  recent  years  workers  have  studied  the  digestion  of  dietary  fats  with  respect 
to  their  fatty  acid  composition.  Chen  et  aL  (1987)  investigated  the  uptake  of 
n-3  fatty  acids  from  triacylglycerol  by  introducing  aqueous  emulsions  of  oleic 
acid  or  different  oil  concentrates,  namely  corn  oil,  menhaden  oil  or  fish  oil 
directly  into  the  duodenum  of  rats.  The  total  recovery  of  fatty  acids  from  n-3 
rich  oils  was  less  than  50%  of  that  obtained  from  n-6  rich  maize  oil.  El 
Boustani  et  aL  (1987)  performed  a  similar  study  in  humans  where  they 
compared  the  absorption  of  ethyl  ester  of  eicosapentaenoic  acid  (EPA;  C20:  5 
n-3)  with  the  free  fatty  acid  or  other  esterified  forms.  Lawson  and  Hughes 
(1988)  compared  the  absorption  of  fish  oil  fatty  acids  in  healthy  human  adults 
when  given  as  triacylglycerol  or  fi7ee  fatty  acids.  The  fish  oil  was  absorbed  at  a 
rate  of  95%  in  the  free  acid  form  but  the  absorption  of  EPA  and  DHA  was  less 
16 than  70%  from  triacylglycerol  and  only  20%  from  ethyl  esters.  This  may  be 
significant  when  considering  which  LCPUFA  should  be  added  to  formula 
milks. 
Long-chain  fatty  acids,  bile  salts  and  monoacylglycerols  form  micelles,  which 
move  easily  into  intestinal  cells.  They  difluse  to  the  surface  of  mucosal  cells 
and  deliver  the  digested  fat  for  absorption.  The  enterocyte  contains  A6  and  A9 
fatty  acid  desaturase  activity.  These  enzymes  may  modify  fatty  acids 
transported  out  of  the  enterocyte  (Garg  et  aL,  1988)  to  systemic  tissues  and 
the  brain. 
Transportation  through  the  blood-stream  requires  that  the  fatty  acids  and 
monoacylglycerols  are  reassembled  into  triacylglycerols,  combined  with 
proteins  and  phospholipids  to  form  lipoproteins.  Lipoproteins  can  be  classified 
according  to  composition,  method  of  isolation  or  physical  properties.  Their 
composition  differs  in  the  ratio  of  total  lipid  to  protein  and  also  in  the 
proportions  of  particular  lipids,  namely  triacylglycerols,  cholesterol,  cholesterol 
ester  and  phospholipids.  In  general  those  lipoproteins  thought  to  have  a 
beneficial  effect  on  human  metabolism  tend  to  contain  the  highest  percentages 
of  phospholipids  (and  protein)  and  hence  long  chain  polyunsaturated  fatty 
acids.  Shorter  chain  fatty  acids  (less  than  14  carbons)  can  also  be  bound  to 
albumin  in  the  plasma  and  transported  as  free  acids  in  the  circulation.  Tissues 
in  the  body  incorporate  different  lipids  dependent  on  their  specific 
requirements  for  structural  and  for  "energy  producing"  fatty  acids.  As  the 
brain  is  largely  fuelled  by  glucose  (and  ketone  bodies)  structural  fatty  acids  are 
preferentially  accreted  from  phospholipids  in  contrast  to  the  energy  providing 
adipose  tissue  stores  composed  predominantly  of  triacylglycerols. 
17 1.4.5.  Fatty  acid  biosynthesis 
Saturated  fatty  acids  can  be  synthesised  de  novo  from  acetyl  CoA  and  the  liver 
is  the  most  important  organ  for  such  synthesis.  It  has  two  systems  for  chain 
elongation.  In  the  mitochondria,  acetyl  CoA  is  used  in  the  presence  of  NADH 
or  NADPH  to  elongate  acetyl  CoA  derivatives.  Elongation  also  takes  place  in 
the  endoplasmic  reticulum  where  2-carbon  units  from  malonyl  CoA  are  made 
in  the  presence  of  NADH.  These  reactions  are  catalysed  by  a  number  of 
enzymes  that  form  a  multi-enzyme  complex  known  as  fatty  acid  synthetase. 
The  end  product  of  these  reactions  would  normally  be  palmitic  acid.  However, 
in  man  there  is  little  requirement  for  saturated  fatty  acid  synthesis  because  of 
adequate  dietary  supply. 
Mono-unsaturated  fatty  acids  are  formed  by  a  desaturation  reaction,  usually  at 
carbon  9,  by  a  A9  desaturase  enzyme.  Desaturation  is  NAD  dependent  and  the 
enzyme  complex  is  found  in  liver  microsomes,  although  it  is  also  found  in 
other  body  tissues.  Its  activity  is  decreased  by  fasting  (i.  e.  protein  and/or 
glucose  deprivation)  and  can  be  restored  by  protein  consumption  or  the 
administration  of  insulin  (Brenner,  1989). 
Plants,  unlike  animals,  can  insert  more  double  bonds  into  oleic  acid  between 
the  C-9  and  the  methyl  end  of  the  molecule.  Therefore  plants  form  linoleic 
acid  under  the  influence  of  a  12-desaturase  enzyme  and  cc-linolenic  acid  by  a 
15-desaturase  enzyme.  Both  of  these  systems  are  oxygen  dependent.  Marine 
algae  have  also  the  ability  to  effect  these  changes  and  therefore  form  PUFA 
with  5  and  6  double  bonds. 
Animals  do  not  possess  the  above  enzyme  systems.  They  must  have  linoleic 
and  (x-linolenic  acids  supplied  in  their  diet.  From  these  two  compounds  plus 
oleic  acid,  animals  produce  more  unsaturated  fatty  acids  by  chain  elongation. 
18 The  A6  desaturase  enzyme  is  responsible  for  the  introduction  of  a  double  bond 
at  position  6  in  each  of  these  three  fatty  acids.  All  three  fatty  acids  can 
compete  for  the  same  enzyme  (Brenner  and  Peluffo,  1968).  The  reaction  rates, 
however,  differ  in  that  cc-linolenic  acid  is  preferred  before  linoleic  acid  and 
then  lastly  oleic  acid.  (Mohrhauer  and  Holman,  1963).  The  activity  of  the  A6 
desaturase  varies  between  species  and  in  individual  tissues  of  one  species,  but 
is  now  not  thought  to  be  rate-limiting  in  the  synthesis  of  PUFA  in  humans 
(Poisson  el  aL,  1993).  A5  desaturase  inserts  a  double  bond  between  carbon 
atoms  5  and  6  and  its  distribution  in  tissues  tends  to  be  similar  to  that  of  A6 
desaturase.  The  enzyme  also  responds  to  dietary  changes  and  hormones 
similarly  to  those  described  for  A6  desaturase  (Brenner,  1989). 
Until  recently,  a  A4  desaturase  system  was  thought  to  be  responsible  for  the 
formation  of  docosapentaenoic  acid  (DPA;  C22:  5n-6)  and  DHA.  However 
microsomal  preparations  and  all  culture  preparations  in  vitro  showed  little  A4 
desaturase  activity  using  appropriate  fatty  acid  substrates. 
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Figure  1.9  -  Desaturation-elongation  pathways  for  synthesis  of 
polyunsaturated  fatty  acids  including  alternative  pathway. 
19 Voss  et  at  (1991)  using  rat  liver  preparations  demonstrated  an  alternative 
route  for  the  formation  of  these  compounds  via  chain  elongation  to  C24:  4n-6 
and  C24:  5n-3  from  C22:  4n-6  and  C22:  5n-3  followed  by  a  desaturation  by  a  A6 
desaturase  enzyme  to  C24:  5n-6  and  C24:  6n-3  (Fig  1.9).  Subsequently  this 
new  pathway  was  confirmed  using  human  skin  fibroblasts  (Moore  et  at, 
1995).  These  reactions  have  been  shown  to  occur  in  the  endoplasmic 
reticulum.  In  the  peroxisomes  a  P-oxidation  step  then  leads  to  the  formation  of 
C22:  5n-6  and  C22:  6n-3.  This  to  some  extent  explains  the  findings  by  Martinez 
(1992a)  of  low  levels  of  DRA  in  tissues  of  adrenoleukodystrophy  (ALD) 
patients  who  are  known  to  have  a  defect  in  peroxisomal  metabolism. 
It  is  well  known  that  chain  elongation  occurs  more  rapidly  than  desaturation 
and  therefore  it  can  be  deduced  that  the  regulation  of  fatty  acid  synthesis  is 
dependent  on  desaturation  reaction  rates  (Voss  et  aL,  199  1). 
1.4.6.  Supply  of  fatty  acids  to  the  fetus  in  utero 
The  placenta  is  involved  in  providing  nutrients  for  the  developing  fetus  and 
also  deals  with  the  metabolic  waste  formed  by  the  fetus.  It  is  also  capable  of 
metabolic  activities  including  glycolysis,  gluconeogenesis,  triglyceride 
synthesis,  and  fatty  acid  synthesis  and  oxidation  (Hay,  1991).  The  placenta 
has  been  shown  to  be  "permeable"  to  free  fatty  acids  but  not  to  phospholipids 
and  triacylglycerols  (Feldman  et  aL,  1992).  Linoleic  acid  has  been  found  in 
fetal  plasma,  and,  as  this  can  only  be  provided  by  diet,  it  would  indicate  a 
placental  transfer  of  fatty  acids  (Robertson  and  Sprecher,  1968).  This  group  of 
workers  also  demonstrated  that  the  placenta  was  capable  of  synthesising  most 
lipid  classes  de  novo,  as  well  as  having  the  ability  to  alter  the  composition  of 
certain  lipids.  The  human  placenta,  however,  has  limited  ability  to  elongate 
and  desaturate  linoleic  and  a-linolenic  acids  (Kuhn  and  Crawford,  1986). 
Placental  membrane  fatty  acid  binding  protein  has  been  shown  to  have  a  role 
in  the  preferential  transfer  of  maternal  LCPUFA  across  the  human  placenta. 
20 Campbell  et  aL  (1998)  demonstrated  that  this  protein  had  higher  affinities  and 
binding  capacities  for  AA  and  DRA  compared  with  linoleic  and  oleic  acids. 
Fetal  brain  concentrations  of  AA  and  DHA  rise  with  increasing  gestational 
age  (Menon  and  Dhopeshwarkar,  1982;  Martinez  et  aL,  1974).  This  could  be 
due  to  the  preferential  transfer  of  these  acids  from  matemal  to  fetal  circulation 
for  membrane  incorporation.  Crawford  et  aL  (1976)  proposed  a  process, 
which  they  referred  to  as  biomagnification,  in  which  there  is  a  progressive 
increase  in  LCPUFA  from  matemal  blood  to  fetal  blood,  fetal  liver  and  fetal 
brain.  Neuringer  el  al.  (1984)  demonstrated  the  effect  in  monkeys  where  the 
levels  of  AA  and  DRA  were  higher  in  foetal  blood  than  in  matemal  blood:  the 
converse  was  found  for  levels  of  linoleic  acid  and  (x-linolenic  acid. 
Clandinin  el  aL  (1980)  suggested  that  80%  of  fetal  brain  DHA  accrued 
between  26  and  40  weeks  of  gestation.  They  reported  low  levels  of  DHA  in 
the  brains  of  infants  born  before  32  weeks.  This  is  an  important  finding  in 
relation  to  the  feeding  of  preterin  infants. 
1.5.1.  Essential  fatty  acid  deficiency  disease  states 
The  first  report  of  a  deficiency  in  essential  fatty  acids  was  described  by  Burr 
and  Burr  in  1929.  An  acute  deficiency  state  in  rats  fed  fat-free  diets  was 
characterised  by  skin  lesions,  where  the  skin  became  more  porous  to  water, 
growth  retardation  and  impairment  of  reproduction.  Moreover,  these 
deficiencies  could  be  corrected  when  certain  fatty  acids  were  added  to  the  diet 
and  as  a  result  they  showed  that  linoleic  acid  was  an  essential  fatty  acid.  In 
1937,  Turpeinen  demonstrated  that  arachidonic  acid  was  even  more  active  in 
reversing  the  induced  deficiency  state  than  linoleic  acid. 
Evidence  for  a  human  requirement  for  linoleic  acid  was  first  described  by 
Hansen  el  aL  (1963).  They  showed  that  infants  fed  on  different  milk  formulas 
21 containing  low  levels  of  linoleic  acid  developed  dermatitis  which  could  be 
cured  by  the  addition  of  linoleic  or  arachidonic  acid.  In  the  1970s,  two 
studies  reported  similar  deficiencies  in  infants  fed  with  low-fat  intravenous 
nutrition  (Caldwell  et  aL,  1972;  White  et  aL,  1973).  "  A  case  of  n-3  fatty  acid 
deficiency  was  reported  by  Holman  et  aL  in  1982,  in  a  six  year  old  girl 
receiving  parenteral  nutrition  for  several  months  following  gastrointestinal 
surgery.  She  subsequently  developed  severe  neurological  abnormalities 
including  sensory,  motor  and  visual  defects.  The  initial  dietary  preparation 
contained  very  high  amounts  of  linoleic  acid  and  almost  no  cc-linolenic  acid. 
When  an  cc-linolenic  acid  supplement  was  added  the  symptoms  disappeared. 
In  1987,  Norwegian  workers  (Bjerve  et  aL)  reported  that  a  group  of  elderly 
patients  fed  by  gastric  tube  displayed  symptoms  associated  with  a-linolenic 
acid  deficiency. 
There  have  been  other  disease  states  linked  with  reduced  levels  of  these  and 
other  polyunsaturated  fatty  acids.  Menkes  et  aL  (1962)  described  a  disease 
known  as  "kinky  hair  disease"  which  was  characterised  by  peculiar,  stubby 
white  hair,  cerebral  and  cerebellar  degeneration,  early  and  severe  mental 
retardation  and  severe  neurological  impairment  starting  within  the  first  months 
of  life.  Analysis  of  the  brains  of  these  infants  showed  that  the  DHA  levels 
were  very  low  in  PS  and  partially  reduced  in  PE.  Svennerholm  et  aL  (1975) 
described  a  progressive  neuropathy  in  which  cerebral  DHA  decreased 
especially  in  PE  and  PS  and  arachidonic  acid  increased.  Other  workers  (Gerstl 
el  aL,,  1965)  described  a  decrease  in  total  polyunsaturated  fatty  acids  in  white 
matter  of  patients  with  multiple  sclerosis.  McAlpine  et  aL  (1972)  suggested 
that  there  may  be  an  inverse  relationship  between  high  dietary  intake  of  n-3 
fatty  acids  and  multiple  sclerosis,  because  in  Japan  where  fish  consumption 
is  high,  there  is  a  low  incidence  of  the  disease.  Also  within  Norway  a  similar 
effect  is  seen  when  comparing  the  population  of  coastal  regions  and  urbanised 
centres.  As  previously  stated,  Martinez  (1992a)  has  reported  low  levels  of 
22 DRA  in  the  brains  of  patients  with  adrenoleukodystrophy,  a  metabolic  disorder 
involving  defective  peroxisomal  metabolism. 
1.5.2.  Animal  studies  using  radio-labelled  substrates 
Radio-labelling  studies  using  animal  models  were  carried  out  in  the  early 
1970s  to  elucidate  fatty  acid  metabolic  pathways.  Mead  and  Dhopeshwarkar 
(197  1)  injected  "C  labelled  acetate  into  rats  of  varying  ages.  Their  results 
showed  that  synthesis  of  fatty  acids  in  the  brain  is  very  rapid  in  the  pre- 
myelination  animal  but  falls  off  to  a  steady  state  in  the  adult  rat.  Hassarn  et 
aL  (1974)  studied  the  incorporation  of  orally  fed  linoleic  acid  and  y-linolenic 
acid  showing  that  A6-desaturation  of  linoleic  to  y-linolenic  acid  was  a  rate 
limiting  step  in  the  conversion  to  arachidonic  acid.  Subsequently  Sinclair 
(1975)  demonstrated  using  oral  feeding  of  "C  labelled  precursor  C18  fatty 
acids  and  AA  and  DHA,  that  dietary  rather  than  synthesised  LCPUFAs  were 
preferentially  incorporated  into  the  developing  rat  brain. 
More  recently,  similar  studies  were  performed  on  near-term  fetal  rat  brains, 
when  "C  labelled  fatty  acids  were  introduced  by  the  intra-cranial  route  (Green 
and  Yavin,  1993).  It  was  concluded  that  the  fetal  brain  had  the  capacity  to 
take  up,  convert,  and  selectively  esterify  essential  fatty  acids  and  their  long- 
chain  derivatives  into  phospholipids.  Pawlosky  et  aL  (1996)  examined 
different  areas  of  the  brain  in  neonatal  rats  and  mice  to  study  the  uptake  of 
radio-labelled  linoleic  and  cc-linolenic  acids.  They  found  a  greater  uptake  of 
a-linolenic  acid  into  the  cerebellum  as  compared  to  the  cortex  whereas  uptake 
of  linoleic  acid  did  not  vary.  Their  results  indicated  that  different  regions 
within  the  brain  may  vary  in  their  capacity  to  synthesise  DHA  and  this  may 
correlate  with  variation  in  regional  growth  rates. 
23 1.5.3.  Animal  studies  inducing  EFA  deficiency  states 
Following  on  from  humans  studies  ,  several  groups  of  workers  returned  to 
animal  models  to  measure  tissue  levels  of  fatty  acids  with  respect  to  EFA- 
deficient  diets. 
Essential  fatty  acid  deficiency  in  animals  has  been  shown  to  produce  increased 
tissue  concentrations  of  n-9  series  PUFA  synthesised  from  oleic  acid  in  an 
attempt  to  "compensate"  for  the  reduction  in  LCPUFA  of  the  n-3  and  n-6 
series  (Mead  and  Slaton,  1956).  When  n-9  series  PUFA  were  identified  in 
significant  amounts,  animals  displayed  clinical  symptoms  of  fat  deficiency 
(Mohrhauer  and  Holman,  1963).  Clausen  and  Moller  in  1967  reported  that  rat 
brains  could  be  made  susceptible  to  an  induced  autoimmune  attack  by 
depleting  their  membranes  through  dietary  deficiency  of  essential  fatty  acids 
and  that  PUFA  were  essential  for  the  integrity  of  the  neural  membrane.  Galli 
et  aL  (1970)  also  noted  reduced  body  and  brain  weight  in  EFA-deficient 
animals  when  compared  with  a  control  group  and  that  the  n-9  series  PUFA 
were  more  abundant  in  the  males.  Sun  (1972)  examined  brain  myelin  and 
microsomal  phosphoglyceride  fractions  in  rats  given  EFA  deficient  diets, 
confirming  Galli's  findings  and  concluding  that  such  alterations  to  membrane 
structure  could  ultimately  lead  to  demyelination  in  addition  to  disturbances  in 
enzyme  activity  in  the  microsomal  membranes. 
In  1984,  Bourre  et  aL  presented  their  first  in  a  series  of  publications  using 
the  rat  as  an  animal  model.  In  the  initial  study  ,  several  generations  of  rats 
were  fed  a  diet  deficient  in  n-3  fatty  acids.  Sunflower  oil  provided  the  n-3 
deficient  feed  whereas  n-3  rich  soyabean  (Table  1.1)  or  rapeseed  oil  were 
given  to  a  control  group.  They  measured  the  fatty  acid  composition  of  various 
neural  cell  types  (neurons,  astrocytes  and  oligodendrocytes)  as  well  as 
subcellular  fiuctions  (myelin  and  synaptosomes)  and  showed  a  deficiency  of 
DHA  which  was  associated  with  an  increase  in  n-6  series  DPA  concentrations. 
24 They  repeated  the  experiment  by  feeding  the  rats  for  only  60  days  and  the 
same  findings  were  observed.  The  n-3  diet  was  then  re-introduced, 
whereupon,  it  took  several  months  for  the  cells  to  recover  their  normal  levels 
of  DRA  at  the  expense  of  n-6  DPA.  The  authors  also  demonstrated  a 
reduction  in  certain  enzyme  activities,  namely  5'-nucleotidase  and  Na-K- 
ATPase,  in  n-3  deficient  animals  (Bourre  et  aL,  1989). 
Anding  and  Hwang  (1986)  used  coconut  oil  (low  in  n-3  fatty  acids)  to  induce 
EFA  deficiency  in  weanling  rats.  After  15  weeks,  graded  amounts  of  a- 
linolenic  acid  with  constant  linoleic  acid  were  re-introduced  to  the  diet. 
Increasing  dietary  cc-linolenic  acid  resulted  in  a  decrease  in  the  n-6  series 
PUFA  in  brain  lipid  suggesting  an  inhibition  of  the  conversion  of  linoleic  acid 
to  arachidonic  acid. 
Carlson  et  aL  (1986)  studied  cerebrum  and  cerebellum  fatty  acids  of  PC  and 
PE  and  also  red  cell  membrane  fatty  acids  from  rats  fed  diets  with  varying 
ratios  of  linoleic  and  cc-linolenic  acids.  These  authors  suggested  that  red  cell 
membrane  composition  could  be  used  as  an  indicator  of  neural  accumulation 
ofLCPUFA. 
Connor  et  aL  (1990)  used  rhesus  monkeys  as  a  primate  model  to  study  fatty 
acid  metabolism.  Initially  the  monkeys  were  fed  n-3  deficient  diets  and  were 
shown  to  have  low  levels  of  DHA  in  the  cerebral  cortex  and  retina  with  a 
compensatory  rise  in  n-6  series  DPA.  Low  levels  of  DHA  were  "corrected" 
by  12  weeks  after  fish  oil  was  introduced  to  their  diet. 
Piglets  have  also  been  used  as  an  animal  model  (Arbuckle  and  Innis,  1992) 
because  the  timing  of  their  perinatal  brain  growth  spurt  resembles  that 
observed  in  humans.  In  addition,  the  fatty-  acid  composition  of  a  sow's  milk 
resembles  human  breast  milk.  The  authors  examined  the  effect  of  feeding 
25 piglets  fi7om  birth  for  15  days  with  linolenate  at  two  different  levels  or  fish  oil 
and  low  level  linolenate  in  combination.  They  concluded  that  dietary  n-3 
PUFA  from  fish  oil  were  more  effective  as  a  source  of  membrane  n-3  fatty 
acids  than  their  precursor,  a-linolenic  acid. 
1.5.4.  Red  cell  membrane  fatty  acids  in  relation  to  diet 
Many  workers  have  reported  measurement  of  red  cell  membrane  fatty  acids 
and  plasma  fatty  acids  in  relation  to  infant  diet.  The  studies  have  been  on 
both  pretenn  and  term  children  and  diets  have  included  breast  milk,  standard 
formulas  and  supplemented  formulas. 
As  early  as  1971,  Olegard  and  Svennerholm  showed  that  the  red  cell 
membrane  fatty  acids  of  breast-fed  babies  at  3  to  4  months  of  age  had  a  greater 
proportion  of  n-3  to  n-6  fatty  acids  when  compared  to  formula  fed  infants. 
This  work  was  confirmed  by  several  other  groups  of  workers.  (Sanders  and 
Naismith,  1979;  Putnam  et  aL,  1982;  Ponder  and  Innes.,  1992)  Moreover 
pretenn  infants  fed  standard  preterm  formulas  had  significantly  lower  DHA 
levels  in  both  red  cell  membrane  phospholipids  and  plasma  lipids  than  infants 
fed  breast  milk  (Carlson  and  Rhodes.,  1986b;  Koletzko  et  aL,  1989). 
Various  groups  then  began  to  study  the  effect  of  the  addition  of  LCPUFA  to 
standard  formulas  on  red  cell  membrane  fatty  acid  concentrations  while  other 
workers  studied  the  effect  of  altered  ratios  of  n-3  to  n-6  fatty  acids  in  the 
formula  milks. 
Carlson  et  aL  (199  1)  showed  that  adding  small  amounts  of  fish  oil  to  standard 
formula  milk  produced  red  cell  membrane  phospholipid  DHA  levels  similar  to 
those  of  breast  fed  infants.  These  authors  also  observed  a  reduction  in  the 
arachidonic  acid  concentration  in  the  red  cell  membranes  of  infants  fed  the 
fish  oil  supplemented  formula.  This  was  a  concern  since  arachidonic  acid  is 
26 an  important  precursor  for  eicosanoid  metabolism  (Martinez,  1989)  and  also 
has  been  shown  to  be  positively  related  to  preterm  growth  in  the  first  year  of 
life  (Carlson  et  aL,  1993). 
Clark  et  aL  (1992)  examined  the  effect  of  varying  the  ratio  of  linoleic  acid/ 
a-linolenic  acid  in  infant  formulas.  They  found  that  decreasing  the  ratio  to 
<5:  1  increased  the  LCPUFA  incorporation  into  red  cell  membranes  but  the 
levels  of  DHA  and  AA  still  did  not  attain  those  found  in  breast  fed  infants. 
1.5.5.  Animal  behavioural  and  visual  studies 
In  animal  studies  several  aspects  of  behaviour  have  been  investigated  in 
relation  to  fatty  acid  content  of  the  diet.  Rats  fed  a  diet  deficient  in  n-3  fatty 
acids  showed  poorer  discriminatory  learning  between  black  and  white  stimuli 
compared  to  those  fed  an  n-3  rich  diet  (Lamptey  and  Walker,  1976).  The 
authors  also  showed  that  this  correlated  with  reduced  levels  of  DHA  in  the 
brain  phospholipids  of  the  n-3  deficient  rats.  Yamamoto  et  al.  (1988)  observed 
differences  in  the  learning  ability  of  rats  fed  diets  either  supplemented  with 
safflower  seed  oil  (rich  in  linoleic  acid)  or  perilla  seed  oil  (rich  in  cc-linolenic 
acid).  They  used  a  brightness  discrimination  learning  test  and  showed  that  the 
group  fed  the  high  n-6  fatty  acid  diet  required  a  significantly  longer  time  for 
extinction  of  the  learning  test  than  the  group  fed  the  high  n-3  fatty  acid  diet  or 
than  a  group  fed  a  normal  diet.  Bourre,  etaL  (1989)  used  a  shuttle  box  test  as  a 
measure  of  learning  in  comparing  rats  fed  low  cc-linolenic  acid  diets  with  rats 
fed  a  normal  diet.  They  found  that  the  group  on  the  low  n-3  fatty  acid  diet 
were  significantly  slower  in  their  learning  ability  than  the  normally  fed  group. 
This  group  of  workers  also  studied  electroretinogram.  measurements  in  relation 
to  diet,  as  the  retina  is  very  rich  in  n-3  fatty  acids,  especially  DHA. 
Deficiencies  in  PUFA  result  in  modifications  of  membrane  fatty  acids  in  the 
retina,  which  can  be  measured  as  changes  to  the  a  and  b  waves  of  the 
27 electroretinogram.  The  results  obtained  revealed  substantial  changes  in  the 
ERG  of  the  n-3  deficient  animals  when  compared  to  the  control  group.  A 
similar  finding  had  already  been  reported  by  Neuringer  et  aL  (1986)  who  used 
rhesus  monkeys  as  a  study  model  and  compared  animals  fed  an  n-3  deficient 
diet  throughout  pregnancy  and  the  infants  receiving  a  similar  diet  after  birth. 
These  workers  observed  not  only  low  levels  of  DHA  in  the  retina  and  cerebral 
cortex  but  also  subnormal  visual  acuity  at  4-  12  weeks  of  age  and  impairment 
of  ERG  measured  at  21  months  of  age  when  compared  to  a  group  of  monkeys 
fed  normally.  These  results  were  observed  despite  a  compensatory  rise  in  n-6 
series  DPA  in  the  retina  as  well  as  the  cortex. 
1.6.1.  Aim  of  this  study 
This  study  is  designed  to  assess  whether  the  fatty  acid  composition  of  brain 
membranes  in  infants  dying  in  the  first  year  of  life  is  influenced  by  their  diet.  It 
is intended  to  study  different  areas  of  the  brain  namely  cerebral  and  cerebellar 
cortex  grey  and  white  matter. 
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MATERULS  AND  METHODS 2.1.  MATERIALS 
In  the  following  section  all  chemicals  and  standards  used  in  the  experimental 
procedures  are  listed  along  with  their  supplier. 
2.1.1.  Chemicals 
a)  Solvents 
The  following  solvents  were  used  in  extraction  procedures  and  thin  layer 
chromatography.  These  were  Analar  grade  unless  otherwise  specified  and 
obtained  fi7om  Merck  Ltd.,  Poo  le,  Dorset  UK- 
Solvent  Catalogue  No. 
Butan-l-ol  10061  6J 
Chloroform  10077  6B 
Diethyl  ether  10094  6B 
n-Hexane  10387  4X 
Methanol  10158  6B 
Methyl  Acetate(GPR  grade)  29202  4E 
Propan-2-ol  10224  Q 
Petroleum  spirit  (40-60  0  C)  10178  4F 
b)  Additional  chemicals 
Reagent  Catalogue  No. 
Acetic  acid  10001  BT 
Copper  acetate  10087  4C 
27  -dichlorofluorescein  20034  M 
Orthophosphoric  acid  10173  AB 
Potassium  chloride  10198  4L 
Sodium  chloride  10241  Q 
2,6-di-tert.  butyl  -p-cresol  (BHT)  (GPR)  28067  4T 
29 Reagent  Catalogue  No. 
Boron  trifluoride  in  methanol  (12  -  140/ow/v)  27419  4T 
Methanolic  HCI  3N  (Supelco)  3-3051 
c)  Lipid  standards 
Lipid  standards  for  TLC  identification  purposes  were  purchased  from  Sigma- 
Aldrich  Company  Ltd.,  Poole,  Dorset,  UK. 
Standard  Catalogue  No. 
L-cc-phosphatidylcholine  (from  bovine  brain)  P6638 
L-a-phosphatidylethanolamine  (from  bovine  brain)  P9137 
L-a-phosphatidylinositol  (from  bovine  liver)  P2517 
L-cc-phosphatidyl  -L-serine  (from  bovine  brain)  P6641 
Sphingomyelin  (from  bovine  brain)  S7004 
Tripalmitin  T5888 
Cholesteryl  stearate  C3549 
Galactocerebrosides  (from  bovine  brain)  C4905 
Sulphaticles  (from  bovine  brain)  S1006 
d)  Fatty  acid  standards 
Fatty  acids  methyl  esters  (FAME)  were  purchased  from  the  same  supplier. 
Standard  Catalogue  No.  Standard  Catalogue  No. 
Saturated  Fatty  Acids:  -  Monounsaturated  Fatty  Acids:  - 
C14:  0  Myristic  Acid  M3378  C14:  1n-5  MyristoleicAcid  M3650 
C16:  0  PalmiticAcid  P5177  C16:  ln-7  PalmitoleicAcid  P6087 
C  18:  0  Stearic  Acid  S5376  C18:  ln-9  OleicAcid  04754 
C20:  0  Arachidic  Acid  A3881  C20:  I  n-9  Eicosenoic  Acid  E6885 
C22:  0  Behenic  Acid  B3271  C22:  I  n-9  Erucic  Acid  E3510 
C24:  0  Lignoceric  Acid  L6766  C24:  I  n-9  Nervonic  Acid  N6767 
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Polyunsaturated  Fatty  Acids:  - 
C18:  2n-6  LinoleicAcid  L1876 
C18:  3n-6  a-Linolenic  Acid  L2626 
C20:  2n-6  Eicosadienoic  Acid  E7877 
C20:  3n-6  Eicosatrienoic  Acid  E3511 
C20:  3n-9  Eicosatrienoic  Acid  (Mead  Acid)  E6013 
C20An-6  Arachidonic  Acid  A9298 
C20:  5n-3  Eicosapentaenoic  Acid  E2012 
C22An-6  Docosatetraenoic  Acid  D3534 
C22:  5n-6  Docosapentaenoic  Acid  D5679 
C22:  6n-3  Docosahexaenoic  Acid  D2659 
An  additional  commercial  standard  was  also  purchased: 
Supelco  37  Component  FAME  Mix  4-7885 
Supelco  UK,  Sigma-Aldrich  Chemical  Company  Ltd.,  Poole,  Dorset,  UK. 
e)  Miscellaneous  items 
Item  Catalogue  No. 
TLC  plates  20cm  x  20  cm  Silica  Gel  60  F2.0.25mm.  5715 
obtained  from  Merck  Ltd.,  Poole,  Dorset,  UK. 
HPTLC  plates  10cm  x  10  cm  LHPK  Silica  Gel  60A  4805-410 
obtained  from  Whatman  International  Ltd.,  Maidstone,  Kent,  UK. 
2.1.2.  Tissue  samples 
Tissue  samples  were  taken  from  precise  loci  at  post-mortem.  from  66  subjects 
who  died  from  sudden  infant  death  syndrome.  In  addition,  the  pathologist's 
examination  excluded  any  other  cause  of  death.  Samples  of  cerebral  parietal 
cortex,  parietal  central  white  matter  (above  the  corpus  callosum)  and 
cerebellum  were  obtained.  Where  possible  cerebellar  tissue  was  also  separated 
31 Table  2.1  Infant  details  relating  to  age,  sex,  gestation,  feeding  regimen, 
birth,  body  and  brain  weights. 
Tissue  No.  Age 
(wk) 
Sex  Gestation  Feed  Group 
(wk) 
Birth 
Wt.  (kg) 
WL  at  death 
(kg) 
Brain 
Wt.  (mg) 
19/85  38  F  40  Breast  Breast  3.60  9.19  NR 
510/85  12  M  40  Ostermilk  CGOST  3.64  5.30  NR 
547/95  14  M  37  Cow&Gate  CGOST  1.90  4.25  660 
617/85  17  M  38  SMA  SMA  NR  8.42  710 
642/85  11  m  39  Osternfflk  CGOST  2.50  4.45  545 
85/86  24  F  40  SNIA  SMA  3.23  5.96  810 
181/86  10  F  40  Breast  Breast  3.24  5.61  652 
217/86  8  F  42  Breast  Breast  2.95  3.54  530 
219/86  7  M  40  SMA  SMA  3.12  4.52  NR 
249/86  18  m  42  SMA  SMA  3.63  6.44  785 
249/86  7  F  40  Breast  Breast  3.93  5.16  575 
602/86  34  M  34  SMA  SMA  Prem  2.33  6.69  1010 
630/86  16  F  40  SMA  SMA  3.94  5.96  820 
7/87  17  M  32  SMA  SMA  Prem  0.91  3.06  540 
38/87  13  M  37  SMA  SMA  2.98  5.78  750 
39/87  4  M  40  SMA  SMA  3.35  4.14  560 
277/87  18  m  37  SMA  SMA  2.21  5.60  670 
291/87  43  F  40  SMA  SMA  2.74  7.37  NR 
581/87  8  F  42  Breast  Breast  3.72  4.59  NR 
593/887  22  M  40  SMA  SMA  3.39  7.52  900 
657/87  10  m  30  SMA  SMA  Prem  1.27  2.95  465 
5/88  18  m  39  SMA  SMA  2.72  5.46  NR 
17/88  9  m  40  Cow&Gate  CGOST  2.67  4.82  680 
67/88  10  F  37  Ostermilk  CGOST  2.61  3.82  490 
133/88  6  M  40  SMA  SMA  3.75  4.89  590 
175/88  21  M  41  Ostermflk  CGOST  3.55  6.86  1030 
189/88  40  F  37  Cow&Gate  CGOST  2.28  5.08  890 
195/88  29  M  40  Cow&Gate  CGOST  3.35  8.02  930 
225/88  11  F  39  Breast  Breast  2.50  4.95  NR 
269/89  16  M  40  SMA  SMA  2.99  6.20  790 
288/88  25  M  32  SMA  SMA  Prem  1.76  7.48  840 
472/88  6  M  40  Breast  Breast  3.07  5.34  640 
2/89  5  1F  37  Breast  Breast  2.47  3.15  530 
32 Table  2.1  Infant  details  (continued) 
Tissue  No.  Age 
(wk) 
Sex  Gestation  I 
(wk) 
Feed  Group  Birth 
WQkg) 
WL  at  death 
(kg) 
Brain 
Wt.  (mg) 
457/89  16  M  40  Breast  Breast  3.66  7.71  780 
51/93  11  m  40  OstemiUk  CGOST  3.21  5.08  570 
75/93  19  m  40  Breast  Breast  4.14  7.55  740 
90/93  21  M  38  Cow&Gate  II  C&G  3.18  4.85  780 
103/93  6.5  F  37  Ostermilk  CGOST  2.50  3.58  520 
163/93  9  m  39  SNIA  SMA  2.58  4.59  645 
197/93  19  m  40  SMA  SMA  3.55  6.73  NR 
256/93  20  M  40  Ostennilk  CGOST  3.80  6.89  845 
263/93  18  M  40  Ostermilk  CGOST  2.04  4.56  605 
279/93  25  M  41  SMA  SMA  3.58  7.18  NR 
51/94  7  M  38  Ostennilk  CGOST  2.53  4.17  565 
81/94  15  m  39  Breast  Breast  2.90  4.17  660 
110/94  18  m  40  Breast/SMA  NEX  3.97  7.40  905 
164/94  33  F  38  Cow&Gate  H  C&G  3.01  8.45  920 
180/94  13  F  39  Cow&Gate  R  C&G  3.01  4.65  600 
193/94  11  m  37  SMA  SMA  2.81  5.02  605 
249/94  9  F  38  Ostennflk  CGOST  3.29  4.34  577 
275/94  5  m  39  Cow&Gate  11  C&G  2.71  3.99  572 
277/94  4  F  41  SMA  SMA  3.37  4.51  527 
283/94  7  M  37  SMA  SMA  2.70  4.41  NR 
333/94  19  F  34  Ostermilk  CGOST  Prem  2.58  5.45  631 
402/94  17  M  40  SMA  SMA  2.90  6.13  779 
447/94  15  m  38  SMA  SMA  2.98  6.02  NR 
48/95  9  F  41  Breast  Breast  3.97  5.40  570 
72/95  7  M  32  Breast/SMA  Mix  Prem  1.19  2.28  400 
114/95  7  F  36  SMA  SMA  Prem  2.04  3.01  470 
251/95  3  F  40  Breast  Breast  3.21  3.16  455 
266/95  0.5  M  38  SMA  SMA  2.80  2.56  380 
276/95  2  F  38  SMA  SMA  3.20  3.53  412 
382/95  1  F  40  Breast  Breast  3.09  2.55  425 
419/95  12  M  35  SMA  SMA  Prem  2.50  4.82  548 
429/95  1  23  M  34  SMA  SMA  Prem  2.27  6.86  802 
33 into  grey  and  white  matter.  Exclusion  criteria  were  based  on  identification  of 
significant  neurological  deficits  prior  to  death  (one  case  with  hypotonia  and 
aphasia)  or  brain  abnormalities  at  necropsy.  A  pathological  classification  of 
minor  gyral  flattening  in  the  parietal  region  (recorded  in  two  term-bom 
formula  fed  infants)  was  not  seen  as  sufficient  justification  for  exclusion.  A 
full  medical  and  dietary  history  was  established  by  inspection  of  police,  post- 
mortem  and  health  visitors'  reports.  Other  dietary  information  was  obtained 
from  the  responses  to  a  questionnaire  completed  at  parental  interview  (see 
appendix).  Individuals  were  classified  as  either  term  (ý:  37  weeks  gestation; 
n--57)  or  pretenn  (<37  weeks  gestation;  n--9).  A  birthweight  between  the  3  rd 
and  97  th  centiles  for  the  appropriate  gestational  age  defined  a  normally  grown 
term  infant  (Keen  and  Pearse,  1985)  and  applied  to  all  term-bom  subjects  in 
this  study.  Whenever  possible  tissue  samples  were  collected  within  48  hours 
of  death  and  stored  in  universal  containers  at  -701C.  Table  2.1  lists  all 
subjects  included  in  the  study  and  information  obtained  from  sources  as 
detailed  above. 
2.1.3.  Milk  feeds 
Infants  from  whom  brain  tissues  were  collected,  were  grouped  according  to 
which  type  of  milk  feed  they  received  during  life.  The  characteristics  of  each 
group  were  as  described  below. 
a)  Breast  feeding 
The  majority  (n=14)  of  this  group  were  exclusively  breast  fed.  However  the  7 
week  old  preterm  and  18  week  old  term  "breast  fed"  infants  had  also  received 
SMA  formula  supplementation  during  the  last  3  and  8  weeks  of  life 
respectively.  These  were  designated  as  mix-fed  infants. 
34 b)  SNIA  SMA,  Wyeth  Laboratories,  Maidenhead,  U.  K. 
This  group  of  infants  (n--3  1)  had  received  either  SMA  gold  cap  or  SMA  white 
cap  exclusively  or  in  some  cases  a  mixture  of  both.  These  formulas  contained 
identical  blends  of  fatty  acids  derived  from  vegetable  oils  and  animal  fats  but 
differed  in  casein:  whey  protein  ratios  and  therefore  amino  acid  compositions. 
The  were  devoid  of  long-chain  PUFAs  but  the  essential  fatty  acid  precursor, 
cc-linolenic  acid  was  present  at  a  concentration  of  1.5%  of  total  fatty  acids. 
c)  CGOST 
Infants  (n=15)  who  received  one  of  the  undermentioned  formula  milks  were 
combined  into  a  single  CGOST  group  because  their  linoleic  and  a-linolenic 
acid  concentrations  were  similar.  The  milks  did  not  contain  any  preformed 
long-chain  PUFAs  and  the  essential  fatty  acid  precursor,  cc-linolenic  acid,  was 
present  within  a  range  of  <0.  I-0.4%  of  total  fatty  acids.  The  milks  included 
in  this  group  are  listed  below: 
Cow  and  Gate  Premium  (pre  1990) 
Cow  and  Gate  Plus  (pre  1990) 
Farley's  Ostermilk  I 
Farley's  Ostermilk  2 
Cow&Gate  Ltd.,  Trowbridge,  U.  K. 
Heinz  Ltd.,  Nottingham,  UX 
(formerly  Crookes  Healthcare) 
d)  C&G  Cow&Gate  Ltd.,  Trowbridge,  U.  K. 
This  group  of  infants  (n=4)  had  received  a  new  formulation  of  Cow  &  Gate 
milk  with  an  increased  cc-linolenic  acid  content  (2.2%)  and  reduced  ratio  of 
linoleic:  cc-linolenic  acid  at  approximately  5:  1.  The  infants  were  fed  either  of 
the  milks  listed  below  or  a  combination  of  both: 
Cow  and  Gate  Premium  (post  1990) 
Cow  and  Gate  Plus  (post  1990) 
Seven  individuals  also  received  solids  in  their  diet  and  were  interspersed 
between  all  feeding  groups. 
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In  spite  of  the  extended  collection  period  of  tissues,  few  significant  changes 
occurred  in  any  of  the  formula  milks  in  respect  of  either  the  non-essential 
saturated  or  mono-unsaturated  fatty  acids  during  this  time  and  in  addition  the 
provision  of  linoleic  acid  remained  relatively  constant  at  between  II  to  20%  of 
total  fatty  acids.  A  summary  of  the  manufacturers'  quoted  values  for  the  fatty 
acid  content  of  milks  is  presented  in  Table  2.2.  This  is  followed  by  published 
ranges  for  human  breast  milk  fatty  acid  concentrations  (Table  2.3). 
Table  2.2  Formula  milk  fatty  acid  compositions  (weight  %  of 
total  ratty  acids)  as  quoted  by  manuracturers 
lFattyAcid  MilkDiet 
SMA  CGOST  CGOST  C&  G 
(1)  (2) 
1myristic  C14:  0  4.31  6.8  4.80  4.3 
Talmitic  C16:  0  21.70  21.0  16.01  17.7 
ýPaltnitoleic  C16:  In-7  0.12  0.5  trace  0.3 
'Stearic  CIS:  0  4.48  4.0  3.32  3.5 
, 
Oleic  CIS:  In-9  35.62  29.5  46.45  45.5 
linoleic  C18:  2n-6  18.92  17.1  11.87  11.4 
iýcx-Linolenic  CI8:  3n-3  1.80  0.4  üace  2.1 
'Dihomo-y-linolenic  C20:  3n-6  <0.05  <0.05  <0.05  <0.05 
'Arachidonic  C20:  4n-6  <0.05  <0.05  <0.05  <0.05 
iDocosahexaenoic  C22:  6n-3  <0.05  <0.05  <0.05  <0.05 
iArachidie  C20:  0  0.31  na  na  0.4 
iEicosenoic  C20:  In-9  0.21  na  <0.05  0.5 
Behenic  C22:  0  0.18  na  na  0.4 
lErucic  C22:  In-9  <0.05  na  <0.05  0.1  i! 
, 
Lignoceric  C24:  0  na  na  na  na 
'Nervonic  C24:  In-9  na  na  na  0.1 
SMA(Wyeth,  UK)  Gold  or  ViIite  Cap 
CGOST  (1)  -  Cow  &  Gate  Premium  or  Plus  (pre  1990) 
CGOST  (2)  -  Farley's  Ostermilk  2 
C&G  -  Cow  &  Gate  Premium  or  Plus  (post  1990) 
all  formula  fatty  acid  compositions  represent  manufacturers'  data. 
na  -  not  quoted  by  manufacturer. 
36 Table  2.3  Published  breast  milk  fatty  acid  compositions 
(weight  %  of  total  fatty  acids) 
lFaltyAcid  (1)  (2)  (3)  (4) 
n--5  n=61  n=14  n=26 
Myristic  C14:  0  4.14-12.66  2.73-8.53  7.48  4.01-16.09 
Talmitic  C16:  0  13.58-22.82  18.80-26.08  23.29  21.44-32.28: 
j, Palmitoleic  C16-In-7  1.72-4.69  2.49-5.09  3.90  1.97-6.47 
iStearic  c18:  0  2.64-8.96  6.34-12.06  8.61  2.75-5.43 
f 
,  Oleic  c18:  In-9  27.90-43.10  35.38-39.62  36.01  21.68-38.69' 
ýLinoleic  C18:  2n-6  0.7-21.9  2.31-19.19  9.96  7.60-10.08: 
. a-Linolenic  CI8:  3n-3  0.08-1.61  0.27-0.91  0.70  0.02-0.58 
: Dihomo-y-linolenie  C20:  3n-6  0.14-0.66  0.13-0.49  0.29  ud-0.55  ýI 
, Arachidonie  C20:  4n-6  0.36-0.64  0.20-0.60  0.36  0.07-0.87 
, 
Docosahexaenoic  C22:  6n-3  0.24-0.56  ud-0.66  0.15  0.32-1.48 
tArachidic  C20:  0  ud-0.36  0.43-1.07  <0.05  0.10-0.42 
'Eicosenoic  C20:  In-9  na  0.44-0.76  0.81  0.11-0.91  ý 
: Behenic  C22:  0  0.02-0.14  ud-0.10  <0.05  0.02-0.10 
iErucic  C22:  In-9  na  ud-o.  10  <0.05  ud-0.40  ý 
, 
Lignoceric  C24:  0  na  0.02-0.14  0.10  0.05-0.33 
, 
Nervonic  C24:  In-9  ud-0.15  0.01-0.05  0.14  ud-0.23 
(1)  Clan&nin  el  aL  (198  1)  -  Fatty  acid  analysis  of  human  milk  at  day  16  of  lactation  from 
Canadian  mothers  of  5  preterm  infants.  Results  given  as  normal  ranges. 
(2)  Gibson  and  Kneebone  (198  1)  -Fatty  acid  analysis  from  an  Australian  population  of  61 
mature  human  milks.  Results  given  as  normal  ranges. 
(3)  Hamer  el  aL  (1983)  -  Fatty  acid  analysis  of  14  breast  milk  samples  from  mothers  at  Day 
22  postpartum.  Results  quoted  as  means. 
(4)  Kneebone  et  aL  (1985)  -Fatty  acid  analysis  from  a  population  of  Malay  mothers  living  in 
Penang.  Results  given  as  normal  ranges. 
na  -  not  available  ud  -  not  detected. 
These  articles  incorporate  data  from  the  analYSes  of  both  term  and  preterm 
breast  milks,  and  from  disparate  geographical  populations.  The  references 
37 chosen  were  those  which  provided  the  most  comprehensive  ranges  of  milk 
fatty  acids  together  with  brief  statistical  analyses  of  the  results.  Most  authors 
quote  the  essential  fatty  acid  concentrations  together  with  those  of  the 
polyunsaturated  fatty  acids  in  their  breast  milk  analyses.  As  this  thesis  also 
examines  very  long  chain  saturated  (lignoceric)  and  monounsaturated,  fatty 
acids  (nervonic),  it  was  necessary  to  consider  publications  which  quoted 
values  for  these  compounds. 
2.2.  METHODS 
2.2.1.  Preparation  of  chemicals 
a)  Solvents 
Solvents  for  thin  layer  chromatography  were  prepared  freshly  before  use  and 
allowed  to  equilibrate  in  the  chromatography  tanks  as  described  in  the 
methodology  section. 
Chloroforni/Methanol/Water  (65:  25:  4)  This  was  prepared  by  combining 
130  mi.  chloroform,  50  mi.  methanol  and  8  mi.  distilled  water  in  a  measuring 
cylinder  with  a  glass  stopper.  The  reagents  were  mixed  well  before  adding  to 
a  chromatography  tank. 
Butanol/Acetic  acid/Water  (60:  20:  20)  This  was  prepared  by  combining  120 
mi.  chloroform,  40ml.  butanol  and  40  mi.  acetic  acid  in  a  measuring  cylinder 
with  a  glass  stopper.  The  reagents  were  mixed  well  before  adding  to  a 
chromatography  tank. 
Hexane/Diethyl  ether  This  solution  was  used  to  rinse  HPTLC  plates  before 
use  and  was  prepared  by  combining  25ml  hexane  with  25  mi  diethyl  ether  in  a 
measuring  cylinder  with  a  glass  stopper.  The  reagents  were  mixed  before 
adding  to  a  chromatography  tank. 
Methyl  acetate/Propan-2-oUChloroform/Methanol/0.25`/`  aqueous  KCI 
(25:  25:  25:  10:  9)  HPLC  Solvent  This  was  prepared  by  mixing  25  mi  methyl 
acetate,  25  mi  propan-2-ol,  25  mi  chloroform,  10  mi  methanol  and  9  mi  0.25% 
38 aqueous  KCI  in  a  100  ml  measuring  cylinder  with  a  glass  stopper.  From  this, 
40  ml  of  solvent  was  used  in  each  chromatography  tank.  In  general  two  tanks 
were  used  in  each  run  to  avoid  waste  of  the  solvent. 
Chloroform  with  BHT  50  mg  of  butylated  hydroxytoluene  was  added  to  one 
litre  of  chloroform  and  this  was  used  in  all  extraction  procedures. 
Methanol  with  BHT  50  mg  of  butylated  hydroxytoluene  was  added  to  one 
litre  of  methanol  and  this  was  used  in  all  extraction  procedures. 
Methanol/Water  To  prepare  this  reagent,  500  ml  of  methanol  containing 
BHT  was  combined  with  500  ml  distilled  water. 
The  chloroforrn  and  methanol  working  solutions  were  stored  in  dark  glass 
bottles  at  room  temperature. 
b)  Chemicals 
The  following  chemicals  were  used  in  either  extraction  of  the  tissues, 
derivatisation  of  the  fatty  acids  or  visual  isation  of  TLC  plates. 
The  chemicals  were  weighed  using  a  Sartorius  RC  21  OD  balance.  (Sartorius) 
Sodium  chloride  Sodium  chloride  (1.8g)  was  dissolved  in  200  ml  distilled 
water  and  stored  in  a  glass  bottle  at  room  temperature. 
Potassium  chloride  Potassium  chloride  (0.25g)  was  dissolved  in  100  ml 
distilled  water  and  stored  at  room  temperature  in  a  plastic  bottle. 
Boron  trifluoride  in  methanol  This  was  stored  at  40C  after  the  addition  of 
50  mg  BHT  to  the  500  ml  glass  bottle. 
3N  Methanolic  HC1  This  was  stored  at  40C  after  the  addition  of  50  mg 
BHT  to  the  400  ml  glass  bottle. 
27  Dichlorofluorescein  (Visualisation  reagent  for  TLC)  This  was  prepared 
by  the  addition  of  200  mg  of  27-dichlorofluorescein  to  100  ml  methanol. 
This  was  then  diluted  further  by  the  addition  of  100  ml  distilled  water.  The 
resulting  solution  was  stored  at  room  temperature  in  a  dark  glass  bottle.  This 
stock  solution  was  diluted  1:  5  with  methanol  immediately  before  use. 
3%  Copper  acetate  in  8%  orthophosphoric  acid  (Charring  reagent  for 
HPTLC  plates)  8  mls  of  orthophosphoric  acid  was  added  slowly  to  92  ml 
39 distilled  water.  Copper  acetate  (3g)  was  dissolved  in  this  mixture  and  the 
resultant  solution  stored  in  a  dark  glass  bottle  at  room  temperature. 
c)  Lipid  standards 
Lipid  standards  were  dissolved  in  chloroforrn:  methanol  (98:  2,  v/v)  at  a 
concentration  of  5  mg/mI  solvent  and  stored  at  -201C  in  2  ml  glass  trident 
vials. 
d)  Fatty  acid  methyl  ester  standards 
Gravimetric  stock  solutions  of  each  fatty  acid  methyl  ester  standard  at  a 
concentration  of  30  mg/ml  in  hexane  were  prepared. 
Working  FAME  solutions  100  pl  of  each  individual  stock  solution  was 
diluted  to  I  ml  with  hexane  (3  mg/ml).  Individual  working  standards  were 
used  as  GLC/GCMS  positional  standards. 
Combined  FAME  standard  A  combined  FAME  standard  was  prepared  from 
the  stock  solutions  and  contained  the  following  fatty  acids  methyl  esters  :  - 
C16:  0,  C16:  1,  C18:  0,  C18:  1,  C18:  2,  C20:  3,  C20:  4,  C22:  6,  C24:  0  and  C24:  1. 
20  pl  of  each  standard  was  used  and  then  made  up  to  2  ml  with  hexane 
(3mg/ml). 
All  stock  and  working  solutions  were  stored  at  -70'C  in  2  ml  trident  glass 
vials,  when  not  in  use,  and  allowed  to  equilibrate  to  room  temperature 
immediately  before  use.  This  ensured  that  the  fatty  acid  standards  were 
completely  solubilised. 
2.3.  Experimental  procedures 
In  this  section  there  is  a  description  of  all  procedures  in  the  preparation  of  total 
lipid  fatty  acid  methyl  esters  from  the  various  brain  tissues,  the  thin  layer 
chromatographic  techniques  involved  in  the  separation  of  the  individual 
phospholipids  and  the  gas  chromatography  methods  employed  in  the  analysis 
of  the  fatty  acid  methyl  esters. 
40 2.3.1.  Lipid  extraction 
Complex  lipids  such  as  those  found  in  brain  tissue  are  usually  constituents  of 
membranes  where  they  are  found  in  close  association  with  proteins.  The  lipid 
molecules  are  linked  to  other  cellular  components  by  weak  hydrophobic  bonds, 
by  hydrogen  bonds  and  by  ionic  bonds. 
When  considering  the  extraction  of  lipids  from  membranes  these  associations 
have  to  be  taken  into  consideration.  Various  solvent  systems  have  been  used 
to  extract  lipids  from  tissues.  These  include  ethanol:  ether:  chloroform, 
ethanol:  petroleum  ether  (Bloor,  1943)  isopropanol:  hexane  (Hara  and  Radin, 
1978).  The  method  of  Folch  et  aL,  (1957)  who  used  chloroform:  methanol  (2:  1 
v/v)  is  the  most  popular  and  frequently  used  extraction  procedure.  Bligh  and 
Dyer  (1959)  adjusted  the  ratio  of  chloroforrn:  methanol  employed  by  Folch  to 
produce  a  single  phase  solution  taking  account  of  water  derived  from  the 
tissue.  Their  method  was  designed  for  the  extraction  of  larger  amounts  of 
tissue  and  was  dependent  on  estimating  the  amount  of  water  in  the  tissue. 
Lipid  extracts  of  tissues  processed  by  the  above  methods  tend  to  contain 
appreciable  amounts  of  non-lipid  contaminants  such  as  sugars,  amino  acids 
and  salts.  Ways  and  Hanahan  (1964)  introduced  a  modified  Folch  procedure 
which  included  a  washing  stage  in  which  the  chloroform/methanol  extract  was 
combined  with  1/4  of  its  volume  of  a  saline  solution.  Once  centrifuged,  the 
mixture  settles  into  two  phases,  the  lower  being  predominantly  chloroform  and 
containing  virtually  all  lipids  while  the  upper  phase  consists  mainly  of 
methanol/water  and  contains  most  of  the  non-lipid  contaminants.  A  second 
wash  of  methanol/water  (1:  1)  can  be  used  to  remove  any  remaining 
contaminants  again  ensuring  that  the  proportions  of 
chlorofonn/methanol/water  are  appropriate  to  avoid  selective  loss  of  lipid 
material. 
41 As  part  of  the  experimental  procedure,  the  approximate  weight  of  tissue  to  be 
extracted  was  recorded  each  time  (it  was  observed  that  the  degree  of  hydration 
of  specimens  was  variable  on  receipt)  together  with  the  weight  of  lipid 
recovered  at  the  end  of  the  extraction  procedure.  This  had  a  two-fold  purpose. 
Firstly  as  an  estimation  of  the  recovery  of  lipid  in  the  extraction  procedure  and 
secondly  to  calculate  the  amount  of  chloroform  to  be  added  to  the  lipid  residue 
prior  to  chromatography  or  derivatisation. 
All  solvents  contained  the  synthetic  antioxidant  BHT.  Polyunsaturated  fatty 
acids  autoxidise  rapidly  when  exposed  to  air,  and  the  more  double  bonds 
present,  the  more  rapid  the  rate  of  oxidisation.  Tissues  will  contain  natural 
antioxidants  such  as  a-tocopherol  but  the  levels  of  these  may  not  be  sufficient 
to  prevent  deterioration  on  storage.  For  the  same  reason,  vials  were  flushed 
with  nitrogen  at  various  stages  in  the  extraction  procedure  and  before  storage 
at  -70'C. 
The  experimental  procedure  is  now  described:  - 
After  removing  the  tissue  from  storage  at  -70"C,  approximately  200  mg  was 
removed  by  means  of  a  scalpel  and  placed  in  a  pre-weighed,  polystyrene 
weighing  boat.  Extraneous  water  was  carefully  removed  with  a  piece  of  filter 
paper  and  the  exact  weight  of  tissue  noted.  The  weighed  tissue  was 
transferred  to  a  glass  hand  homogeniser  and  6ml  chloroform  containing  BHT 
added.  After  homogenisation  the  solution  was  transferred  to  a  10  ml  glass 
centrifuge  tube,  3  ml  methanol  containing  BHT  added  and  the  homogenisation 
process  repeated.  The  methanol  and  chloroform  extracts  were  combined,  and 
shaken  vigorously  by  hand  for  60  seconds.  2  ml  sodium  chloride  were  added 
to  the  extract  to  aid  removal  of  any  non-lipid  contaminants,  shaken  again  for 
20  seconds  before  centrifugation  for  5  minutes  at  3,000  r.  p.  m.  (1000g;  MSE 
centrifuge).  The  upper  aqueous  methanol  layer  was  discarded  and  4.5  ml 
methanol/water  (1:  1  v/v)  added  to  the  remaining  chloroform  phase  followed 
42 by  gentle  mixing  and  centrifugation  as  before.  The  lower  chloroform  layer 
containing  the  purified  lipid  was  transferred  using  a  glass  pasteur  pipette  to  a 
10  ml  glass  tube  and  evaporated  to  dryness  under  nitrogen  at  401C  using  a 
Techne  "Dri-Block"  sample  concentrator.  (Model  No.  SD  300-10,  SC3;  Merck 
Ltd.  )  Evaporation  of  the  final  I  ml  of  solvent  was  carried  out  in  a  pre-weighed 
2  ml  glass  vial,  which  on  completion  was  re-weighed.  The  weight  difference 
was  taken  as  total  weight  of  lipid  extracted  and  this  was  dissolved  in 
chloroform  to  yield  a  final  lipid  concentration  of  2mg/100gl  and  stored  at 
-70T. 
2.3.2.  Total  lipid  transesterification 
Methyl  esters  are  the  most  widely  used  derivatives  formed  from  fatty  acids 
prior  to  GLC  analysis.  The  fatty  acids  on  the  various  phospholipids  or 
triacylglycerols  can  be  directly  transesterified  to  fatty  acid  methyl  esters. 
Various  reagents  have  been  used  to  carry  our  this  reaction,  namely 
diazomethane,  sodium  methoxide  in  anhydrous  methanol,  hydrochloric  acid  or 
sulphuric  acid  in  anhydrous  methanol  and  boron  trifluoride  in  methanol.  Non- 
polar  lipids,  such  as  triacylglycerols  and  cholesterol  esters,  are  insoluble  in 
reagents  composed  primarily  of  methanol,  and  therefore  a  small  amount  of 
another  solvent  such  as  chloroform  has  to  be  present  for  solubilisation. 
Metcalfe  el  aL  (1966)  were  the  first  group  to  use  boron  trifluoride  in  methanol 
but  since  then  there  have  been  many  modifications  by  various  groups  of 
workers  including  changing  the  percentage  composition  of  boron  trifluoride  in 
methanol.  Morrison  and  Smith  (1964)  described  the  procedure  including 
esterifying  different  phospholipids  and  using  petroleum  ether  to  extract  them 
post  derivatisation  and  this  is  the  basis  of  the  technique  described  below.  It 
was  however  noted  that  esterification  of  galactocerebrosides  and  sulphatides 
43 was  not  so  readily  achieved  by  the  latter  reagent  and  therefore  methanolic 
hydrochloric  acid  was  employed  when  derivatising  white  matter  tissue. 
For  cerebral  cortex  and  cerebellar  grey  matter,  100  pl  (2  mg)  of  lipid  extract 
was  derivatised,  in  a5  ml  "Reactivial"  by  adding  2  ml  boron  trifluoride  in 
methanol.  The  vial  was  flushed  with  nitrogen  and  closed  tightly  before 
heating  at  80'C  for  30  minutes.  For  parietal  white  matter  and  cerebellar  white 
matter,  100pl  of  lipid  extract  was  added  to  100  gl  chloroform  and  2  ml 
methanolic  hydrogen  chloride  in  a  specially  tapered  20  ml  test  tube.  These  test 
tubes  were  used  to  allow  reflux  of  the  solution  without  any  loss  of  volume.  A 
glass  stopper  and  parafilm  were  used  to  seal  the  test  tube.  After  mixing  the 
tubes  were  transferred  to  a  heating  block  for  2  hours  at  90'C. 
After  removal  from  the  heating  block  the  solutions  were  allowed  to  cool  to 
room  temperature  and  transferred  to  10  ml  glass  tubes  containing  5  ml 
distilled  water  in  order  to  remove  any  polar  impurities  produced  by  the 
derivatisation  reaction.  The  FAME  were  extracted  twice  with  3  ml  petroleum 
spirit,  and  after  centrifugation  at  3000  r.  p.  m  for  5  minutes,  the  combined 
petroleum  spirit  layers  were  evaporated  to  dryness  under  nitrogen  at  40'C. 
The  FAME  were  then  re-dissolved  in  I  ml  hexane,  transferred  to  a2  ml  glass 
vial  and  again  the  solvent  evaporated.  The  final  extract  was  dissolved  in  200PI 
hexane  and  stored  at  -70'C  pending  GLC  analysis. 
2.3.3.  Thin  layer  chromatography 
Thin  layer  chromatography  (TLC)  has  been  used  for  the  last  fifty  years  as  a 
means  of  separating  lipid  mixtures  into  their  various  classes.  There  have  been 
many  different  solvent  systems  developed  in  an  attempt  to  separate  as  many 
compounds  as  possible  in  a  single  run.  Chloroform/methanol/water  (65/25/4) 
was  initially  employed  as  the  standard  method  for  separating  phospholipids 
44 (Svermerholm  and  Vanier,  1972,  Martinez  et  al.,  1974).  The  results  obtained 
in  our  laboratory  using  this  system  were  unsatisfactory  (Tables  3.1  and  3.2, 
Results  chapter)  most  probably  due  to  variations  in  environmental  temperature 
and  humidity.  (Tsao,  1982)  Several  different  solvents  were  thus  assessed  for 
use  in  a  two  dimensional  TLC  system  to  improve  separation  of  the 
phospholipids  of  interest,  namely  PC,  PE  and  PS.  It  was  important  to  ensure 
that  these  major  phospholipids  were  also  separated  from  the  less  abundant  ones 
(e.  g.  PI)  and  also  from  the  cerebrosides  and  sulphatides.  The  solvent 
combinations  tested  included  n-butanol  /  acetic  acid  /  water,  chloroform  / 
methanol  /  ammonia,  chloroform  /  acetone  /  methanol  /  acetic  acid/water  and 
tetrahydrofuran/methylal/methanol/amm"onia.  The  combination  of  chloroform/ 
methanol/water  followed  by  butanol/acetic  acid/water  (Rouser  et  al.,  1967) 
proved  to  be  the  most  satisfactory  and  was  therefore  employed  as  described 
below.  The  TLC  plates  used  for  both  systems  were  commercially  prepared 
Silica  Gel  60  with  a  fluorescent  indicator  to  allow  detection  of  the  individual 
phospholipids  using  a  non-destructive  chemical. 
One  dimensional  high  performance  thin  layer  chromatography  (HPTLC) 
(Vitiello  and  Zanetta,  1978)  was  used  for  separation  of  white  matter  lipids 
prior  to  quantitation  by  scanning  densitometry  (Olsen  and  Henderson,  1989). 
This  method  worked  well  for  small  quantities  of  lipid  but  would  not  have  been 
suitable  for  the  preparative  stage.  The  FIPTLC  plates  incorporated  a 
concentration  zone  at  one  end  of  the  plate.  The  adsorbent  in  this  zone  was  a 
silica  of  very  high  pore  diameter  and  small  surface  area.  The  sample  applied  to 
this  area  was  concentrated  by  the  developing  solvent  front  into  a  narrow  band 
and  carried  up  on  to  the  silica  gel. 
a)  One  dimensional  chromatography 
In  this  procedure,  plates  were  activated  for  at  least  I  hour  at  100"C  before  use. 
Lipid  extract  (4  mg)  was  applied  as  a  band  about  7  cm  long  and  two  samples 
run  on  each  plate.  An  additional  narrow  band  of  lipid  standards  was  applied 
45 adjacent  to  the  test  samples.  The  walls  of  the  chromatography  tanks  were  lined 
with  filter  paper  and  200ml.  of  chloroform/methanol/water  added,  and  the  tank 
equilibrated  for  I  hour  at  room  temperature  before  introducing  the  plates.  The 
plates  were  run  for  90  minutes,  dried  in  air  on  removal  and  developed  using 
2'7'-dichlorofluorescein. 
b)  Two  dimensional  TLC 
Two  plates  per  sample  were  run  in  order  to  obtain  enough  of  the  less 
predominant  lipids  for  derivatisation  and  subsequent  GLC  analysis.  Plates 
were  activated  for  at  least  I  hour  at  100'C  before  use.  Lipid  extracts  (1.5mg) 
were  spotted  in  the  left-hand  comer  of  each  plate.  The  walls  of  the 
chromatography  tanks  were  lined  with  filter  paper,  200ml  of  chloroform/ 
methanol/water  added,  and  the  tank  equilibrated  for  I  hour  at  room 
temperature  before  introducing  the  plates.  The  plates  were  run  for  90 
minutes,  on  removal  dried  at  401C  for  30  minutes  before  placing  in  the  second 
tank  containing  butanol/acetic  acid/water  and  run  for  a  further  four  hours  at 
ninety  degrees  to  the  first  run. 
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Figure  2.1  -  Two  dimensional  TLC  separation  of  cerebral  cortex 
phospholipids. 
46 The  plates  were  dried  for  30  minutes  at  40*C,  sprayed  lightly  with  27 
dichlorofluorescein  and  the  lipids  viewed  as  yellow  spots  under  UV  light  at 
254  nm  (Spectroline  CX-20  viewing  cabinet  Supelco  UK.,  Sigma-Aldrich 
Chemical  Company  Ltd.,  Poole,  Dorset)  The  spots  corresponding  to  PC,  PE, 
PS  and  SPH  were  marked  with  a  pencil  (Fig  2.1).  TIhe  silica  gel  from  these 
marked  areas  on  both  plates  were  scraped  off  using  a  disposable  scalpel  and 
the  total  material  from  both  was  stored  in  5ml  "Reactivials"  at  -70"C  pending 
Rifther  analysis. 
2.3.4.  Individual  lipid  transesterification 
To  each  vial  containing  the  silica  gel  removed  from  the  PC,  PE  and  PS  spots, 
2  ml  boron  trifluoride  methanol  containing  BHT  was  added  and  the  vials 
flushed  with  nitrogen,  closed  tightly  and  placed  in  the  hot  block  for  30  minutes 
at  80"C.  The  extraction  procedure  following  heating  was  as  for  the  total  lipid 
esterification  but  the  final  extracts  were  dissolved  in  50  pl  hexane  prior  to 
GLC  analysis. 
2.3.5.  Analysis  of  fatty  acid  methyl  esters 
a)  Gas  liquid  chromatography 
Gas  liquid  chromatography  (GLC)  is  the  most  widely  used  analytical  method 
for  the  determination  of  the  relative  proportions  of  fatty  acids  in  animal  tissues. 
The  technique  was  first  used  in  the  1950s  and  initially  packed  columns  of 
either  stainless  steel  or  glass  were  fitted.  The  average  length  of  these  columns 
was  2  m6ires  and  they  were  easy  to  prepare  in  the  laboratory  with  an 
appropriate  packing  either  purchased  fi7om  a  manufacturer  or  again  prepared 
on  site.  The  analysis  of  fatty  acids  on  these  columns  was  time  consuming,  run 
times  could  exceed  2  hours  if  the  separation  included  longer  chain  fatty  acids, 
and  there  was  a  lack  of  component  resolution. 
47 A  further  development  was  the  introduction  of  glass  capillary  columns  with  the 
availability  of  commercial  glass  drawing  machines.  The  glass  columns  had  to 
be  treated  to  ensure  adhesion  of  the  liquid  phase.  A  variety  of  techniques  were 
employed  to  achieve  this.  Fused  silica  was  then  introduced  in  the  early  1980s 
as  an  alternative  for  capillary  columns  as  it  proved  to  be  an  inert  material  and 
was  more  flexible  than  glass.  Liquid  phases  were  bonded  chemically  to  the 
surface  of  the  column.  This  resulted  in  improved  stability  at  high 
temperatures. 
Wide  bore  capillary  columns  were  also  manufactured  (0.53  mm.  and  0.75  mm 
ID)  as  they  could  be  adapted  to  both  injection  and  detector  ends  of  GLC  units 
for  packed  columns  relatively  simply  with  little  additional  cost.  Thus  direct 
injection  without  stream-splitting  was  possible.  Using  wide  bore  columns  it 
was  possible  to  reduce  run  times  and  yet  resolve  monoethylenic  isomers. 
A  Pye,  Unicarn  304  Gas  Chromatograph  with  flame  ionisation  detector  linked 
to  a  Philips  single  pen  recorder  PM8251  and  a  Pye  Unicarn  CDP  I  computing 
integrator  was  employed  in  the  measurement  of  the  fatty  acid  methyl  esters. 
The  flame  was  ignited  using  hydrogen  from  a  Canberra  Industries  Hydrogen 
Generator  (Model  B7526)  and  air  from  a  British  Oxygen  Company  cylinder. 
Helium  was  used  as  carrier  gas  and  also  make-up  gas. 
The  following  conditions  were  set  when  running  the  FAME  samples:  - 
Oven  temperature  -  1301C  for  4  minutes  then  rising  at  4/minute  to  200*C 
Injection  temperature  -  2500C  Detector  Temperature  -  2801C 
Carrier  gas  flow  rate  -5  ml/minute  Make-up  gas  flow  rate  -  20  ml/niinute 
Column  -A  25  metre  fused  silica,  wide  bore  (0.53mm)  capillary  column  with 
cyanopropyl  siloxane  stationary  phase  BPX70  (Scientific  Glass  Engineering, 
Milton  Keynes,  UK.  ) 
48 SaMple  -A  sample  size  of  0.1  ul  and  detector  attenuation  setting  2X  100  was 
used  to  determine  the  total  lipid  samples  whereas  for  individual  phospholipid 
samples  0.3  gI  sample  was  injected  and  detector  attenuation  set  at  8X  10.  A 
typical  chromatographic  tracing  is  illustrated  in  Figure  2.2. 
b)  Gas  chromatography-mass  spectrometry  (GCMS) 
A  Hewlett-Packard  GCMS  was  used  from  1995  onwards.  A  mass 
spectrometer  consists  of: 
a)  sample  inlet  system. 
b)  source  of  ions 
c)  mass  measuring  system 
d)  means  of  ion  detection,  amplification  and  recording. 
a)  The  Hewlett-Packard  5890  Gas  Chromatograph  was  the  sample  introduction 
technique  employed  in  this  case.  After  separation  of  the  fatty  acids  by 
capillary  column,  they  are  transferred  to  the  mass  spectrometer.  The  gas 
chromatograph  was  fitted  with  an  autosampler  (Part  No.  3880).  The 
introduction  of  this  technology  allowed  batch  analysis  either  during  the 
working  day  or  on  occasion  overnight. 
b)  The  Hewlett-Packard  5972A  Mass  Detector  was  fitted  with  an  electron 
ionisation  ion  source.  The  ion  source  fragments  and  ionises  sample  molecules 
and  directs  ions  through  a  series  of  lenses  into  the  mass  filter.  The  mass  filter 
parameters  determine  which  ions  can  move  from  the  ion  source  to  the  detector. 
It  filters  the  ions  according  to  their  mass  to  charge  ratio.  The  charged  molecule 
fragments  into  a  unique  pattern  which  is  characteristic  of  that  specific 
molecule.  This  includes  the  molecular  ion  (M)  which  provides  the  molecular 
weight  of  the  compound. 
49 Figure  2.2  -  GLC  recording  of  cerebellar  cortex  phospholipid  fatty  acids 
(a 
LO  vMN 
----------- c)  The  measuring  system  used  by  Hewlett-Packard  is  a  quadrupole  analyser 
which  comprises  four  parallel  rods.  Ions  injected  into  the  system  undergo 
complex  oscillations  under  the  influence  of  the  electrical  field.  Mass 
separation  is  achieved  by  varying  the  voltages  on  the  quadrupole  rods.  The 
system  can  operate  in  two  modes,  namely  SCAN  or  single  ion  monitoring.  The 
analyser  was  set  on  SCAN  mode  which  measured  all  ions  between  the  mass 
ranges  selected.  This  mode  is  not  as  sensitive  but  allows  identification  of 
unknown  compounds. 
d)  The  mass/charge  ions  then  collide  with  the  detector  where  they  are  counted 
and  a  signal  generated  which  is  proportional  to  the  total  number  of  ions  of  each 
mass.  Finally  a  summary  of  the  mass  of  the  ions  and  their  abundances  is 
plotted  by  the  data  system  (Fig  2.3).  This  system  is  able  to  display  real  time 
spectra  or  store  them  for  later  use.  The  data  system  also  controls  all  aspects  of 
the  mass  spectrum  hardware.  It  contains  a  library  (NBS-75)  for  identification 
of  unknown  compounds.  A  separate  library  was  created  for  all  the  FAME 
standards  purchased  from  Sigma  for  ease  of  identification. 
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Figure  2.3  -  GCMS  recording  of  cerebral  white  matter  total  lipid 
fatty  acids. 
50 Tle  Gas  Chromatograph  was  fitted  with  a  30m  x  0.32  mm  capillary  column 
with  bonded  PEG  stationary  phase  (Supelco  Omegawax  320)  obtained  from 
Supelco  UK. 
The  following  conditions  were  employed:  - 
Oven  temperature  -  150'C  for  2  minutes  then  P/minute,  to  220'C  followed  by 
101/minute  to  2501C  for  5  minutes. 
Injection  temperature  -  2501C 
Detector  temperature  -  280'C 
Carrier  gas  (Helium)  flow  rate  -I  ml/minute  Split  -  25:  1 
2  pl  sample  injected. 
2.3.6.  Method  evaluation 
a)  Precision  studies 
The  FAME  standard  was  injected  into  both  systems  daily  and  this  produced 
data  for  between  batch  reproducibility.  To  test  for  precision  of  the  method  as 
currently  described,  a  large  sample  of  cerebral  cortex  was  extracted  ten  times 
in  the  same  batch.  This  formed  the  basis  for  within  batch  analysis.  For 
between  batch  precision  studies,  a  separate  piece  of  the  same  cerebral  cortex 
tissue  was  extracted  daily  over  a  period  of  two  weeks.  A  manufacturer's 
standard  with  quoted  weight  percentages  of  37  fatty  acids  was  injected  into  the 
GCMS  as  an  accuracy  check. 
b)  Recovery  studies 
For  the  method  as  a  whole,  recovery  studies  were  carried  out  as  previously 
described  using  radiolabelled  fatty  acid  substrates  (Abassi,  PhD  thesis)  to 
assess  the  percentage  of  lipids  extracted  and  therefore  assess  any  losses  at 
various  stages  of  the  extraction  procedure. 
51 c)  Method  comparison 
Cerebellar  cortex  samples  (n--30)  were  analysed  by  both  GLC  and  GCMS 
systems  and  results  compared.  Regression  analysis  was  carried  out  using  the 
Microsoft  Excel  statistics  program. 
2.3.7.  High  performance  thin  layer  chromatography 
Chloroform  extracts  of  cerebral  parietal  white  and  cerebellar  white  tissues 
were  run  on  HPTLC  plates.  I  jil  (20  gg  lipid)  was  spotted  as  aI  cm  long 
narrow  band  together  with  a  mixed  standard  containing  SPH,  PC,  PE,  PS,  PI, 
SU  and  GaICer  prepared  as  follows.  Each  phospholipid  standard  was  made  up 
at  a  concentration  of  5  mg/mI  in  CHC13  as  were  those  of  the  cerebrosides  and 
sulphatides  but  in  CHC13/MeOH  (I:  lv/v).  100  pI  of  each  solution  were 
combined  in  a  standard  mixture  and  2  pI  (10  pg  total  lipid)  of  this  run  on  each 
plate. 
Plates  were  rinsed  in  hexane:  diethyl  ether  and  activated  at  120"C  for  I  hour. 
The  TLC  tank  was  lined  with  filter  paper  and  allowed  to  equilibrate  for  at  least 
I  hour  with  35  ml  of  solvent  before  introduction  of  the  plates.  These  were  run 
to  I  cm  from  the  top  of  the  plate  (approximately  40  minutes),  then  removed 
from  the  tank  and  dried  for  10  minutes  at  room  temperature  before  heating  in 
an  oven  at  II  O'C  for  I  hour.  After  dipping  in  the  developing  reagent  the  plates 
were  charred  in  an  oven  at  1601C  for  20  minutes.  A  typical  separation  pattern 
is  shown  in  Figure  2.4. 
The  resultant  bands  were  quantified  using  a  Shimadzu  scanning  densitometer 
at  the  following  settings:  - 
Mode  -  reflectance  Beam  -  Zigzag 
Wavelength  -  340  nm  Band  width  -8  mm 
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7  Galactocerebrosides Baselines  were  drawn  for  each  peak  using  manual  integration.  Peak  areas  for 
standards  and  tests  were  calculated  for  each  individual  lipid.  Since  it  is 
known  that  the  relationship  between  absorption  and  lipid  concentration  varies 
between  different  lipid  classes,  the  total  lipid  was  defined  as  the  sum  of  the 
phospholipids  plus  galactosphingolipids  (including  sulphatides).  Cholesterol 
was  not  measured  in  this  experiment. 
Standard  values  were  calculated  which  compared  the  areas  obtained  for  each 
lipid  in  the  standard  run.  Tests  were  then  corrected  using  these  standard 
values.  A  standard  was  run  with  each  plate  to  take  into  account  any  variations 
which  might  be  caused  by  the  charring  procedure.  Each  test  was  finally 
recalculated  for  each  individual  lipid  correcting  to  100%. 
Within  batch  precision  was  calculated  by  scanning  the  same  tissue  ten  times  - 
manually  integrating  each  time.  Between  batch  precision  was  calculated  using 
the  standard  run  with  each  plate  (n--12). 
2.3.8.  Statistical  analysis  and  data  handling 
The  following  statistical  analyses  were  used  in  the  evaluation  of  the  results 
obtained  in  this  study. 
a)  Students  "t"  test  (two-tailed) 
Between  group  differences  in  normally  distributed  fatty  acid  compositions 
were  calculated  by  Students"  t  test  where  results  were  not  age  dependent. 
Values  of  t  x,  -  X2/4SD,  2/n,  + 
SD22  M2 
where  m  and  ný  are  the  group  sizes  and  x-I  and  X2  group  means. 
Probabilities  for  each  derived  value  of  t  were  computed  (Excel  Version  7.0) 
for  the  appropriate  degree  of  freedom  (df  =  n,  +  n,  -  2) 
53 b)  Non-parametric  two  tailed  Mann  Whitney  U  test 
Between  group  differences  in  non-normally  distributed  fatty  acid  compositions 
(and  which  could  not  be  transformed)  were  assessed  by  the  Mann-Whitney  U 
rank  test. 
(n,  xný)-c 
where  c=  no.  of  times  a  value  in  group  I  is  either  higher  (C+  )  or  lower  (C  ) 
than  that  in  group  2.  c=  c+  or  c7  ,  whichever  is  numerically  smaller. 
Calculation  is  independent  of  group  size  (i.  e.  n,  #  rtý  )  and  probabilities  related 
to  the  calculated  U  values  are  found  from  statistical  tables  (Mann  &  Whitney, 
1947). 
c)  Wilcoxon  signed  rank  test  (two-tailed) 
Between  group  differences  in  fatty  acid  compositions  for  age-matched  data  (±I 
week)  were  assessed  by  the  Wilcoxon  signed  rank  test.  The  sums  of  positive 
(T+)  and  negative  ranks  (T-)  were  calculated. 
T+  +  T-  =n  (n+  1)/2  where  n=  number  of  pairs. 
Probabilities  were  calculated  from  the  numerically  smaller  rank  sum  (T) 
(Wilcoxon,  1945). 
d)  General  linear  model  analysis  of  covariance  (ANCOVA-GLM) 
Between  group  differences  in  fatty  acid  compositions  for  non  age-matched 
data  were  assessed  by  GLM  analysis  of  covariance  when  results  were  both  age 
dependent  and  not  normally  distributed.  Application  was  restricted  to  log- 
transformed  data  and  to  dietary  and  age  effects  over  narrow  age  ranges  (<20 
weeks).  Age  measurements  as  the  independent  variable  (x)  were  considered 
error  ftee.  Significances  were  calculated  using  Minitab  Version  10. 
e)  Bonferroni  correction 
Multiple  group  comparisons  of  normally  distributed  results  were  subject  to  the 
Bonferroni  correction  which  essentially  increased  the  requirement  for 
54 significance  from  the  standard  p<0.05  to  p  <0.05/n  where  n=  number  of 
comparisons. 
f)  Chi-square  test 
This  test  was  applied  to  assess  differences  in  dichotomous  variables  (sex  ratio) 
between  feeding  groups.  It  was  calculated  using  Microsoft  Excel  7.0. 
g)  Correlation  coefficient  (Age) 
Age  was  considered  to  be  the  only  major  confounding  covariate  in  this  dietary 
fatty  acid  study.  Because  of  the  relatively  small  group  sizes,  only  where  age 
was  found  to  correlate  strongly  (p<0.01),  either  directly  or  inversely  with  the 
concentrations  of  any  given  fatty  acid,  no  further  between  group  statistical 
analysis  was  undertaken  with  unpaired  data. 
h)  Regression  analysis 
This  was  used  in  the  assessment  of  the  GCMS  and  GLC  tissue  fatty  acid 
compositions.  Resultant  regression  equations  were  calculated  using  Microsoft 
Excel  Version  7.0. 
i)  Graphical  presentation  -  polynomials 
Where  fatty  acid  concentrations  varied  in  a  curvilinear  manner  with  age, 
whenever  appropriate,  polynomial  equations  for  best-fit  curves  were  derived 
(Microsoft  Excel  Version  7.0)  and  presented  in  graphical  form.  Otherwise 
fatty  acid  concentrations  with  respect  to  age  and  dietary  group  were  presented 
as  non-delineated  scattergrams. 
*  Assessment  of  group  gender  differences  with  respect  to  fatty  acid  compositions  did  not 
however  come  within  the  scope  of  this  work. 
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RESULTS 3.1.  Method  evaluation 
This  section  presents  the  results  of  method  evaluations  carried  out  during  the 
course  of  this  study. 
3.1.1.  One  dimensional  chromatography 
The  results  for  the  cerebral  cortex  tissues  analysed  by  this  technique  are  shown 
in  Tables  3.1  &  ).  2.  The  SEM  for  the  individual  fatty  acids  in  the  different 
groups  were  variable  and  unacceptably  large  in  a  few  cases.  It  was  observed 
that  the  technique  was  not  reproducible  and  did  not  always  achieve  complete 
separation  of  individual  phosphollpids. 
'Fable  3.1  Cerebral  cortex  phosphatidyleholine  fatty  acid  results 
by  1-D  TLC 
PC'  Feed  Fatty  Acid 
C14:  0  06ý0  C  16:  1  CI&O  C18  1  C20  4  C22:  4  C216 
Breast 
Mean  n=5  1.6  39.7  5.3  15.6  27.9  5.4  1.5  2.1 
SEM  0.33  4.33  0.47  3.33  1.49  0.26  0.43  0.56 
SMA 
Mean  n=5  1.7  41.7  5.0  16.9  22.6  5.9  2.3  3.1 
SEM  0.18  0.60  0.38  0.69  1.18  0.35  0.11  0.35 
CGOST 
Mean  n=5  1.5  42.6  5.4  13.7  25.6  5.9  1.9  1.9 
SEM  0.45  2.40  0.34  1.70  1.92  0.35  0.64  0.69 
Table  3.2  Cerebral  cortex  phosphatidylethanolamine  fatty  acid  results 
b,,,  I-D  TLC 
PE  Feed  Fat(v  Acid 
C]6ýO  C18:  0  C18A  C20:  4  C22:  4  C22  6 
Breast 
Mean  n-5  5.0  15.4  129  9.6  12.4  10.4 
SEM  0.65  3.60  1.71  1.95  0.95  1.25 
SMA 
Mean  n=5  7.2  22.1  IIA  15.5  10.6  9.8 
SEM  0.46  2.05  1.45  0.56  0.85  0.82 
CGOST 
Mean  n=5  5.5  19.0  15.7  15.7  13.0  8.1 
SEM  0.17  1.99  0.73  073  0.91  0.60 
56 3.1.2.  Recovery  studies 
Table  3.3  presents  the  results  for  recovery  studies  carried  out  by  Abassi 
(1989).  These  were  performed  to  assess  losses  at  each  stage  of  the  extraction 
procedure. 
Table3.3  Recovery  of  labelled  L-3-PC,  I-stearyl,  2(1-  14  Q  arachidonyl 
after  chloroform:  methanol  extraction 
Results  from  Abassi,  PhD  thesis,  1989. 
3.1.3.  Precision  studies 
Within  batch  and  between  batch  recovery  studies  for  tissue  extraction  and 
derivatisation  are  given  in  Tables  3.4  &  3.5  respectively.  FAME  were 
subsequently  analysed  by  GCMS.  The  coefficients  of  variation  for  all  fatty 
acids  are  in  general  below  an  acceptable  5%  level.  On  the  only  occasions  in 
which  the  CV  exceeded  5%  the  fatty  acid  concentration  represented  less  than 
2%  of  total  fatty  acids. 
Table  3.4  Within  batch  precision  results  (GCMS  analysis) 
Fatty,  4  cid  j  ('14:  0  ('16:  0  ('16:  1  ('18:  0  ('18:  1  ('20:  3  (20:  4  (22:  4  (22:  5  (22:  6 
Mean  1.17  30.38  2.78  25.24  1&  12  0.59  9.23  5.25  1.76  7.66 
(n=]O) 
S.  D.  0.078  0444  0.109  0.312  0.473  0.021  0.076  0.061  0.105  0.112 
C.  V.  1  667  1  40  3  99  1  24  293  3  56  0.81  1,16  5.97  1.45 
57 Table  3.5  Between  batch  precision  results  (GCMS  analysis) 
FattyAcid  C]4.,  O  CI&O  C16.1  C18.,  O  C]8.  *]  C20.3  C2U.  4  CZZ:  4  UZZ.  3 
Mean  1.49  30.01  3.21  22.54  15.44  0.65  10.70  5.57  1.82  8.56 
(n=10) 
S.  D.  0.060  0.519  0.156  0.427  0.703  0.037  0.138  0.137  0.069  0.355 
Cv.  4.03  1.73  4.86  1.89  4.64  5.67  1.29  2.46  3.79  4.15 
Table  3.6  summarises  a  similar  within  batch  experiment  where  the  analysis 
was  performed  by  GLC.  In  most  cases,  the  CV  values  are  higher  than  those  for 
the  GCMS  more  especially  again  for  those  fatty  acids  which  are  present  at  low 
concentration. 
Table  3.6  Within  batch  precision  results  (GLC  analysis) 
FaffyAcid  UtO  CJ6--O  C16.1  CI&O  CI&I  C20.3  C20.4  C22:  4  C22:  5  C22:  6 
Mean  0.52  27.97  2.06  21.57  17.30  0.36  12.43  6.17  2.47  8.63 
(n--7) 
S.  D.  0.086  0.818  0.079  0.431  0.245  0.074  0.315  0.330  0.111  0.450 
Cv.  16.54  2.92  3.83  2.00  1.42  20.56  2.54  5.35  4.49  5.21 
Between  batch  studies  for  sampling  precision  only  were  also  carried  out  by 
GC  and  GCMS,  using  the  FAME  standard  which  was  injected  daily  into  both 
systems  and  the  results  obtained  during  one  month  (n=20)  are  illustrated  in 
Table  3.7. 
Table  3.7  FAME  standard  precision  studies 
Fatly  Acid  C16.0  Cl  61  C]8.  *O  C18.1  C20.4  C22.6  C24.  ý  0  C24:  1 
C.  V.  (GLC) 
C.  V.  (GCMS) 
2.91 
1.54 
2.83 
1.47 
1.77 
1.56 
1.92 
0.88 
2.34 
1.62 
3.53  -- 
1.01  1.27  1.00 
58 The  FAME  standard  may  illustrate  improved  precision  associated  with  GCMS 
automatic  sampling.  The  FAME  standard  was  also  used  to  calculate  detector 
response  factors  for  each  fatty  acid  by  both  GLC  and  GCMS  analysis. 
A  gravimetric  standard  with  known  weight  percentages  of  37  fatty  -acids 
(Supelco  37)  became  available  through  the  latter  part  of  the  experimental  work 
and  was  run  on  the  GCMS  as  a  test  of  accuracy  of  the  system.  The  results  (wt 
%)  obtained  are  in  close  agreement  with  the  manufacturer's  quoted  values  and 
both  are  given  in  Table  3.8. 
Table  3.8  Analysis  of  Supelco  37  standard  by  GCMS 
FattyAcid  C14:  0  C16:  0  C16:  1  CIS:  O  C18:  1  C18:  2  C20:  3  C20:  4  C22:  6  C24:  0  C24:  1 
GCMS  3.87 
Supelco  4 
5.99 
6 
1.98 
2 
4.20 
4 
3.96 
4 
1.97 
2 
1.90 
2 
1.95 
2 
1.96 
2 
4.28 
4 
2.05 
2 
Results  for  Supelco  standard  and  GCMS  values  given  as  weight 
3.1.4.  Method  comparison 
Regression  analysis  was  used  to  assess  results  of  GLC  and  GCMS  fatty  acid 
compositions.  Figure  3.1  comparing  cerebellar  grey  docosahexaenoic  acid 
gives  an  example  of  the  graph  obtained,  including  the  curve  equation  and 
regression  coefficient.  The  equations  and  regression  coefficients  for  the 
remaining  fatty  acids  are  given  in  Table  3.9. 
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GLC  (weight  %  of  total  fatty  acids) 
Figure  3.1  -Regression  analysis  of  cerebellar  cortex  docosahexaenoic  acid 
Table  3.9  Regression  analysis  for  cerebellar  cortex  tissues 
Fattv  Acid  Equation  of  the  line  R2 
C16-0  v=0.6526x  -  11.1  335  0.5476 
C16-1  y=0.8525x  -  0.2528  0.8877 
C1810  y=0.8200x  +  4.2048  0.6638 
C  18:  1  v-0.6388x  +  6.3687  0.8200 
CI8:  2n-6  v=0.7958x  -  0.11  3'ý  0.9517 
C20-')n-6  y=1.0623  3x  -  0.3  3284  0.9690 
C20-.  4n-6  y=0.7038x  -ý-  3.5729  0.8044 
C22.4n-6  y=0.7084x  +  1.33  )65  0.7960 
C22-.  5n-6  y=0.9260x  -  0.162  5  0.9495 
C22:  6n-33  v=1.162  1x-1.063  )0  0,9465 
v-  GCMS  values  .x= 
GC  values. 
60 3.1.5.  HPTLC  precision  studies 
The  within  batch  and  between  batch  precision  study  results  are  shown  in 
Tables  3.10  and  3.11.  The  between  batch  analysis  in  which  the  mixed  lipid 
standard  was  analysed  on  each  plate  gave  satisfactory  CVs.  The  results  for  the 
within  batch  studies  where  the  same  tissue  was  scanned  several  times  were 
also  in  good  agreement  with  a  CV  >5%  only  for  PI  which  was  present  in  low 
concentration  (-2%). 
Table  3.10  Between  Batch  HPTLC  Precision  Results 
SPH  PC  PS  PI  PE  SU  GaICerA  GaICerB 
Mean  13.80  10-30  13.36  13.44  13.03  15.20  10.64  9.91 
(n=12) 
S.  D.  0.471  0.440  0.762  0.354  0.497  0.296  0.692  0.508 
Cv.  3.41  4.27  5.70  2.63  3.81  1.95  6.50  5.13 
Table  3.11  Within  Batch  HPTLC  Precision  Results 
SPH  PC  PS  m  PE  SU  GaICerA  GaICerB 
Mean  6.57  21.82  14.63  2.17  26.87  7.53  10.87  9.06 
0=10) 
S.  D.  0.112  0.332  0.361  0.123  0.348  0.137  0.152  0.385 
Cv.  1.70  1.52  2.47  5.67  1.30  1.82  1.40  4.25 
Note  that  GalCer  A  and  GalCer  B  represent  hydroxy  and  non-hydroxy 
galactocerebrosides. 
61 3.2.  Milk  analysis  results 
The  breast  milk  fatty  acid  results  from  a  local  population  of  mothers  together 
with  those  of  the  formula  milks  are  given  in  Table  3.12.  These  were  analysed 
as  a  comparison  to  published  ranges.  (Table  2.3  -  Methods  chapter) 
Table  3.12  Milk  fatty  acid  compositions  in  relation  to  diet 
(weight  %  of  total  fatty  acids) 
Fatty  A  cid  Milk  Diet 
Breast  Milk  SMA  CGOST  C&G 
jMyristic  C14:  0  3.8-11.5  4.49  4.50  4.68 
'Pahnitic  C16:  0  20.3-29.0  22.03  18.25  19.64 
IPahnitoleic  C16:  ln-7  1.5-3.9  0.18  0.09  0.23 
i  Stearic  C18:  0  4.6-9.5  3.86  3.60  4.05 
101eic  C18:  ln-9  31.3-43.4  38.98  43.32  46.52 
'Linoleic  C18:  2n-6  6.3-15.7  18.15  14.93  11.35 
la-Linolenic  C18:  3n-3  0.5-1.2  1.72  0.07  2.12 
ýDihomo-y-linolenic  C20:  3n-6  0.20-0.77  <0.05  <0.05  <0.05 
Arachidonic  C20:  4n-6  0.31-0.79  <0.05  <0.05  <0.05 
! Docosahexacnoic  C22:  6n-3  0.12-0.50  <0.05  <0.05  <0.05 
jAracMdic  C20:  0  0.15-0.32  0.35  0.89  0.36 
Pcosenoic  C20:  ln-9  0.40-0.74  0.18  0.67  0.34 
Sehenic  C22:  0  0.10-0.22  0.31  1.45  0.26 
lErucic  C22:  ln-9  0.08-0.23  <0.05  <0.05  <0.05 
'Lignoceric  C24:  0  <0.05-0.19  0.12  0.65  0.12 
'Nervonic  C24:  ln-9  <0.05-0.32  <0.05  <0.05  <0.05 
Breast  milk  results  are  quoted  as  weight  %  ranges  for  13  mature  milks  from  a  local  population  of 
mothers. 
SMA(Wyeth,  UK)  VVhite  Cap,  C&G  -  Cow  &  Gate  Premium  (post  1990),  CGOST  -  Farley's 
Ostermilk  2-  results  represent  laboratory  analysis  of  manufacturers'  milks  and  are  given  as  means 
of  duplicate  analysis. 
62 3.3.  Study  results 
The  following  section  details  the  study  results  and  has  been  divided  into 
subsections  for  each  individual  tissue. 
3.3.1.  Cerebral  cortex  total  phospholipid  fatty  acids 
Table  3.13  illustrates  the  infant  feeding  group  characteristics.  Between  group 
differences  for  the  continuous  variables  were  assessed  by  Student's  t  test  and 
those  for  dichotomous  variables  (male/female  ratios)  were  estimated  by  the 
Chi-square  test.  No  significant  differences  between  feeding  groups  in  birth 
weight  was  found  although  the  mean  birth  weights  of  the  formula  fed  infants 
were  noted  to  be  lower  than  that  of  the  breast  fed  group.  However  there  were 
differences  observed  in  male/female  ratios  between  the  breast-fed  group  and 
both  the  SMA  and  CGOST  groups  (p<0.02)  with  a  preponderance  of  males  in 
the  formula  groups  and  females  in  the  breast  fed  group. 
Table  3.13  Infant  details  for  cerebral  cortex  tissues 
Infant  Data  Milk  Diet 
Breast  SMA  CGOST  C&G  SMA 
Fed  Prem 
Birth  weight  (g)  3324  2997  2902  2978  1968 
(530)  (397)  (530)  (169)  (427) 
Gestational  age  (wk)  39.9  (1.4)  39.1  (1.3)  38.8  (1.6)  .  38.5  (0.5)  33.4  (2.1) 
Age  (wk)  11.2  14.4  16.4  18  15.4 
Age  range  (wk)  1-38  0.543  6.540  5-33  7-25 
Male/Female  4/9  12/4  a  7/4 
a 
2/2  4/1 
Results  are  shown  as  means  with  standard  deviations  in  parenthesis. 
Dichotomous  variables  were  analysed  by  x2  test  and  applied  only  to  malelfemale  ratios. 
a=  p<0.02  for  significant  differences  between  the  breast  feed  and  formula  fed  (SMA  and 
CGOST)  groups. 
Table  3.14  lists  the  cerebral  cortex  total  phospholipid  fatty  acid  results  for  each 
individual  in  the  study  (See  appendix).  Each  fatty  acid  concentration  (wt  %) 
was  recalculated  after  correcting  for  the  detector  response  and  the  total 
63 rounded  to  100%.  As  individuals  could  not  be  age-matched  between  groups, 
the  degree  of  correlation  of  each  fatty  acid  with  age  was  estimated.  Significant 
correlations  were  taken  as  p<0.01  (Table  3.15)  and  in  the  case  of  palmitic  acid 
and  palmitoleic  acid  no  statistical  analysis  was  possible.  Results  showing 
means  and  standard  errors  for  total  phospholipid  fatty  acids  in  the  cerebral 
parietal  cortex  in  relation  to  feeding  groups  are  given  in  Table  3.16.  Student's 
t  test  was  performed  to  compare  values  for  the  breast  fed  group  with  the  SMA 
and  the  CGOST  groups.  In  addition  a  similar  comparison  was  made  between 
the  SMA  group  and  the  CGOST  and  SMA  preterm  groups.  Values  flor  "p"  of 
<0.02  were  taken  to  imply  significant  differences  between  feeding  regimens 
after  application  of  the  Bonferrom  correction  for  multiple  group  comparisons. 
The  results  for  the  C&G  group  (n=4)  are  also  provided  11or  information  without 
statistical  analysis  due  to  the  group  size.  In  figures  3.2  -  3.11,  each  individual 
fatty  acid  is  plotted  with  respect  to  diet  and  age. 
Table  3.15  Correlation  coefficients  for  cerebral  cortex 
fatty  acid  concentration  vs  age  in  relation  to  feeding  group 
Fatty  Acid  Breast  SMA  CGOST  C&G  SMA  Prem 
r  r  r  r  r 
C16:  0  -0.69536  -0.80  14  6 
-0.73876  -0.94996  -0.890  16 
C16:  1  n-7  -0ý9196 
6 
-0.78016  -0.88556  -0.6028  -0.7087 
C18:  0  -0.0099  0.4145  0.3983  0.2788  0.6245 
C  18:  1  n-7+n-9  0.4758  0.5844  0.4747  0.95776  -0.0009 
C  18:  2  n-6  0.7719'ý  0.2662  0.6504  0,4501  0.3782 
C203  n-6  0.66256  0.3257  -0.1092  0.2795  -0.0916 
C20:  4  n-6  0.4980  0.6015  0.5425  0.1367  0.6369 
C22:  4  n-6  -0.1995  0.3859  0.4210  0.4782  0.7954 
C22.5  n-6  -0.3848  0.6079  0.75536  0.1592  0.97346 
C22.  -6  n-3  0.5327  -0.4680  -0.3162  -0.2524  -0.3436 
Significant  correlation  of  individual  fatty  acid  concentrations  (wt  %)  with  age.  (p<0.01  ) 
64 In  this  study  when  statistical  analysis  was  possible,  neither  of  the  saturated 
(stearic  acid,  Fig  3.4)  nor  monounsaturated  (oleic  acid,  Fig  3.5)  fatty  acids 
showed  any  significant  differences  between  feeding  groups  (Table  3.16).  As 
previously  stated  however,  relative  amounts  of  the  equivalent  C16  palmitic 
(Fig3.2)  and  palmitoleic  acids  (Fig  3.3)  were  found  to  correlate  negatively  with 
age,  palmitic  acid  failing  from  31%  to  26%  over  the  first  forty  weeks  and 
palmitoleic  acid  failing  from  3%  to  less  than  1%. 
Table  3.16  Cerebral  cortex  phospholipid  fatty  acid  compositions 
Fatq,  Acid  Milk  Diet 
Breast  SMA  CGOST  C&G  SMA  Prem 
n=13  n=16  n=11  n=4  n=5 
CI&O  29.02  28.59  "T27  28.35 
(0.23)  (0.45)  (0.73)  (1.35)  (0.89) 
C16:  ln-7  2.12  1.94  1.70  1.75  2.06 
(0.18)  (0.26)  (0.26)  (0.33)  (0.48) 
C18.0  22.09  21.93  21.97  22.66  21.71 
(0.24)  (0.28)  (0.37)  (0.59)  (0.48) 
CIS  I  n-74-n-9  15.95  15.63  16.61  16.62  16.92 
(0,42)  (0.33)  (0.39)  (1.23)  (0.71) 
CI8:  2n-6  0.44  0.58  0.58  0.52  0.67 
(0.06)  (0.04)  (0.05ý  (0,06)  (0.11) 
C20:  3n-6  1.23  1.57  1.84  1.57  1.60 
(0.11)  (0.11)  (0.11)  (0.18)  (0.17) 
C20:  4n-6  11.29  1  ".  26  12.48  b  11.56  12.66 
(0.28)  (0.28)  (0.35)  (0.48)  (0.54) 
C22:  4n-6  6.24  6.69  6  go  b  6.24  6.47 
(0.17)  (0-11)  (0.13)  (0.14)  (0.38) 
C22-5n-6  2.03  2.958  3.85  ax  2.14  3.10 
(0.14)  (0.16)  (0.37)  (0.31)  (0.53) 
C22-6n-3  9.66  7,96  a  6.85  ax  8.60  6.57 
(0.22)  (0-22)  (0.38)  (0.50)  (1.04) 
Fatty  acid  results  are  expressed  as  weight  percentages  of  total  fatty  acids  and  are  given  as 
means  and  standard  errors.  Significant  between  group  differences  calculated  by  Student's  t 
test  are  given  by  -a=  p<0.001  Ib=  p<0.01  for  BF  vs  formula  fed  (SMA  and  CGOST) 
groups  and  c=  p<0.02  for  SMA  vs  CGOST.  No  significant  differences  were  found  between 
the  SMA  and  SMA  preterm  group. 
65 Although  linoleic  acid  concentrations  (Fig  3.6)  were  in  general  lower  in  the 
breast  fed  infants  than  those  fed  formula  milk,  neither  essential  fatty  acid, 
linoleic  nor  oc-linolenic,  was  a  prominent  feature  of  the  infant  cerebral  cortex. 
Examination  of  the  n-6  series  fatty  acids  derived  from  linoleic  acid  showed 
that  dihomo-y-linolenic  acid  concentrations  (DGLA;  C20:  3n-6)  (Fig  3.7)  were 
greater  in  both  SMA-fed  and  CGOST-fed  infants  compared  with  those  breast 
fed.  A  positive  correlation  of  fatty  acid  concentrations  with  age  in  the  breast 
fed  group  (r=0.6625,  p<0.01)  however  precluded  statistical  analysis  of  the 
data.  In  addition  no  significant  difference  was  found  between  the  SMA  group 
and  the  SMA  preterm  group. 
Arachidonic  acid  concentrations  (Fig  3.8)  were  significantly  lower  in  the 
breast  fed  than  CGOST  group  (p<0.01)  and  although  also  lower  in  the  SMA 
group,  the  difference  was  not  significant  (p=0.0238).  No  significant 
differences  existed  between  the  SMA  and  CGOST  formula  groups  nor  the 
term  and  preterm  SMA  fed  infants.  The  arachidonic  acid  compositions  of  the 
small  C&G  group  tended  to  align  more  closely  with  the  breast  fed  infants.  The 
relative  amount  of  docosatetraenoic  acid  (DTA;  C22:  4n-6)  (Fig  3.9)  was 
significantly  greater  in  the  CGOST-fed  than  the  breast-fed  group  (p  <0.01), 
and  although  also  higher  in  the  SMA-fed  group  than  breast  fed  the  difference 
was  not  significant.  Here  again  none  of  the  preterm  infants  showed  obvious 
differences  when  compared  to  their  term  contemporaries. 
Although  CGOST  docosapentaenoic  acid  concentrations  (Table  3.15)  were 
found  to  correlate  strongly  with  age,  nevertheless,  the  results  were  considered 
to  represent  skewed  data  resulting  primarily  from  dietary  rather  than  age- 
related  effects  and  are  discussed  in  that  context. 
66 Docosapentaenoic  acid  values  (Fig  3.10)  were  significantly  greater  in  both 
SMA-fed  (p<0.001)  and  CGOST-fed  babies  (p<0.001)  when  compared  with 
those  breast-fed.  As  the  data  in  the  CGOST  group  were  skewed,  results  were 
also  compared  by  the  non-parametric  Mann-Whitney  U  test.  Similar  levels  of 
significance  between  groups  were  confirmed  (BF  vs  CGOST;  p<0.001).  Also 
the  CGOST-fed  infants  had  higher  DPA  concentrations  than  the  SMA-fed 
(p<0.02).  Again  similar  C22:  5n-6  results  were  obtained  for  the  C&G  group 
(X=  2.14)  as  for  the  breast  fed  group  (  X=  2.03).  This  finding  was  also  evident 
in  C22:  5n-6  concentrations  of  both  partially  breast  fed  infants.  Results  of  the 
SMA  group  were  not  significantly  different  from  those  of  the  SMA  preterm 
group  and  that  of  the  CGOST  fed  pretenn  infant  comparable  to  that  of  its  term 
born  counterparts  (Fig  3.10). 
Docosahexaenoic  acid  values  were  greater  in  the  breast-fed  group  than  in  the 
SMA  (p<0.00  1)  and  CGOST  group  (p<0.00  1)  (Fig  3.11).  DHA  concentrations 
were  also  significantly  greater  in  the  SMA-fed  than  CGOST-fed  infants 
(p<0.02).  In  the  youngest  infants  the  DHA  concentrations  in  both  the  C&G 
fed  and  mixed-fed  infants  were  adjacent  to  those  of  exclusively  breast  fed 
infants  although  it  was  noted  that  the  lowest  DHA  concentration  in  the  C&G 
group  was  found  in  the  33  week  old  infant  (7.4%).  DHA  concentrations  were 
lower  in  the  SMA  preterm  than  the  SMA  group  but  did  not  attain  significance. 
The  lowest  DHA  concentration  was  found  in  the  19  week  old  CGOST  preterm 
infant  (4.23%)  although  similarly  "low"  levels  were  encountered  in  the  7  week 
old  CGOST  term  infants  of  relatively  low  birth  weights  of  2.50  kg  and  2.53  kg 
respectively.  The  SMA  fed  preterm  infant  born  at  30  weeks  gestation  and 
who  died  at  10  weeks  had  a  DHA  concentration  of  4.27%  together  with 
detectable  concentrations  of  Mead  acid  (1.3%)  and  dihomo  Mead  acid  (0.9%). 
These  two  fatty  acid  were  not  found  in  other  infant  tissues. 
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Sp!:  )e  Awl  lelol  lo  %  Jt4r:  )Iem 3.3.2.  Cerebral  cortex  individual  phospholipid  fatty  acids 
Tbree  major  phospholipids  (PC,  PE  and  PS)  were  separated  by  thin  layer 
chromatography  as  described  in  the  methods  section  and  fatty  acids  measured 
in  each  phospholipid  fraction.  This  procedure  was  performed  in  a  small 
subgroup  of  the  tissues  used  for  cerebral  cortex  total  lipid  analysis.  The 
subgroup  comprised  5  breast-fed 
,6 
SMA-fed,  5  CGOST-fed  and  I  SMA-fed 
preterm  tissues  and  Table  3.17  below  lists  the  infant  details  for  this  subgroup. 
Table  3.17  Infant  details  for  individual  phospholipid  analysis 
Infant  Data  Milk  Diet 
Breast  Milk  SMA  CGOST 
Mean  birth  weight  (g)  3235(574)  3011(593)  3044(475) 
Mean  gestational  age  (wk)  39.8(l.  5)  39.2(l.  3)  39.5(l.  7) 
Mean  age  (weeks)  15.8  20.5  21.8 
Age  range  (wk)  6-38  6-43  9-40 
Range  Apgar  score 
I  minute  7-9  8-9  8-9 
5  minutes  9-10  9  9-10 
Male/Female  2/3  6/0  a  3/2 
Results  are  shown  as  means  with  standard  deviations  in  parenthesis. 
Dichotomous  variables  were  analysed  by  X2  test  and  applied  only  to  male/female  ratios. 
a=  P<0.02 
The  individual  fatty  acid  results  for  each  phospholipid  are  presented  in  Tables 
3.18-3.20  in  the  appendix.  The  only  strong  correlations  of  fatty  acid 
concentrations  with  age  (after  allowance  was  made  for  group  size)  were  those 
of  the  CGOST  group  PE  and  PS  docosapentaenoic  acid  (r  =  0.98;  p<0.01; 
r=0.97:  p<0.01  )  and  PE  docosahexaenoic  acid  (r  =  0.96;  p<0.01).  Otherwise 
the  most  notable  feature  of  the  data  was  the  remarkable  consistency  in  fatty 
acid  concentrations  in  each  phospholipid  throughout  the  first  year  of  life.  With 
the  above  exceptions  in  the  CGOST  fed  infants  no  group  coefficients  of 
variation  were  in  excess  of  10%  for  any  of  the  most  prominent  constituent  fatty 
68 acids.  Tables  3.21,3.22  and  3.23  summarise  the  means,  standard  errors  and  t 
test  values  for  each  phospholipid  fatty  acid.  Figures  3.12  -  3.35  show  the  fatty 
acids  for  each  phospholipid  plotted  with  respect  to  diet  and  age.  The  graphs 
for  the  polyunsaturated  fatty  acids  are  presented  below  while  the  remaining 
saturated  and  unsaturated  fatty  acids  can  be  found  in  the  appendix. 
Phosphatidy1choline  was  composed  of  greater  than  90%  saturated  and 
monounsaturated  fatty  acids  with  palmitic  and  oleic  acid  being  the  two  major 
fatty  acids  found.  (Table  3.21) 
Table  3.21  Phosphatidy1choline  fatty  acid  compositions 
Fatly  Acid  Breast  SMA  CGOST  BF1 
SMA 
BF1 
CGOST 
SMAI 
CGOST 
p  p  p 
C14:  0  1.88  2.02  1.82  0.5943  0.8680  0.5640 
(0.17)  (0.19)  (0.29) 
C16:  0  53.78  54.40  53.33  0.5744  0.7722  0.4588 
(0.84)  (0.72)  (1.26) 
C16:  ln-7  4.31  4.37  4.42  0.9143  0.8953  0.9310 
(0.60)  (0.18)  (0.59) 
C18:  0  9.42  9.74  9.88  0.6529  0.5995  0.9730 
(0.46)  (0.50)  (0.70) 
C18:  1  25.80  24.50  24.38  0.0820  0.1451  0.9008 
n-7+n-9  (0.32)  (0.54)  (0.82) 
C  18:  2  n-6  0.74  0.86  0.96  0.3240  0.1461  0.3351 
(0.10)  (0.05)  (0.09) 
C20:  3  n-6  0.87  1.03  1.12  0.2261  0.0258  0.4541 
(0.07)  (0.09)  (0.05) 
C20:  4  n-6  3.15  3.31  3.91  0.8265  0.0940  0.4043 
(0.30)  (0.58)  2  6) 
Fatty  acids  are  expressed  as  weight  percentages  and  are  given  as  means  with  standard  errors 
in  parenthesis. 
p  values  represent  between  group  differences  as  calculated  using  Student's  t  test. 
Arachidonic  acid  (Fig  3.19)  was  the  only  polyunsaturated  fatty  acid  present  at 
levels  greater  than  2%.  There  were  no  significant  differences  found  in  any  of 
the  fatty  acids  in  PC  between  different  feeding  groups.  "Outliers"  identified 
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Cb tended  to  be  associated  with  the  preterm  SMA  fed  infant  as  can  be  seen  with 
palmitoleic  acid  (Fig  3.14)  and  to  a  lesser  extent,  stearic  (Fig  3.15)  and  linoleic 
acid  (Fig  3.17). 
Table  3.22  Phosphatidylethanolamine  fatty  acid  compositions 
Fatty  Acid  Breast  SMA  CGOST  BF1 
SMA 
BF1 
CGOST 
SMAI 
CGOST 
p  p  p 
C16:  0  8.40  6.37  7.57  0.0610  0.4543  0.0683 
(0.95)  (0.37)  (0.46) 
C18:  0  30.82  31.42  28.78  0.6476  0.1650  0.0276 
(1.15)  (0.66)  (0.76) 
C18:  1  8.79  9.23  9.20  0.5333  0.6294  0.9350 
n-7+n-9  (0.68)  (0.31)  (0.46) 
C20:  3  n-6  1.47  2.05  1.95  0.0161  0.0417  0.7056 
(0.07)  (0.17)  (0.18) 
C20:  4  n-6  17.59  20.08  19.58  0.0005  0.0182  0.4587 
(0.33)  (0.33)  (0.59) 
C22:  4  n-6  11.97  12.63  14.32  0.3904  0.0032  0.0567 
(0.35)  (0.60)  (0.44) 
C22:  5  n-6  3.22  4.84  7.04  0.0026  0.0027  0.0263 
(0.26)  (0.28)  (0.85) 
C22:  6  n-3  17.74  13.41  11.57  0.0003  0.0002  0.0623 
(0.59)  (0.49)  (0.73) 
Total  n-6  34.25  39.59  42.89  0.0027  0.0003  0.0533 
(0.76)  (0.95)  (1.16) 
Total  n-3+n-6  51.99  53.00  54.47  0.4465  0.0834  0.2642 
(0.92)  (0.87)  (0.84) 
Fatty  acids  are  expressed  as  weight  percentages  and  are  given  as  means  with  standard 
errors  in  parenthesis 
p  values  represent  between  group  differences  as  calculated  using  Student's  t  test. 
Significant  difference  are  in  bold  type. 
In  contrast  phosphatidylethanolamine  was  found  to  contain  over  50% 
polyunsaturated  fatty  acids  (Table  3.22).  Of  the  polyunsaturated  fatty  acids 
detected,  mean  concentrations  of  both  arachidonic  and  docosahexaenoic  acid 
were  virtually  identical  (17.59%  vs  17.74%)  in  the  breast-fed  group.  However 
each  of  the  n-6  series  polyunsaturated  fatty  acids  was  found  to  be  higher  in 
both  the  SMA  and  the  CGOST  group  than  the  breast-fed  group.  Statistically 
significant  differences  were  identified  in  every  case  with  the  exception  of 
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LL docosatetraenoic  acid  (Fig  3.25)  which  although  higher  in  the  SMA  than 
breast-fed  group  did  not  reach  a  level  of  significance  (Table  3.22).  As  a  result 
the  sum  of  the  n-6  series  fatty  acids  was  significantly  greater  in  both  the  SMA 
and  CGOST  groups  (p  =  0.0027  and  p=0.0003  respectively)  than  the  breast- 
fed  group.  Docosahexaenoic  acid  (Fig  3.27)  was  conversely  present  at  greater 
levels  in  breast-fed  infants  than  SMA-fed  infants  (p  =  0.0003)  and  CGOST- 
fed  infants  (p  =  0.0002).  No  significant  differences  existed  between  the  SMA 
and  CGOST  groups,  although  higher  docosatetraenoic  and  docosapentaenoic 
acid  and  lower  DHA  concentrations  were  found  in  the  CGOST  group.  The 
lowest  PE  DHA  concentration  (7.6  1  %)  was  identified  in  the  preterm  SMA-fed 
infant.  On  this  occasion  no  concurrent  increase  in  the  n-6  series  fatty  acids 
was  observed  in  the  term  bom  formula  fed  infants.  However  levels  of  Mead 
acid  (C20:  3n-9)  of  2.29%  and  dihomo-Mead  acid  (C22:  3n-9)  of  1.47%  were 
detected  in  the  PE  fraction  of  this  tissue.  After  summation  of  n-3  and  n-6  fatty 
acid  concentrations  no  significant  differences  were  observed  between  feeding 
groups.  Stearic  acid  was  the  major  saturated  fatty  acid  at  a  level  of 
approximately  30%. 
The  phosphatidylserine  fraction  represents  about  15%  of  total  cerebral  cortex 
phospholipids  in  the  first  year  of  life.  Phosphatidylserine  was  found  to  be 
composed  of  55%  saturated  and  monounsaturated  fatty  acids  and  45% 
polyunsaturated  fatty  acids.  (Table  3.23)  Stearic  acid  was  again  the  major 
saturated  fatty  acid  present  at  a  level  of  approximately  45%  with  palmitic  acid 
and  oleic  acid  present  in  lesser  amounts.  There  were  no  significant  differences 
in  either  saturated  or  monounsaturated  fatty  acids  between  the  three  feeding 
groups. 
71 Table  3.23  Phosphatidylserine  fatty  acid  compositions 
FattyAcid  Breast  SMA  CGOST  BF1 
SMA 
BF1 
CGOST 
SMAI 
CGOST 
p  p  p 
C16:  0  2.67  2.16  2.76  0.4049  0.9102  0.3798 
(0.47)  (0.36)  (0.56) 
C18:  0  44.64  44.60  43.67  0.7063  0.2947  0.4572 
(0.76)  (0.62)  (0.45) 
1  C18:  1  6.31  6.80  8.92  0.6681  0.2741  0.2223 
n-7+n-9  (1.14)  (0.32)  (0.90) 
C20:  3  n-6  1.68  2.02  2.30  0.1801  0.0491  0.3695 
(0.12)  (0.18)  (0.23) 
I  C20:  4  n-6  7.90  9.01  8.97  0.2520  0.2566  0.9597 
(0.73)  (0.57)  (0.49) 
C22:  4  n-6  7.90  8.46  9.30  0.3989  0.0906  0.2168 
(0.47)  (0-38)  (0.53) 
C22:  5  n-6  5.33  7.66  10.42  0.0109  0.0105  0.0661 
(0.65)  (0.39)  (1.39) 
C22:  6  n-3  23.55  19.32  14.41  0.0019  0.0000  0.0009 
(0.60)  (0.74)  (0.66) 
Total  n-6  22.84  27.15  30.99  0.0154  0.0038  0.0433 
(1.30)  (0.76)  (1.55) 
Total  n-3+n-6  46.39  46.47  45.40  0.9122  0.6288  0.4364 
(1.27)  (0.38)  (1.38) 
Fatty  acids  are  expressed  as  weight  percentages  and  are  given  as  means  with  standard 
errors  in  parenthesis. 
p  values  represent  between  group  differences  as  calculated  using  Student's  t  test. 
Significant  differences  are  in  bold  type. 
PS  also  displayed  higher  n-6  series  LCPUFA  in  the  two  formula  milk  fed 
groups  when  compared  to  the  breast  milk  group.  However  only 
docosapentaenoic  acid  (Fig  3.34)  was  significantly  greater  in  both  the  SMA 
(p  =  0.0109)  and  CGOST  group  (p  =  0.0105)  than  the  breast  fed  group. 
Application  of  non-parametric,  two  tailed  Mann  Whitney  U  test  statistics  to  the 
phosphatidylserine  DPA  concentrations  confirmed  that  both  the  formula  fed 
groups,  SMA  (p<0.05)  and  CGOST  (p<0.02)  contained  higher  percentage 
contents  than  the  breast-fed  group.  Similarly  total  n-6  series  fatty  acids  were 
significantly  greater  in  both  the  SMA  group  (p=0.0  154)  and  the  CGOST  group 
(p=0.0038)  when  compared  to  the  breast  fed  group.  Although  total  n-6  fatty 
72 acid  concentrations  were  greater  in  the  CGOST  (30.99%)  than  SMA  group 
(27.15%)  the  difference  did  not  reach  significance  (p  =  0.043)  for  multi-group 
comparison.  Docosahexaenoic  acid  (Fig  3.35)  concentrations  were  found  to 
be  greater  in  the  breast-fed  infants  than  both  the  SMA  (p=0.0019)  and 
CGOST-fed  groups  (p<0.0001).  At  greater  than  20%  of  total  fatty  acids  the 
cerebral  cortex  phosphatidylserine  DHA  compositions  of  the  breast-fed  infants 
(with  the  exception  of  certain  retinal  structures)  are  not  surpassed  in  any  other 
human  tissue.  The  highest  DHA  concentration  (25.79%)  was  found  in  the  16 
week  old  breast  fed  infant.  It  was  also  noted  that  whereas  the  DHA 
concentrations  in  the  term  bom  SMA-fed  group  appeared  to  remain  stable  at 
about  20%  a  continual  drift  downwards  in  DHA  compositions  was  witnessed 
in  the  older  CGOST-fed  infants,  to  a  level  only  50%  of  that  of  the  age- 
comparable  breast-fed  infant  (Fig  3.35).  Docosahexaenoic  acid  concentrations 
were  also  significantly  greater  in  the  SMA-fed  than  CGOST-fed  infants 
(p  =  0.0009).  At  12.39%  of  total  fatty  acids  the  SMA-fed  preterm  infant  had  a 
lower  level  of  DHA  compared  to  term  bom  infants  of  comparable  age.  1.04% 
of  Mead  acid  and  1.58%  of  dihomo-Mead  acid  were  also  found  in  the  PS 
fraction  of  this  tissue. 
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Table  3.24  illustrates  the  infant  group  characteristics.  Between  group 
differences  for  the  continuous  variables  were  assessed  by  Student's  t  test  and 
those  for  dichotomous  variables  were  estimated  by  the  Chi-square  test. 
Table  3.24  Infant  details  for  cerebellar  cortex  tissues 
Infant  Data  Milk  Diet 
Breast  SMA  CGOST  C&G  SMA 
Fed  Prem 
Birth  weight  (g)  3356  2996  2944  2978  1968 
(517)  (314)  (580)  (169)  (427) 
Gestational  age  39.9  38.6  39.0  38.5  33.4 
(wk)  (1.2)  (1.2)  (1.4)  (0.5)  (2.1) 
Age  (wk)  9.2  10.0  17.9  18  15.4 
Age  range  (wk)  1-19  0.5-19  6.5-40  5-33  7-25 
Male/Female  3n  8/2  c'  6/3  Cc  2/2  4/1 
Results  are  shown  as  means  with  standard  deviations  in  parenthesis. 
Dichotomous  variables  were  analysed  by  X2  test  and  applied  only  to  male/fernale,  ratios. 
a=  p<0.02  for  significant  differences  between  the  breast  fed  and  formula  fed  (SMA  and 
CGOST)  groups. 
Results  for  total  phospholipid  fatty  acids  for  each  cerebellar  grey  tissue  are 
presented  in  Table  3.25  in  the  appendix.  Each  fatty  acid  concentration  (wt  %) 
was  recalculated  after  correcting  for  the  detector  response  and  the  total 
rounded  to  100%. 
The  degree  of  correlation  of  each  fatty  acid  with  age  was  estimated  and 
significance  taken  as  p<0.01  (Table  3.26).  All  LCPUFA  concentrations  in  the 
CGOST  group  correlated  strongly  with  age,  and  as  no  age-matching  was 
possible  between  this  and  the  other  feeding  groups,  no  statistical  evaluation  of 
the  CGOST  data  was  possible.  Three  fatty  acids  correlated  with  age  in  the 
SMA  group  (C16:  1,  C18:  0  and  C22:  6)  and  as  breast-fed  and  SMA-fed 
individuals  could  be  age-matched  (to  within  I  week),  the  resultant  9  data  pairs 
74 were  assessed  for  each  fatty  acid  using  the  Wilcoxon  signed  rank  test.  This 
resulted  in  the  exclusion  of  one  8  week  old  breast-fed  and  one  15  week  old 
SMA-fed  infant. 
Table  3.26  Correlation  coefficients  for  cerebellar  cortex 
fatty  acid  concentration  vs  age  in  relation  to  feeding  group 
Fatty  Acid  Z:  ýýSt  SMA  CGOST  C&G  SMA  Prem 
r  r  r  r  r 
C16ýO  -0.1919  -0.5496  -0.3932  -0.9261  0.4979 
C  16:  1  -0.8643'ý  -0.98316  -0.89856  -0.92126  -0.9157'ý 
C18:  0  0.3578  0.81866  0.5897  0.9153  0.7933 
C  18:  1  0.0070  0.4468  -0.5773  0.7894  -0.3025 
C  18:  2  0.5743  0.4336  0.5860  0.93416  -0.1124 
C20:  3  0.5941  0.5202  -0.80016  -0.8758  -0.3188 
C20A  0.5110  0.5340  0.7979  '3  0.0140  0.7169 
C22:  4  -0.2475  -0.1937  0.82796  0.6601  -0.0428 
C22:  5  -0.2531  0.6518  0.84576  0.1072  0.5752 
C22:  6  -0.3071  -0.8648'ý  -0.75336  -0.8375  -0.6723 
8=  Significant  correlation  of  individual  fatty  acid  concentrations  (wt  %)  with  age.  (p<0.0  I) 
Results  showing  means  and  standard  errors  for  total  phospholipid  fatty  acids  in 
the  cerebellar  cortex  together  with  the  Wilcoxon  signed  rank  test  significances 
for  the  paired  breast-fed  and  SMA  groups  are  given  in  Table  3.27.  The  results 
for  the  CGOST  group,  C&G  group  and  the  SMA  preterm  group  are  also 
provided  for  information  without  statistical  analysis.  In  figures  3.36  -  3.45, 
each  individual  fatty  acid  is  plotted  with  respect  to  diet  and  age.  As  with  the 
cerebral  cortex  results,  included  are  results  from  two  mixed  fed  infants  (aged  7 
and  18  weeks),  both  initially  breast  fed  for  4  and  10  weeks  respectively,  then 
given  SMA  formula. 
75 Table  3.27  Cerebellar  cortex  phospholipid  fatty  acid  compositions 
Fatty  Acid  Milk  Diet 
Breast  SMA  CGOST  C&G  SMA  Prem 
n=10  n=]O  n=9  n==4  n=5 
C16:  0  28.50  29.77  28.94  28.74  29.44 
(0,34)  (0.42)  (0.30)  (0.82)  (0,30) 
C16An-7  3.21  3.13  178  291  332 
(0.23)  (0.1-))  (0.30)  (0.49)  (0.23) 
C18:  0  18.19  18.17  19.04  18.25  18.05 
(0.37)  (0.31)  (0.53)  (0.70)  (0.35) 
C  18:  1  n-7+n-9  20.04  19,52  20A5  21.05  20.41 
(0.33)  (0.37)  (0.29)  (1,17)  (0.61) 
CI8:  2n-6  0.87  107  0.92  1.04  1.35 
(0.14)  (0.09)  (0.06)  (0.06)  (0.11) 
C20:  3n-6  2.02  2.43  c  2.47  2.53  2.70 
(0,21)  (0.21)  (0.17)  (0.13)  (0.22) 
C20:  4n-6  11.15  11.10  11.63  11.11  11.35 
(0.19)  (0.22)  (0.39)  (0.40)  (0.35) 
C22An-6  4ý74  5.12 
b 
5.59  4.67  5.04 
(0.17)  (0.19)  (0.27)  (0.12)  (0.16) 
C22.5n-6  0.69  1.08  C  1.95  1.05  1.38 
(0.19)  (0.08)  (0.16)  (0.13)  (0.19) 
C22:  6n-3  8.44  6.54  4.68  7.15  6.16 
(0.25)  (0.34)  (0.36)  (0.36)  (0.57) 
Fatty  acids  are  expressed  as  weight  percentages  and  are  given  as  ineans  with  standard  errors 
in  parenthesis. 
Significant  differences  in  fatty  acid  concentrations  between  feeding  groups  (BF  vsSMA  only) 
were  calculated  by  the  Wilcoxon  signed  rank  test  for  paired  data  (n=9) 
a=  p<0.0  1,  b=  p<0.02.  c=  p<0.05 
As  already  observed  in  the  study  of  cerebral  cortex  tissues,  none  of  the 
saturated  or  monounsaturated  fatty  acids  showed  any  differences  between 
feeding  groups  (Table  3.27).  However  relative  amounts  of  palmitoleic  acid 
(Fig  3.37)  decreased  with  age  as  confirmed  by  their  correlation  coefficients 
(Table  3.26). 
The  mean  dihomo-y-linolenic  acid  concentration  (Fig  3.41)  for  breast  fed 
infants  was  significantly  lower  than  those  for  the  SMA-fed  group  (p<0.05)  as 
76 shown  in  Table  3.27.  Perinatal  cerebellar  dihomo-y-linolenic  acid 
concentrations  (Fig  3.41)  at  about  1%  increased  rapidly  to  approximately  3% 
of  total  fatty  acids  by  8  weeks  of  age  and  then  appeared  to  decline  from  20 
weeks  onwards. 
No  statistical  difference  was  observed  in  arachidonic  acid  compositions 
between  breast  and  SMA  groups  (Fig  3.42).  Arachidonic  acid  had  a  mean 
concentration  of  about  11%  of  total  fatty  acids  which  was  maintained  in  each 
feeding  group  throughout  early  life.  The  increasing  trend  in  arachidonic  acid 
concentrations  seen  in  the  CGOST  group  could  not  be  confirmed  (or  refuted) 
in  the  other  feeding  groups  due  to  lack  of  data  from  older  infants  (Fig  3.42). 
After  perhaps  an  initial  fall  in  docosatetraenoic  acid  concentrations  in  the  first 
month  of  life  (Fig  3.43),  the  distribution  of  results  was  similar  to  that  for 
arachidonic  acid  with  a  mean  concentration  of  about  5%.  The 
docosatetraenoic  acid  composition  of  the  SMA  group  was  significantly  greater 
than  the  breast-fed  (p<0.02).  Again  the  pattern  of  CGOST  results  pertaining 
with  arachidonic  acid  was  repeated  in  the  direct  correlation  of 
docosatetraenoic  acid  concentrations  with  age  (r  =  0.843;  p<0.01). 
Docosatetraenoic  acid  concentrations  were  generally  at  their  highest  in  the 
CGOST  group.  Again  no  obvious  trend  in  results  from  the  preterm  infants  was 
evident  (Fig  3.43). 
Docosapentaenoic  acid  (Fig  3.44)  was  present  in  significantly  lower 
concentrations  in  the  breast  fed  group  than  the  SMA  group.  As  for  DTA,  the 
highest  DPA  concentrations  were  found  in  the  CGOST  group.  The  two  mixed 
fed  infants  displayed  DPA  concentrations  similar  to  those  of  breast-fed  infants 
of  a  corresponding  age.  It  was  observed  that  the  highest  concentration  of  this 
fatty  acid  (3.06%)  was  found  in  the  CGOST  preterm  infant.  It  should  be  stated 
that  although  concentrations  of  DGLA,  AA  and  DTA  (as  weight  %)  were  very 
77 similar  in  both  the  cerebellar  cortex  and  cerebral  cortex  (Figs  3.41-3.43  and 
3.16-3.18)  the  increase  in  cerebellar  cortex  DPA  in  the  term  born  CGOST 
group  infants,  to  a  maximum  of  <3%  of  total  fatty  acids  is far  less  pronounced 
than  that  seen  in  the  cerebral  cortex  (Figs3.44  and  3.19). 
Docosahexaenoic  acid  concentration  (Fig  3.45)  was  significantly  greater  in  the 
breast  fed  than  SMA  fed  group  (p<0.01).  Although  no  statistical  analysis  was 
possible,  with  the  exception  of  one  9-week  old  infant,  all  CGOST  DHA 
concentrations  were  lower  than  those  for  infants  for  equivalent  age  in  other 
feeding  groups.  Observation  of  the  term  18  week  old  mix  fed  infant  showed  a 
level  of  DRA  similar  to  that  of  the  19  week  old  exclusively  breast  fed  infant, 
whereas  the  DHA  concentration  in  the  7  week  old  preterm  mix  fed  infant  was 
more  closely  matched  with  the  term  SMA-fed  group  values  (Fig  3.45).  SMA 
group  DHA  concentrations  were  higher  than  those  of  the  SMA  preterm  group. 
In  consideration  of  the  CGOST  group  compositions  a  parallel  with  the  cerebral 
cortex  results  seemed  evident  in  the  7  week  old  infants  of  low  birth  weights 
(2.50  and  2.53  kg)  who  exhibited  relatively  reduced  DHA  concentrations  (4.88 
%  and  4.73%)  for  their  age.  Overall,  cerebellar  cortex  DHA  concentrations 
were  slightly  lower  in  each  feeding  group  than  in  the  corresponding  cerebral 
cortex  groups.  The  cerebellar  DRA  "deficit"  in  formula  fed  infants  was  again 
apparently  greatest  in  the  CGOST  group  and  the  compensatory  effect  of 
increased  incorporation  of  n-6  series  LCPUFA  seemed  more  evenly  spread 
throughout  all  of  these  fatty  acids  in  contrast  to  the  cerebral  cortex  in  which 
ultimately  incorporation  of  n-6  series  DPA  predominated  (Figs  3.44  and  3.19). 
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co  'IT  (N 3.3.4.  Phospholipids  and  cerebrosides 
The  procedure  of  HPTLC  followed  by  densitometry  was  employed  in  the  case 
of  cerebral  and  cerebellar  white  matter  to  elucidate  the  lipid  composition  of 
tissues  in  cerebral  white  matter  marked  ?  locus  and  also  to  define  the  probable 
source  of  the  increasing  lignoceric  and  nervonic  acids. 
Figures  3.46  and  3.47  show  total  phospholipids,  sulphatides  and  total 
cerebrosides  (hydroxy  and  non-hydroxy)  with  respect  to  age  for  cerebral 
parietal  white  matter  and  cerebellar  white  matter  respectively.  Ratios  were 
calculated  for  each  phospholipid  and  expressed  as  percentages  of  total 
phospholipid  and  again  plotted  with  respect  to  age  (Figs  3.48  and  3.49). 
Finally  Figure  3.50  is  a  plot  of  total  cerebrosides  versus  nervonic  acid  in 
parietal  white  matter. 
It  can  be  seen  from  Figure  3.46  that  at  birth  cerebrosides  and  sulphatides  were 
absent  in  cerebral  parietal  white  matter  and  therefore  phospholipids  account 
for  100%  of  total  lipid  (cholesterol  was  not  measured  in  this  experiment).  At 
around  8  weeks  of  age  cerebrosides  and  sulphatides  started  to  increase, 
cerebrosides  reaching  35%  of  total  lipids  and  sulphatides  about  8%  by  40 
weeks.  The  tissues  marked  ?  locus  in  contrast  displayed  detectable  and 
increasing  concentrations  of  total  cerebrosides  and  sulphatides  from  4  weeks 
of  age.  The  cerebrosides  in  particular  were  30%  of  total  lipids  in  comparison 
to  tissues  of  a  similar  age  of  less  than  10%.  This  resulted  in  an  equivalent 
decrease  in  percentages  of  total  phospholipids.  In  cerebellar  white  tissues  (Fig 
3.47)  cerebrosides  comprised  just  over  20%  of  total  lipids  at  birth  and 
sulphatides  approximately  3%.  Cerebellar  cerebrosides  rose  to  35%  by  40 
weeks  and  sulphatides  to  about  10%. 
On  examination  of  the  individual  phospholipid  ratios  for  parietal  white  matter 
(Fig  3.48),  PI  was  present  at  approximately  5%  of  phospholipids  at  birth  falling 
79 to  2%  at  40  weeks.  Sphingomyelin  was  also  present  at  5%  at  birth  but  this 
climbed  to  10%  by  40  weeks.  PS  remained  fairly  constant  at  about  15%  of 
phospholipids.  PE  rose  about  5%  over  the  period  of  study  from  between  30- 
35%  to  35-40%  whilst  PC  fell  similarly  from  40-45%  to  35-40%. 
The  cerebellar  white  tissues  (Fig  3.49)  gave  similar  ratios  PI  falling  from  5% 
at  birth  to  2%  at  40  weeks,  sphingomyelin  slightly  higher  at  8%  at  birth  rising 
to  14%,  PS  fairly  constant  around  18%,  and  both  PC  and  PE  between  30-40% 
but  no  obvious  trend  in  either  phospholipid  evident. 
The  plot  of  total  cerebrosides  versuý  nervonic  acid  (Fig  3.50)  in  parietal  white 
matter  showed  an  exponential  rise  in  nervonic  acid  with  increasing 
percentages  of  total  cerebrosides. 
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(0  u-)  le  (Y)  C,  4  CD 3.3.5.  Cerebral  parietal  white  matter  total  lipid  fatty  acids 
Table  3.28  illustrates  the  infant  group  characteristics.  Between  group 
differences  for  the  continuous  variables  (birth  weights  and  gestational  ages) 
were  assessed  by  Student's  t  test  and  those  for  dichotomous  variables  (sex 
ratio)  were  estimated  by  the  Chi-square  test. 
Table  3.28  Infant  details  for  cerebral  parietal  white  matter  tissues 
1  Infant  Data  Milk  Diet  I 
Breast  Fed  SAM  CGOST  SAM  Prem 
Birth  weight  (g)  3458(459) 
Gestational  age  (wk)  40.1(0.9) 
Age  (wk)  13.8 
Age  range  (wk)  3-38 
Male/Female  3/6 
3160(493)  2840(699)  1664(572) 
39.3(1.7)  39.0(1.5)  32.  g(2.3) 
16.0  19.1  18.6 
143  740  7-34 
7,3  c'  7/2  (1  4/1 
Results  are  shown  as  means  with  standard  deviations  in  parenthesis. 
Dichotomous  variables  were  analysed  by  X2  test  and  applied  only  to  male/female  ratios. 
a=  P<0.02 
The  results  for  the  individual  fatty  acids  for  cerebral  white  matter  are  given  in 
Table  3.29  in  the  appendix.  Twelve  major  fatty  acids  were  identified  and  the 
concentrations  of  only  three  of  these,  namely  myristic  (Fig  3.51),  stearic 
acid(Fig  3.54)  and  dihomo-y  -linolenic  acid  (Fig  3.56)  did  not  vary  with  age  as 
shown  in  Table  3.30.  Group  results  expressed  as  weight  percentages  of  total 
lipid  fatty  acids  are  therefore  shown  as  medians  and  ranges  for  all  fatty  acids 
(Table  3.3  1). 
The  three  which  did  not  vary  with  age  were  subjected  to  Student's  t  test  to 
check  for  differences  between  feeding  groups  and  these  results  are  presented 
in  Table  3.32.  The  remaining  fatty  acid  compositions  were  plotted  with 
respect  to  age  and  diet  and  where  data  could  be  normalised.  by  logarithmic 
81 transformation,  this  was  performed  and  the  derived  curves  presented  for 
lignoceric  (Fig  3.61)  and  nervonic  acid  (Fig  3.62).  Equations  for  the  curves 
are  given  for  each  term  bom  group  and  the  effect  of  diet  and  age  detennined 
by  application  of  the  general  linear  model  analysis  of  covariance  over  the 
restricted  age  range  9-24  weeks  inclusive  (Minitab  10).  The  significance  level 
was  set  at  p<0.02  and  the  results  presented  in  Table  3.34. 
Table  3.30  Correlation  coefficients  for  cerebral  parietal  white  matter 
fatty  acid  concentration  vs  age  in  relation  to  diet 
Fatty  Acid  Breast  SNIA  CGOST  SMA  Prem 
r  r  r  r 
C14:  0  0.81058  0.0363  -0.6290  0.3306 
C16:  0  -0.87348  -0.88778  -0.85538  -0.9581 
C16:  1  n-7  -0.3740  -0.91528  -0.76018  -0.89638 
C18:  0  -0.6494  -0.1807  -0.1801  0.91388 
C18:  1  0.86508  0.94338  0.93048  0.90798 
C20:  3  n-6  0.2999  0.2975  -0.3758  -0.4294 
C20:  4  n-6  -0.82438  -0.83578  -0.90468  -0.4770 
C22:  4  n-6  0.89718  0.84688  0.82968  0.8085 
C22:  5  n-6  -0.84355  -0.71295  -0.74135  -0.7841 
C22:  6  n-3  -0.90998  -0.99318  -0.95458  -0.7396 
C24:  0  0.81118  0.78148  0.81918  0.93698 
C24:  1  n-9  0.79208  0.97258  0.93698  0.7944 
5=  Significant  correlation  of  individual  fatty  acid  concentrations  (wt  %)  with  age.  (p<0.01) 
Otherwise  data  points  for  each  group  were  merely  analysed  by  visual 
inspection  for  general  trends  without  application of  statistical  analysis,  again 
due  to  lack  of  age-matching  of  individuals.  This  analysis  applied  to  palmitic 
(Fig  3.52),  oleic  (Fig  3.55),  arachidonic  (Fig  3.57),  docosatetraenoic  (Fig 
82 3.58),  docosapentaenoic  (Fig  3.59)  and  docosahexaenoic  acid  (Fig  3.60) 
concentrations. 
Table  3.31  Cerebral  parietal  white  matter  and  myelin 
total  lipid  fatty  acid  compositions 
Fatty  Acid  Milk  Diet 
Breast  SMA  CGOST  SMA-Prem 
n=9  n=]O  n=9  n=S 
C14:  0  1.40  1.36  1.20  1.48 
(0.92-2.48)  (1.12-1.97)  (1.02-1.76)  (1.22-1.77) 
C16:  0  24.50  24.65  21.63  27.95 
(18.43-29.43)  (19.66-29.66)  (19.94-27.97)  (21.99-29.60) 
C16:  ln-7  2.38  2.37  2.19  2.54 
(2.19-3.22)  (1.52-3.11)  (1.26-2.97)  (1.73-3.03) 
C18:  0  22.50  23.10  22.56  22.57 
(21.15-23.69)  (20.91-24.71)  (20.67-24.15)  (21.74-23.72) 
C  18:  1  n-7+n-9  19.43  18.02  20,66  16.33 
(14.12-26.49)  (14.79-28.03)  (14.07-28.50)  (14.46-21.48) 
C20:  3n-6  1.47  1.53  1.56  1.75 
(0.95-1.66)  (0.73-1.95)  (1.11-1.75)  (1.28-2.62) 
C20:  4n-6  9.53  10.50  10.09  10.55 
(7.00-11.90)  (6.95-11.37)  (6.15-11.81)  (9.76-12.19) 
C22-.  4n-6  6.96  7.23  8.24  6.80 
(6.11-9.34)  (6.20-8.45)  (7.12-9.26)  (6.14-9.10) 
C22:  5n-6  1.62  2.20  2.93  2.69 
(0.48-2.49)  (1.24-3.06)  (1.84-4.03)  (2.18-3.42) 
C22:  6n-3  7.23  6.22  3.81  4.42 
(3.67-9.24)  (3.24-8.76)  (1.78-6.93)  (3.24-7.25) 
C24:  0  1.46  1.31  1.35  0.36 
(<0.10-3.14)  (<0.10-2.68)  (<0.10-2.72)  (<0.10-2.19) 
C24:  I  n-9  1.01  1.25  2.06  0.69 
I 
i 
(<O.  10-3.93)  (<O.  10-4.22)  (<O.  10-4.3  0)  (<O.  10-2.47) 
Fatty  acids  are  expressed  as  weight  percentages  and  are  given  as  medians  and  ranges 
The  five  points  displayed  on  the  graphs  marked  "?  Locus"  refer  to  tissues 
collected  consecutively  over  a  four  month  period  (March  -  June  1994)  and  as 
can  be  seen  most  of  their  fatty  acid  compositions  were  markedly  different  from 
those  of  infants  of  the  same  age.  These  tissues  were  reanalysed  and  similar 
results  obtained.  With  their  relatively  "increased"  levels  of  lignoceric  and 
nervonic  acids,  it  would  appear  that  they  may  have  been  obtained  from  a  site 
83 outwith  the  white  matter  parietal  lobe  and  in  which  the  myelination  process 
had  occurred  at  an  earlier  age.  This  assertion  could  not  be  confirmed  by  our 
pathology  colleagues.  However  as  the  results  were  obtained  only  during  this 
short  period  of  time,  the  derived  data  was  considered  separately. 
Table  3.32  "t"  test  p  values  for  cerebral  white  fatty  acids 
Feed  C14:  0  C18:  0  C20:  3 
BF/SMA  0.9364  0.03746  0.5133 
BF/CGOST  0.2960  0.7490  0.2291 
SMA/CGOST  0.1763  0.6341  0.7799 
There  were  no  significant  differences  between  feeding  groups  in  myristic  acid 
(Fig  3.5  1)  as  determined  using  Student's  'T'  test  and  as  already  mentioned  the 
concentration  of  this  fatty-  acid  did  not  vary  with  age  being  maintained  between 
I  and  2%.  In  the  parietal  central  white  matter  neonatal  palmitic  acid 
concentrations  represented  around  30%  of  total  fatty  acids.  Thereafter  a 
downward  cascade  in  results  was  apparent  in  all  the  term  bom  infant  feeding 
groups.  Subsequently  palmitic  acid  levels  stabilised  at  about  20%  after  5 
months.  It  appeared  that  there  was  an  approximate  4  week  "delay"  in  this 
palmitic  acid  reduction  in  the  preterm  SMA  infants  with  respect  to  the  term 
SMA  group  and  an  equivalent  delay  in  the  latter  group  when  comparison  was 
made  with  infants  in  the  breast-fed  group.  The  CGOST  group  palmitic  acid 
concentrations  tended  to  occupy  intermediary  positions  between  those  of  the 
SMA  and  breast-fed  infants  of  similar  age  (Fig 3.52). 
A  reversal  of  this  pattern  of  results  was  encountered  on  examination  of  the 
oleic  acid  concentrations  (Fig  3.55).  From  neonatal  compositions  at  15%  of 
total  fatty  acids  a  rapid  increase  occurred  to  a  maximum  of  between  25  and 
84 30%  towards  the  end  of  the  first  year  of  life  in  the  main  feeding  groups.  It  was 
apparent  that  the  rise  in  oleic  acid  concentrations  was  instigated  about  one 
month  earlier  in  the  breast  fed  than  formula  fed  infants  and  that  a  subsequent 
further  "delay"  in  oleic  acid  accretion  may  exist  between  the  term  and  preterm 
SMA  fed  infants  respectively.  Whilst  the  highest  palmitic  acid  level  was  found 
in  the  7  week  old  mixed  fed  preterm  (32  weeks  gestation)  infant,  in  contrast 
this  individual  also  displayed  the  lowest  oleic  acid  concentration. 
Palmitoleic  acid  concentrations  (Fig  3.53)  fell  sharply  in  the  first  two  months 
and  from  hence  more  gradually.  After  transformation  of  data,  results  were 
subjected  to  ANCOVA  analysis  (Table  3.33).  No  between  group  dietary 
differences  were  revealed  (p>0.02). 
Table  3.33  ANCOVA  statistics  for  palmitoleic  acid 
Feed  Diet  Age  DietxAge 
Breastl  0.234  <0.001  0.538 
SNIA 
Breastl  0.435  <0.001  0.613 
CGOST 
SNW  0.556  <0.001  0.365 
CGOST 
There  were  no  significant  differences  between  groups  in  stearic  acid  (Fig  3.54) 
as  calculated  by  Student's  'T'  test  and  no  concentrations  outwith  a  narrow 
band  from  20  to  25%  of  total  fatty  acids.  After  a  slight  rise  in  neonatal 
dihomo-y-linolenic  acid  (Fig  3.56)  subsequent  concentrations  were  fairly  static 
at  about  1.5%  of  total  fatty  acids.  There  were  no  significant  differences 
between  feeding  groups. 
85 Arachidonic  acid  concentrations  remained  relatively  constant  at  about  II%  of 
total  fatty  acids  in  all  feeding  groups  during  the  first  two  months  of  life  (Fig 
3.57).  This  was  immediately  followed  by  a  steady  decline  in  arachidonic  acid 
compositions  initially  exclusively  in  the  breast-fed  group.  After  a  further  6 
weeks  of  life  this  pattern  of  results  was  repeated  in  the  term  born  SMA  and 
CGOST  formula  fed  infants.  At  40  weeks  of  age  AA  concentrations  in  all 
feeding  groups  appeared  to  converge  at  values  between  6  and  7%  of  total  fatty 
acids.  In  the  small  preterm  SMA  fed  group,  AA  results  may  be  indicative  of  a 
further  "postponement"  in  their  reduction  with  respect  to  their  term  born 
equivalents  and  indeed  the  highest  AA  concentration  encountered  (12.2%) 
was  that  of  the  17  week  old  preterm  SMA  fed  infant  (Fig  3.57). 
In  contrast  to  the  cerebral  cortex  analysis  in  which  docosatetraenoic  acid 
concentrations  merely  mirrored  those  of  AA,  albeit  at  about  half  of  the 
composition  (12%  vs  6%),  in  the  cerebral  white  matter  DTA  concentrations 
commenced  at  between  6  and  7%  but,  uniquely  among  the  polyunsaturated 
fatty  acids,  increased  in  concentration  with  time  until  by  40  weeks  they  were 
ultimately  in  excess  of  those  of  AA  at  about  9%  of  total  fatty  acids  in  each 
feeding  group.  Docosatetraenoic  acid  (Fig  3.58)  concentrations  did  not 
however  appear  to  be  significantly  different  between  feeding  groups,  with  all 
groups  displaying  a  similar  rising  trend  over  the  40  week  period. 
Docosapentaenoic  acid  was  never  prominent  in  any  feeding  group  with 
concentrations  seldom  higher  than  4%  of  total  fatty  acids  and  declining 
universally  to  under  3%  by  20  weeks  of  age.  The  initial  reduction  in  the  breast 
fed  infants  in  advance  of  the  formula  fed  groups  (by  a  minimum  of  5  weeks) 
was  again  a  notable  feature  of  the  results  (Fig 3.59). 
Docosahexaenoic  acid  concentrations  at  birth  represented  ca  9%  of  total  fatty 
acids  and  underwent  a  similar  fall  in  values  as  those  of  AA,  however  the 
86 earlier  reduction  in  the  breast  fed  infants  was  here  reversed  with  the  initial 
steep  decline  noted  in  the  SMA  preterm  and  CGOST  fed  groups  marginally  in 
advance  of  that  detected  in  both  the  SMA  and  breast-fed  groups  (Fig  3.60).  By 
about  20  weeks,  all  results  have  tended  to  coalesce  at  a  minimum  of  4%  of 
total  fatty  acids  in  all  feeding  groups  (although  a  further  overall  reduction  in 
the  CGOST  fed  group  may  be  evident). 
Examination  of  the  age-related  nervonic  acid  and  lignoceric  acid  compositions 
(Figs  3.61  and  3.62  respectively)  demonstrated  "parallel"  logarithmic  curves  in 
which  the  increase  for  breast-fed  and  formula-fed  infants  was  evident  at  the 
end  of  approximately  two  and  three  months  respectively.  Although 
insufficient  data  for  the  preterm  infants  precluded  statistical  analysis,  there 
appeared  to  be  in  general  a  ftirther  delay  in  their  accretion  relative  to  their  term 
counterparts. 
Table3.34  ANCOVA  statistics  for  lignoceric  and  nervonic  acids 
Lignoceric  acid  Nervonic  acid 
Feed  Diet  Age  DietxAge  Diet  Age  DietxAge 
Breast/  <0.001  <0.001  0.193  <0.001  <0.001  0.839 
SMA 
Breast/  0.007  <0.0.01  0.788  0.007  <0.001  0.961 
CGOST 
SMA/  0.027  <0.001  0.282  0.005  <0.001  0.805 
CGOST 
Although  present  in  the  figures  (3.61  and  3.62)  the  lignoceric  and  nervonic 
concentrations  which  were  undetected  (<O.  I%  of  total  fatty  acids)  were 
excluded  from  the  statistical  analysis.  As  a  result  logarithmic  curves  could  be 
derived  for  lignoceric  and  nervonic  acids  only  for  the  term  infant  groups.  A 
significant  dietary  effect  on  both  lignoceric  and  nervonic  acid  concentrations 
87 was  found  between  the  breast-fed  and  both  SMA-fed  (p<0.001)  and  CGOST- 
fed  infants  (p  =0.007)  by  ANCOVA  analysis  over  the  age  range  9-  24  weeks. 
It  was  less  clear  that  a  significant  dietary  effect  existed  between  the  SMA  and 
CGOST  groups  in  cerebral  white  lignoceric  acid  (p  =  0.027)  although  the 
difference  was  more  emphatic  in  nervonic  acid  (p  =  0.005). 
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Figure  3.62  -  Cerebral  parietal  white  matter  and  myelin 
nervonic  acid  (C24:  1)  in  relation  to  infants'  diet  and  age. 
0X0, 3.3.6.  Cerebellar  white  matter  total  lipid  fatty  acids 
Table  3.35  illustrates  the  infant  group  characteristics.  Between  group 
differences  for  the  continuous  variables  (birth  weights  and  gestational  ages) 
were  assessed  by  Student's  t  test  and  those  for  dichotomous  variables  (sex 
ratio)  were  estimated  by  the  Chi-square  test. 
Table  3.35  -  Infant  details  for  cerebellar  white  matter  tissues 
Infant  Data  Afilk  Diet 
Breast  SAIA  CGOST  C&G  SAIA 
Fed  Prem 
Birth  weight  (g)  3292  3147  2812  2978  2160 
(507)  (395)  (672)  (169)  (253) 
Gestational  age  39.9  38.6  38.9  38.5  34.2 
(wk)  (1.3)  (1.2)  (1.4)  (0.5)  (1.3) 
Age  (wk)  9.4  10.8  17.8  18.0  20.2 
Age  range  (wk)  1-19  0.5-19  640  5-33  7-34 
Male/Female  3/6  7/3  8/2  a  2/2  4/1 
Results  are  shown  as  means  with  standard  deviations  in  parenthesis. 
Dichotomous  variables  were  analysed  by  X2  test  and  applied  only  to  male/female  ratios. 
a=  P<0.02. 
Results  for  individual  fatty  acids  for  each  cerebellar  white  tissue  are  presented 
in  Table  3.36  in  the  appendix.  These  values  have  been  adjusted  for  detector 
response  factors  and  recalculated  to  100%.  Results  for  cerebellar  white  matter 
total  lipid  fatty  acids  are  shown  in  Figures  3.63  -  3.72  where  they  have  been 
plotted  with  respect  to  feeding  group  and  age  (excluding  C14:  0,  C20:  1  and 
C20:  2).  The  correlation  coefficients  for  the  main  feeding  groups  for  each  fatty 
acid  are  listed  in  Table  3.37.  In  general  groups  were  not  composed  of  age- 
matched  individuals  and  as  several  fatty  acid  concentrations  were  age- 
dependent  it  was  not  possible  to  assess  feeding  group  differences  using  a 
standard  parametric  analytical  procedure.  However  breast-fed  and  SMA-fed 
infants  could  be  age-matched  (to  within  I  week)  and  the  resultant  8  data  pairs 
were  assessed  using  the  Wilcoxon  signed  rank  test.  Note  that  this  required 
exclusion  of  one  9  week  old  breast-fed  and  two  17  week  old  SMA-fed  infants. 
89 No  such  age  matching  was  possible  with  the  CGOST  group  as  this  tended  to 
be  populated  by  "older"  individuals  than  either  the  breast  or  SMA-fed  groups 
(Table  3.35).  Neither  did  the  results'  distributions  with  respect  to  age,  allow 
for  nonnalisation  of  the  data. 
Table  3.37  Correlation  coefficients  for  cerebellar  white  matter 
fatty  acid  concentration  vs  age  in  relation  to  feeding  group 
Fatty  Acid  Breast  SMA  CGOST  C&G  SMA  Prem 
r  r  r  r  r 
C14.0  0.0171  -0.0870  -0.3058  1  -0.5960  --0.6180 
C16:  0  -0.95298  -0.97648  -0.5326  -0.4982  -0.8432 
C16:  1  n-7  -0.9167 
8 
-0.96038  -0.5845  -0.8528  -0.6382 
C18:  0  0.74825  0.3016  0.0701  0.9636  r'  0.5983 
C18:  1  0.81908  0.94908  0.5033  0.97728  0.7905 
C20:  1  0.92158  0.95458  0.6409  0.6546  0.7719 
C20:  2  0.82248  0.85898  0.1662  0.1977  0.7773 
C20:  3  n-6  0.6228  0.3333  -0.1766  -0.3699  -0.5025 
C20:  4  n-6  -0.82508  -0.92586  -0.2617  -0.92806  -0.7845 
C22:  4  n-6  0.5065  0.3150  0.5446  -0.95098  0.7450 
C22:  6  n-3  -0.7227  -0.88918  -0.6046  -0.7291  -0.89708 
C24:  0  0.6634  0.7306  0.0663  0.3211  0.6350 
C24:  1  0.88698  0.94398  0.4299  0.96228  0.7771 
5=  Significant  correlation  of  individual  fatty  acid  concentrations  (wt  %)  with  age.  (p<0.0  I) 
Table  3.38  lists  medians  and  ranges  for  each  fatty  acid  together  with  the 
Wilcoxon  signed  rank  test  significances  for  the  paired  breast-fed  and  SMA 
groups.  In  addition  a  non-statistical  visual  inspection  of  results  for  all  groups 
was  undertaken  to  assess  the  general  trends  in  fatty  acid  incorporation  into 
infant  cerebellar  white  matter. 
90 Table  3.38  Cerebellar  white  matter  and  myelin  total  lipid 
fatty  acid  compositions 
FallyAcid  Alilk  Diet 
Breast  SAIA  CGOST  C&G  SMA  Prem 
n=9  n=10  n=10  n=;  4  n=5 
C14:  0  1.38  1.32  0.98  1.27  1.53 
(1.05-2.22)  (0.72-1.58)  (0.79-1.60)  (0.83-1.56)  (0.92-2.51) 
C16:  0  19.82  19.93  19.13  19.94  19.27 
(16.74-22.93)  (16.68-24.12)  (15.62-23.80)  (16.44-22.86)  (15.67-26.10) 
C  16:  1  n-7  2.70  2.52  2.07  2.40  2.65 
(2.03-3.69)  (1.78-3.43)  (1.20-3.36)  (2.00-2.96)  (1.77-3.43) 
C18:  0  21.50  22.32  22.96  22.67  21.06 
(19.38-22.84)  (21.13-23.64)  (19.36-25.55)  (20.53-25.09)  (20.43-22.55) 
C18:  1  27.10  26.83  28.97  28.39  27.93 
n-7+n-9  (22.74-31.41)  (21.36-30.69)  (24.30-31.49)  (25.35-31.17)  (25.35-31.50) 
C20:  1  n-9  1.59  1.59  1.84  2.14  2.12 
(0.99-2.55)  (0.60-2.31)  (1.11-2.54)  (1.17-3.77)  (0.65-2.89) 
C20:  2  n-6  0.74  0.80  0.78  0.88  1.03 
(0.49-0.97)  (0.42-1.07)  (0.49-1.09)  (0.76-1.59)  (0.51-1.11) 
C20:  3  n-6  1.49  1.39  1.47  1.63  1.75 
(0.98-1.96)  (0.97-1.80)  (1.11-2.05)  (1.23-1.92)  (1.38-2.23) 
C20:  4  n-6  7.60  7.32  7.11  6.20  7.11 
(5.81-9.55)  (5.94-9.89)  (5.34-9.86)  (4.68-7.17)  (5.47-8.93) 
C22:  4  n-6  5.72  6.47  a  5.80  5.91  6.67 
(5.00-6.58)  (5.23-7.20)  (4.56-7.54)  (4.73-6.66)  (4.88-7.76) 
C22-6  n-3  6.55  4.76 
b  3.43  3.44  4.03 
(4.32-10.24)  (2.64-8.16)  (2.06-5.56)  (1.99-4.25)  (2.32-6.28) 
C24:  0  1.88  2.23  a  2.23  2.59  2.23 
(1.29-2.48)  (1.60-2.96)  (1.18-3.27)  (2.21-3.08)  (0.75-3.04) 
C24:  1  n-9  2.25  2.62  2.91  3.90  3.24 
(1.12-3.12)  (0.91-4.14)  (0.70-4.65)  (2.29-5.66)  (0.70-4.15) 
Fatty  acids  are  expressed  as  weight  percentages  and  are  given  as  medians  and  ranges 
Significant  differences  in  fatty  acid  concentrations  between  feeding  groups  (BF  vs  SMA  only) 
were  calculated  by  the  Wilcoxon  signed  rank  test  for  paired  data  (n7-8) 
a=  p<0.02;  b=  p<0.01 
As  represented  by  the  medians  (and  ranges)  there  would  appear  to  be  little 
variation  in  the  fatty  acid  concentrations  between  groups  in  cerebellar  white 
matter.  Palmitic  acid  (Fig  3.63)  decreased  in  concentration  from  around  24% 
at  birth  to  less  than  20%  by  5  months  of  age  in  all  feeding  groups.  Absence  of 
data  for  older  (>20  weeks)  infants  in  both  the  breast-fed  and  term  born  SMA- 
91 fed  groups  precluded  a  comparative  between  group  analysis  beyond  this  age. 
The  median  concentration  for  palmitic  acid  was  approximately  20%  for  all 
feeding  groups  and  within  a  range  of  16  to  24%  in  the  term  born  infants. 
Higher  concentrations  were  revealed  however  in  the  7  week  old  preterm  SMA 
(26.10%)  and  mixed-fed  (28.37%)  infants.  Although  a  similar  trend  in  results 
was  noted  in  cerebral  white  matter  for  both  the  preterin  and  term  infants,  the 
median  concentrations  were  about  5%  higher  in  this  tissue  (Fig  3.52). 
Palmitoleic  acid  fell  sharply  in  the  first  10  weeks  of  life  and  then  stabilised  at 
about  2%  of  total  fatty  acids  (Fig  3.64).  It  was  observed  that  for  stearic  acid 
cerebellar  white  matter  medians  and  ranges  (Table  3.38)  were  very  similar  to 
those  of  cerebral  white  matter  (Table  3.31).  At  approximately  23%  at  birth, 
oleic  acid  concentrations  (Fig  3.66)  increase  rapidly  over  the  first  5  months  to 
>30%  of  total  fatty  acids  by  25  weeks.  Whilst  as  discussed  the  lowest  brain 
total  lipid  palmitic  acid  concentrations  were  present  in  the  cerebellar  white 
matter,  the  converse  is  true  for  oleic  acid.  No  significant  differences  were 
found  in  saturated  and  monounsaturated  fatty  acids  between  the  breast-fed  and 
term  born  SMA-fed  groups  by  the  Wilcoxon  test. 
Dihomo-y  -linolenic  acid  (Fig  3.67)  was  present  at  fairly  low  concentrations 
(about  1.5%  of  total  fatty  acids)  in  all  feeding  groups.  The  remaining 
polyunsaturated  fatty  acids,  AA,  DTA  and  DHA,  all  exhibited  lower  group 
medians  and  ranges  than  in  the  equivalent  cerebral  white  matter  tissues. 
Arachidonic  acid  concentrations  (Fig  3.68)  fell  from  around  10%  of  total  fatty 
acids  at  birth  to  about  7%  at  10  weeks  of  age  and  thereafter  remained  relatively 
constant.  No  overt  between  group  differences  were  apparent  and  the  results 
ftom  the  pretenn  infants  appeared  to  be  confined  within  the  ranges  established 
for  the  term  bom  groups.  Again  no  statistically  significant  difference  existed 
between  the  paired  breast  and  SMA-fed  infants.  Concentrations  of 
docosatetraenoic  acid  (Fig  3.69)  were  significantly  higher  in  the  age-matched 
SMA-fed  infants  than  those  breast-fed  (p<0.02).  In  stark  contrast  to  its 
92 behaviour  in  the  cerebral  white  matter  in  which  its  concentration  increased  by 
50%  over  the  first  6  months,  here  docosatetraenoic  acid  did  not  display  any 
significant  positive  correlation  with  age.  Median  concentrations  were 
maintained  at  about  6%  of  total  fatty  acids  in  all  groups  and  on  no  occasion 
could  the  results  of  the  preterm  infants  be  classified  as  outliers.  Interestingly 
n-6  series  docosapentaenoic  acid  was  never  a  prominent  feature  in  the 
cerebellar  white  matter  fatty  acids  accounting  for  <0.5%  of  total  fatty  acids  and 
not  considered  in  this  analysis.  Docosahexaenoic  acid  concentrations  were 
significantly  greater  in  the  breast-fed  infants  than  their  age-matched  SMA-fed 
counterparts  (p<0.01).  Neonatal  DHA  compositions  varied  widely  (Fig  3.70) 
but  decreased  to  <5%  of  total  fatty  acids  in  all  formula  fed  infants  by  10  weeks. 
A  subsequent  further  decline  to  about  3%  was  evident  in  the  older  (>20 
weeks)  infants.  As  defined  by  the  statistical  analysis  (Wilcoxon)  DHA 
concentrations  in  the  breast-fed  infants  were  generally  greater  than  those  of 
age-equivalent  formula  fed  infants,  but  they  too  declined  inexorably  to  around 
5%  of  total  fatty  acids  before  20  weeks  of  life. 
Whereas  both  lignoceric  and  nervonic  acids  increased  with  age  in  cerebral 
white  matter,  the  former  did  not  show  a  correlation  with  age  in  cerebellar 
white  matter  in  any  feeding  regimen  with  lignoceric  acid  concentrations 
appearing  randomly  distributed  with  age.  Lignoceric  acid  (Fig  3.71)  was 
however  significantly  greater  in  the  SMA  group  than  the  breast-fed  group 
(p<0.02).  Unlike  the  polyunsaturated  fatty  acids,  however,  in  which  the  results 
from  the  preterm  infants  were  indistinguishable  from  their  term  born 
contemporaries,  here  the  youngest  (7  weeks  old)  preterm  infants  displayed  the 
lowest  concentrations  of  lignoceric  acid  (SMA  fed-0.75%;  mixed-fed  -  0.67%), 
the  corollary  of  that  in  the  precursor  palmitic  acid  (Fig  3.63).  Nervonic  acid 
concentrations(Fig  3.72)  were  approximately  1%  of  total  fatty  acids  at  birth 
increasing  to  4%  at  about  5  months.  This  was  in  contrast  to  cerebral  parietal 
white  matter  where  both  nervonic  acid  and  lignoceric  acid  were  undetected  at 
93 birth  and  for  the  first  8  weeks  of  life.  No  significant  differences  in  nervonic 
acid  existed  between  the  age-matched  breast  and  SMA-fed  individuals.  The 
youngest  preterni  individuals  were  again  identified  with  the  lowest  nervonic 
acid  concentrations  (Fig  3.72). 
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DISCUSSION 4.1.  Method  Evaluation 
There  follows  a  brief  discussion  of  the  method  evaluations  followed  by 
consideration  of  patient  results. 
4.1.1.  Chromatography 
One-dimensional  chromatography  is  preferred  as  a  preparative  step  for  the 
separation  of  phospholipids  owing  to  the  larger  amount  of  sample  which  can 
be  applied  to  each  plate.  Working  conditions,  particularly  temperature  and 
humidity,  must  however  be  fairly  rigidly  controlled  to  ensure  reproducible 
separation  (Tsao,  1982).  This  was  not  possible  in  the  department  as  the  room 
temperature  could  vary  by  I  O'C  from  day  to  day  or  even  during  the  course  of  a 
day.  Controlling  the  temperature  by  immersing  the  tanks  in  a  water  bath  was 
tried  for  a  short  time  but  this  did  not  improve  consistency  of  separation.  It  is 
apparent  from  the  results  of  more  particularly  the  saturated  fatty  acids  that  PC 
and  PE  bands  were  not  discrete  (Tables  3.1  and  3.2)  but  on  occasion  were 
merged  with  other  lipids.  This  resulted  in  high  standard  errors  (e.  g.  breast-fed 
group  PC  C16:  0)  compared  with  those  associated  with  two-dimensional  TLC 
(Tables  3.21  and  3.22). 
Two-dimensional  chromatography  was  thus  employed  to  ensure  complete 
separation  of  the  major  phospholipids  from  those  present  in  lesser  amounts. 
Several  solvents  were  assessed  to  find  the  combination  most  suitable  for  the 
separation  of  PC,  PE  and  PS.  Two  chromatography  plates  were  spotted  per 
sample  in  order  to  obtain  sufficient  material  to  derivatise  PS  which  is  present 
at  a  much  lower  concentration  than  PC  and  PE. 
In  recent  years,  several  groups  of  workers  have  chosen  HPLC  for  the 
separation  of  the  phospholipids  (Yeo  and  Horrocks,  1988;  Hundreiser  and 
Clark,  1988).  This  technique  has  the  advantage  of  quantifying  phospholipid 
95 classes  as  it  is  non-destructive.  The  intact  phospholipid  fractions  can  then  be 
subsequently  analysed  for  their  fatty-  acid  composition. 
4.1.2.  Recovery  studies 
These  studies  which  were  carried  out  by  Abbasi  (1989)  demonstrated  that  over 
80%  of  lipid  was  recovered  in  the  first  chlorofonn/methanol  extraction  (Table 
3.3)  therefore  a  single  organic  extraction  without  internal  standard  was 
performed  routinely.  Accurate  weighing  of  specimens  proved  impractical 
because  of  their  varying  degree  of  hydration  on  receipt.  For  this  reason  all 
fatty  acid  data  presented  in  this  study  were  expressed  as  weight  percentage  of 
total  fatty  acids  rather  than  weight  percentage  of  unit  tissue  weight  although  it 
is  appreciated  that  the  latter  leads  to  a  clearer  picture  of  overall  LCPUFA 
incorporation  in  the  growing  brain. 
4.1.3.  Precision  studies 
As  a  result  of  the  good  precision  in  both  GLC  and  GCMS  techniques,  it  was 
considered  that  this  minimisation  of  error  would  enhance  the  identification  of 
significant  differences  in  fatty  acid  compositions  between  feeding  groups. 
4.1.4.  GCMS 
The  introduction  of  the  GCMS  resulted  in  slightly  lower  overall  CVs  probably 
largely  due  to  automatic  sampling.  Capillary  columns  allowed  improved 
separation  of  fatty  acids  with  the  added  benefit  of  split  injection,  neither  of 
which  were  fitted  to  the  GLC  system  used  in  the  study.  In  addition  mass 
spectrometry  offered  identification  of  unknown  compounds.  Mead 
acid  was  identified  by  GCMS  from  its  fragmentation  patterns,  when  compared 
with  a  commercial  standard.  On  a  similar  theme,  there  were  occasions  when 
other  unidentified  peaks  appeared  on  the  chromatogram.  By  use  of  the  GCMS 
these  were  rapidly  identified  as  phthalates  which  are  commercial  plasticisers 
and  most  probably  arose  due  to  cross-contamination  from  pipette  tips. 
96 The  derivatisation  procedure  of  esterification  continued  to  be  employed  with 
the  introduction  of  the  GCMS,  although  other  derivatives  such  as  pyrrolidides 
or  picolinyl  esters  are  often  recommended  as  methods  of  choice.  Methyl  esters 
provided  adequate  sensitivity  for  the  purposes  of  the  study  and  also  gave 
satisfactory  El  fragmentation  patterns  which  were  readily  compared  to  a  library 
compiled  from  commercial  standards. 
4.1.5.  Human  and  Formula  Milks 
Breast  milk  fatty  acid  concentrations  from  our  local  milk  bank  (Table  3.12) 
were  compared  with  data  published  world-wide  and  quoted  in  the  methods 
chapter  (Tables  2.3).  Remarkably  there  is  little  apparent  demographic  effect 
on  breast  milk  fatty  acid  compositions  (Koletzko  et  al.,  1992)  with  the 
exception  of  populations  with  a  high  dietary  fish  intake  such  as  those  of  the 
Penang  (Table  2.3)  and  Inuit  mothers  (Innis,  1992)  in  whom  breast  milk  DHA 
concentrations  were  at  their  highest.  Prior  to  the  more  extensive  analyses  of 
human  milks  (Jensen  et  al.,  1992)  which  have  included  identification  of 
positional  (cis:  trans)  isomers,  trans  fatty  acids  (Koletzko,  1992)  and  the  army 
of  LCPUFA  present  in  trace  amounts,  lack  of  knowledge  has  led  to  the 
formulation  of  milk  substitutes  bereft  of  all  LCPUFA.  To  date,  however,  no 
viable  human  milk  sample  devoid  of  the  major  cerebral  LCPUFA,  arachidonic, 
docosatetraenoic  and  docosahexaenoic  acids,  has  been  identified. 
4.2.  Study  results 
It  is  appreciated  that  ideally  there  should  be  equal  numbers  of  subjects  in  each 
feeding  group  and  also  that  the  subjects  should  be  age-matched.  However,  by 
the  very  nature  of  this  study  using  tissue  from  cot-death  infants,  this  was  not 
possible.  The  incidence  of  cot  death  has  also  fallen  appreciably  over  the 
period  since  the  start  of  the  study.  The  Greater  Glasgow  Health  Board  area 
has  very  low  levels  of  breast-feeding  (27%)  when  compared  to  other  areas  of 
Scotland  (Aberdeen  -  53%)  (Ferguson  et  aL,  1994)  and  therefore  it  has  been 
97 difficult  to  obtain  tissues  fi7om  exclusively  breast-fed  infants  especially  in  the 
older  ages.  The  same  philosophy  applies  to  sex-matching  of  groups.  Statistical 
differences  were  found  between  groups  with  a  preponderance  of  females  in  the 
breast  fed  group  and  in  general  males  in  the  formula  fed  groups. 
Tissues  from  premature  infants  were  also  analysed.  Although  insufficient  data 
were  available  for  statistical  analysis,  it  was  nevertheless  included  as 
observational  data  in  view  of  the  unique  neurodevelopmental.  and  vascular 
disorders  associated  with  prematurity  (Crawford  et  aL,  1997). 
Ilis  discussion  section  is  set  out  similarly  to  the  results  section  examining  the 
results  for  each  part  of  the  infant  brain  separately  and  then  a  final  section 
reviewing  the  results  obtained  with  published  research  on  infant  visual  and 
neurodevelopmental  outcomes. 
4.2.1.  Cerebral  Cortex 
It  appears  that  irrespective  of  wide  variation  between  infant  formula  feeds  in 
their  content  of  saturated  and  mono-unsaturated  fatty  acids,  "genetic"  control 
has  a  powerful  influence  on  the  incorporation  of  these  fatty  acids  into  the 
cerebral  cortex.  Direct  dietary  uptake  or  de  novo  synthesis  of  saturated  and 
mono-unsaturated  fatty  acids  must  supply  the  cerebral  cortical  tissue,  although 
it  is  thought  that  the  ma  ority  of  cerebral  saturated  fatty  acids  and  cholesterol 
are  synthesised  in  situ  (Edmond  et  aL  1991).  If  this  apparently  strictly 
controlled  mechanism  also  operates  for  LCPUFA,  where  synthesis  would 
require  the  parent  essential  linoleic  and  a-linolenic  fatty  acids  to  be  available, 
then  the  mechanism  is  clearly  under  severe  stress  in  the  postpartum  period  and 
may  have  failed  to  operate  in  the  case  of  two  preterm  singletons  and  two 
unrelated  7  week  old  twin  infants. 
98 Before  the  introduction  of  the  new  Cow  &  Gate  (1990)  formula, 
manufacturers'  milks  (in  the  UK)  did  not  contain  more  than  1.5%  by  weight  of 
cc-linolenic  acid  and,  unlike  breast  milk,  were  devoid  of  endogenous  DHA. 
These  formula  milks  also  had  higher  than  recommended  (Aggett  et  al  1991) 
n6:  n3  essential  fatty  acid  ratios  of  between  10:  1  -  40:  1  and  low  absolute 
amounts  of  (x-linolenic  acid.  As  linoleic  and  (x-linolenic  acids  are  metabolised 
by  essentially  the  same  elongase  and  desaturase  enzyme  systems,  the  increased 
competition  provided  by  linoleic  acid  may  in  turn  have  had  an  inhibitory  effect 
on  the  enzymatic  formation  of  DHA  from  its  parent  (x-linolenic  acid.  This 
appears  to  be  reflected  in  the  lower  percentages  of  n-3  series  fatty  acids  found 
in  the  cerebral  cortex  of  the  CGOST  formula  fed  relative  to  the  SMA  fed 
infants. 
Although  the  numbers  are  small,  infants  fed  the  C&G  formulation  with  an 
a-linolenic  acid  concentration  of  2.2%  of  total  fatty  acids,  have  cerebral  cortex 
DHA  levels  greater  than  the  SMA  fed  infants  with  no  concomitant  increase  in 
n-6  series  fatty  acids  (Table  3.16).  As  neonatal  microsomal/peroxisomal 
synthesis  of  DRA  from  its  precursor,  cc-linolenic  acid,  has  now  been  identified 
(Carnielli  el  al.,  1997)  this  may  be  evidence  of  a  direct  correlation  between 
exogenous  substrate  (cc-linolenic)  and  endogenous  product  (DHA) 
concentrations.  However  dietary  provision  of  such  "non-physiological"  levels 
of  a-linolenic  acid  to  the  infant  may  have  detrimental  metabolic  consequences 
by  reducing  AA  synthesis  and  restricting  growth.  (Jensen  et  aL,  1997;  Carlson, 
1993).  In  addition  the  linoleic  acid  concentration  in  this  revised  formula  at 
11%  of  total  fatty  acids  is  lower  than  previously  used  (Table  2.2)  resulting  in  a 
n6:  n3  ratio  of  5:  1. 
The  ratio  of  linoleic:  cc-linolenic  acid  in  breast  milk  is  on  average  around  10:  1 
but  endogenous  DHA  and  DPA  (both  n-3  and  n-6)  in  the  mothers'  milk 
reduce  this  ratio  to  nearer  5:  1  and  perhaps  this  is  the  balance  which  should  be 
99 aimed  for  by  manufacturers  of  formula  milks.  In  this  investigation,  pretenn 
infants  displayed  lower  DHA  levels  than  their  term  counterparts.  This  could 
be  due  in  part  to  lower  subcutaneous  tissue  reserves  of  DHA  associated  with 
preterm  delivery  along  with  relative  immaturity  of  fatty  acid 
elongase/desaturase  enzyme  systems.  The  10  week  old  preterin  infant  fed 
exclusively  SMA  formula  also  had  an  "apparent  need"  to  incorporate 
substantial  amounts  of  n-9  series  Mead  and  dihomo-Mead  acids  to  maintain 
the  balance  between  PUFA  and  saturated  and  monounsaturated  fatty  acids. 
Such  a  finding  in  animal  studies  (Galli  et  aL,  1970;  Sun,  1972)  was  associated 
with  feeding  of  diets  deficient  in  both  n-3  and  n-6  fatty  acids.  Together  with 
the  possibility  of  some  immaturity  in  peroxisomal  activity  and  reduced  hepatic 
capacity  (Farquharson  el  aL,  1995),  this  may  indicate  a  need  to  also  supply  AA 
in  milk  formulae  designed  for  preterm  infants.  If  maintenance  of  higher  DHA 
concentrations  in  the  cerebral  cortex  of  breast-fed  infants  is  beneficial  to 
neurodevelopment  and  function  then  the  "deficiency"  in  formula  fed  infants 
may  be  detrimental.  It  had  always  been  thought  that  even  trace  amounts  of 
parent  (x-linolenic  acid  in  the  diet  of  infants  would  provide  sufficient  amounts 
of  precursor  to  allow  for  synthesis  of  the  required  amounts  of  DHA.  However 
at  the  time  of  rapid  brain  growth  this  may  not  be  true  (Fig  3.11). 
In  addition,  animal  studies  show  the  incorporation  of  dietary  DHA  into  brain 
tissue  is  much  greater  than  the  rate  of  in-vivo  synthesis  from  the  (x-linolenic 
acid  precursor  (Sinclair  el  aL,  1975).  DHA  deficiency  in  rats  leads  to 
increased  accumulation  of  n-6  series  fatty  acids,  especially  DPA,  in  brain 
phospholipids,  (Carlson  et  aL,  1986)  a  finding  that  is  confirmed  by  the  cerebral 
cortex  results.  Martinez  et  aL  (1992)  demonstrated  a  steady  rise  in  brain  DHA 
during  human  fetal  development,  and  it  seems  unlikely  that  this  prenatal  rise 
would  be  followed  by  a  gradual  reduction  starting  immediately  after  birth 
when  neurological  development  is  still  active.  Makrides  et  aL  (1994) 
presented  a  study  analysing  cerebral  cortex  tissue  from  SIDS  infants 
100 comparing  breast  fed  to  formula  fed  infants.  In  this  work  the  formula  fed 
infants  received  a  milk  with  (x-linolenic  acid  concentrations  in  the  range  1.0  - 
1.6%  of  total  fatty  acids,  similar  to  that  of  the  SMA  fed  group.  Their  results 
show  differences  in  cerebral  cortex  DHA  and  n-6  fatty  acids  between  breast 
fed  and  formula  fed  groups  which  are  comparable  to  the  present  study 
findings. 
Analysis  of  human  brain  fatty  acid  composition  necessarily  involve  analyses  of 
necropsy  material  which  is  difficult  to  obtain.  Animal  studies  to  ascertain 
cerebral  fatty  acid  concentrations  resulting  from  both  essential  fatty  acid 
deficient  and  replete  diets  have  invariably  demonstrated  structural  fatty  acid 
differences  with  "low"  cc-linolenic  acid  diets  devoid  of  LCPUFA  and  some 
workers  (Bourre  et  al.,  1989;  Neuringer  et  al.,  1986)  have  sought  to  relate 
these  findings  to  electrophysiological  (mainly  visual)  and  direct  neurological 
outcome.  With  necropsy  material  this  is  clearly  not  possible. 
4.2.2.  Cerebral  Cortex  Individual  Phospholipids 
Cerebral  cortex  neuronal  membrane  phospholipids  are  composed  of 
phosphatidylcholine,  phosphatidylethanolamine,  phosphatidylserine  and 
phosphatidylinositol.  While  the  membrane  receptor  and  secondary  messenger 
characteristics  of  PI  and  its  metabolites  have  been  extensively  investigated 
(Fisher  et  at,  1987;  Araki  et  at,  1992;  Henzi  et  at,  1992)  the  functions  of 
other  phospholipids  are  less  certain.  PC  is  known  to  confer  a  stabilising 
influence  within  the  neuronal  membrane  (Cullis  and  De  Kruijff,  1979).  The 
carboxyl  groups  of  PS  function  as  ion-exchange  sites  (Cook  et  at,  1972)  while 
both  PS  and  PE  have  an  important  influence  on  the  distribution  of  protein 
molecules  in  the  membrane  (Fenske  et  at,  1990).  Incorporation  of  proteins 
into  the  PS  and  PE  rich  areas  of  membrane  is  critically  dependent  on  the  chain 
length,  degree  of  unsaturation,  and  hence  configuration  of  the  2  fatty  acids 
attached  to  each  PE  moiety  (Salem  et  at,  1986).  It  is  therefore  the  presence  of 
101 high  concentrations  of  DHA  on  PE  and  PS,  particularly  at  the  inner  aspect  of 
the  phospholipid  bilayer  that  allows  rapid  and  repeated  complex  biochemical 
activities  to  take  place  at  the  neuronal  synaptosomes  (Stubbs  and  Smith  1984; 
Salem  1988).  DHA  has  a  highly  specific  distribution  and  is  the  predominant 
membrane  fatty  acid  of  synaptosomes,  retinal  photoreceptors,  mitochondria 
and  spermatozoa.  Membrane  thickness,  elasticity,  porosity  and  ability  to 
support  or  transmit  other  molecules  depends  on  the  organic  bases  such  as 
choline,  ethanolamine,  serine  and  inositol  which  are  attached  to  the 
phosphoglycerides.  The  control  mechanism  that  determines  the  siting  and  the 
type  of  phospholipid  in  the  lipid  bilayers  of  membranes  is  unknown.  Stability 
of  mammalian  membranes  is  crucially  dependent  upon  the  presence  of  long 
chain  polyunsaturated  fatty  acids.  Whereas  protein  synthesis  will  cease  if 
essential  amino  acid  supplies  are  deficient,  incorporation  of  fatty  acids  into 
membrane  phospholipids  will  proceed  and  it  appears  from  the  results  that  the 
fatty  acid  closest  in  molecular  structure  is  substituted  thus  altering  the 
properties  of  that  membrane.  In  severe  fatty  acid  deficiency  states  LCPUFA  of 
the  n-3  and  n-6  series  are  replaced  by  LCPUFA  of  the  n-9  family.  Where  there 
is  a  lesser  deficiency  of  n-3  series,  then  n-6  fatty  acids  alone  may  substitute  for 
them. 
The  differences  in  the  DHA  concentrations  in  phosphatidylserine  and 
phosphatidylethanolamine  between  the  breast  and  fon-nula  fed  infants  are  of  an 
order  of  magnitude  which,  in  vitro,  would  be  sufficient  to  alter  membrane 
function  and  could  therefore  critically  affect  the  resultant  responses  to 
electrical  and  chemical  stimulation  and  alter  membrane  and  neurotransmitter 
function.  It  can  be  seen  from  Figs  3.26  and  3.34  that  there  is  a  preferential 
replacement  of  DHA  in  the  phospholipid  membrane  by  DPA.  This  selective 
substitution  has  already  been  reported  in  animal  studies  (Bourre  et  aL,  1984; 
Galli  et  aL,  1971;  Mohrhauer  and  Holman  1963).  It  appears  that  it  is  only 
from  about  the  fourth  month  of  life  (Figs  3.26  &  3.34)  that  DHA  is  specifically 
102 replaced  by  DPA  and  this  is  particularly  prominent  in  the  CGOST  group  where 
the  ratio  of  linoleic  to  cc-linolenic  acid  is  approximately  40:  1.  Synthesis  of 
both  DRA  and  DPA  from  the  parent  essential  fatty  acids  is  probably  ultimately 
dependent  on  a  peroxisomal  P-oxidation  reaction  which  may  not  be  working 
maximally  in  early  infancy. 
Svennerholm  and  Vanier  (1973)  reported  fatty  acid  percentages  for  the  major 
phospholipids  from  fetal  and  infant  cerebral  cortex  tissue.  It  is  difficult  to 
make  comparisons  with  the  present  study  as  only  7  of  their  tissues  collected 
were  from  infants  who  died  in  the  first  6  months  of  life,  however,  the  n-3  fatty 
acids  of  PE  and  PS  did  appear  to  fall  with  age  during  the  first  six  months  and 
the  authors  mention  in  their  paper  that  when  DHA  was  low,  DPA  n-6  was 
high.  They  also  state  that  the  infants  were  fed  formula  milks  after  two  months. 
When  comparing  breast-fed  and  SMA-fed  infants,  it  may  be  that  the  DHA 
content  of  phosphatidylserine  in  cortical  neuronal  membranes  is  "protected" 
and  preferentially  incorporated  when  compared  with  the  degree  of  substitution 
of  DRA  with  DPA  seen  in  phosphatidylethanolamine.  From  the  data  presented 
in  Table  3.23  it  can  be  seen  that  the  DHA  concentrations  in  the 
phosphatidylserine  of  the  SMA  group  are  nearer  to  those  of  the  breast  fed 
infants,  although  still  significantly  lower.  Subcutaneous  fat  reserves  of  the 
parent  essential  fatty  acid  cc-linolenic  acid  are  negligible  at  birth  and  those 
reserves  of  DHA  which  are  present  are  rapidly  exhausted  (Farquharson  et  aL, 
1993).  This  increased  DHA  must  have  been  synthesised  from  dietary  cc- 
linolenic  acid  and  preferentially  distributed  to  phosphatidylserine  as  no 
significant  differences  were  found  between  the  formula  fed  groups  in  the 
phosphatidylethanolamine  fraction.  From  Fig  3.27  it  can  be  seen  that  there  is 
one  breast  fed  infant  with  the  highest  DHA  content  (25.8%).  This  infant  had  a 
very  high  concentration  of  (x-linolenic  acid  (0.9%)  in  subcutaneous  tissue 
triglyceride  (Farquharson  et  aL,  1993).  It  appears  that  optimal  synthesis  of 
103 DHA  does  not  occur  until  an  (x-linolenic  acid  substrate  concentration  in  excess 
of  I%  of  total  fatty  acids  is  present  in  the  diet,  although  this  value  was  found  in 
only  30%  of  breast  milks  analysed.  In  human  milk,  however,  DHA  is  provided 
directly  from  the  milk  feed  so  that  the  need  for  synthesis  of  DHA  from  (x- 
linolenic  acid  is  not  as  critical  in  the  breast  fed  infant.  Anderson  et  aL  (1990) 
in  animal  studies  have  confirmed  the  earlier  work  of  Sinclair  (1975)  that 
preformed  long  chain  PUFA  are  incorporated  into  the  developing  rat  brain 
with  a  greater  than  ten  fold  efficiency  when  compared  with  those  synthesised 
from  the  parent  essential  fatty  acids.  It  should  also  be  noted  that  there  are 
major  differences  in  the  DHA  content  of  PE  and  PS  between breast  and 
artificially  fed  infants  even  at  40  weeks  after  birth  in  term  infants.  The  finding 
of  significant  amounts  of  Mead  acid  and  dihomo  Mead  acid  in  the  PS  and  PE 
fractions  of  the  pretenn  infant  is  very  disturbing.  These  n-9  series  fatty  acids 
are  very  unstable  and  are  most  unlikely  to  allow  the  membranes  to  function 
normally. 
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Figure  4.1  -  PS  and  PE  polar  head  groups  -  structural  relationship  to 
glutamate  and  GABA  cerebral  neurotransmitters. 
104 There  is  a  clustering  of  PS,  PE  and  PC  head  groups  into  membrane  areas 
known  as  domains.  The  PS  and  PE  domains  are  critically  important  for 
neurotransmitter  function.  It  has  long  been  recognised  that  there  are  structural 
similarities  between  phosphoserine,  which  is  the  hydrophilic  moiety  of  PS,  and 
the  major  central  nervous  system  activatory  neurotransmitter  glutamate  (or 
aspartate)  and  the  polar  phosphoethanolamine  of  PE,  which  resembles  the 
inhibitory  amino  acid  neurotransmitter  y-amino  butyric  acid  (GABA)  (Fig  4.1). 
The  phospholipids  PE  and  PS  are  known  to  exchange  polar  head  groups 
directly  in  vivo.  PS  may  also  be  converted  to  PE  in  a  simple  irreversible 
decarboxylation  reaction  similar  to  that  which  neutralises  the  effect  of 
glutamate  by  its  conversion  to  GABA  (Porcellati  et  aL,  1971).  Although  there 
is  no  direct  evidence  that  PS  functions  in  tandem  with  glutamate  it  is  known 
that  L-AP4  (1,2-amino-4-phosphonobutanoic  acid),  a  phosphorus  containing 
molecule  structurally  similar  to  phosphoserine  is  a  proven  Lglutamate  agonist 
at  presynaptic  terminals  and  retinal  bipolar  receptors  (Forsyth  and 
Clements,  1990;  Nawy  and  Jahr,  1990;  Slaughter  and  Miller,  1981).  As  can  be 
seen  (Fig  4.2),  PS  and  LAP4  differ  only  in  the  replacement  respectively  of  an 
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105 ester  oxygen  by  a  methylene  (CH2)  group,  both  species  with  very  similar 
charge  characteristics  and  molecular  dimensions  which  would  be  essential  if 
phosphoserine  were  to  mimic  the  neuroexitatory  role  of  L-AP4.  It  may  be  then 
that  PS  and  PE  have  a  neurotransmitter  function  which  could  be  independent 
or  work  in  parallel  with  the  glutamate-GABA  system. 
4.2.3.  Cerebellar  cortex 
In  evolutionary  terms,  after  the  brain-stem,  the  cerebellum  was  next  to  develop 
in  humans  from  the  anterior  dorsal  part  of  the  primitive  mid-brain.  The 
cerebellum  is  composed  of  two  hemispheres  connected  by  the  vermis  in  the 
midline.  The  hemispheres  display  numerous  deep  fissures  with  folia  between. 
Similar  to  the  cerebrum,  the  cerebellum  is  also  composed  of  lobes,  the  oldest  in 
evolutionary  terms  being  the  flocculonodular  followed  by  the  anterior  and 
posterior.  The  cerebellum  acts  to  temper  and  balance  the  sensory  stimuli 
reaching  the  cerebral  cortex  with  that  of  the  generated  neurological  response 
and  it  therefore  has  a  "fine-tuning"  remit.  The  cerebellum  was  thought  to 
specialise  predominantly  in  the  co-ordination  of  movement  and  balance  but  it 
may  also  undertake  some  of  the  higher  sensory  functions  until  recently 
considered  to  be  the  preserve  of  the  cerebral  cortex  (Kolb  and  Whishaw,  1985; 
]Leiner  et  aL,  1991).  In  humans  it  was  thought  that  the  increased  cerebellar 
complexity,  particularly  the  lateral  expansion  of  the  posterior  lobe,  was 
associated  with  our  increased  manual  dexterity.  However  positron  emission 
tomography  appears  to  show  maximal  activity  in  the  cerebellar  posterior  lobe 
in  response  to  cognitive  and  linguistic  tasks,  generatly  centred  in  the  cerebral 
prefi7ontal  cortex  (Fox  et  aL,  1985). 
From  previous  studies  it  has  been  shown  that  in  the  infant,  the  cerebellum  has 
a  faster  and  shorter  growth  spurt  when  compared  to  the  cerebrum,  starting  later 
but  achieving  adult  proportions  earlier  (Dobbing  and  Sands,  1973)  and 
involves  incorporation  of  specific  PUFA  (Ballabriga  and  Martinez,  1978). 
106 Despite  missing  the  growth  spurt,  formula  fed  premature  infants  do  not  appear 
to  be  "disadvantaged"  relative  to  their  term  bom  contemporaries  in  terins  of 
accretion  of  LCPUFA,  specifically  DHA,  in  the  first  year  of  life.  Indeed 
cerebellar  grey  DHA  concentrations  of  the  SMA  fed  group  were  not 
significantly  higher  than  those  of  the  SMA-prem  group  (Table  3.27)  and 
although  prenatal  accretion  may  explain  these  findings  it  is  also  worth  noting 
that  provision  of  cc-linolenic  acid  at  1.5%  of  total  fatty  acids  (SMA  group)  may 
have  been  more  than  adequate  to  allow  for  synthesis  of  sufficient  DHA.  The 
cerebellar  cortex  constitutes  <I  0%  by  weight  of  that  of  the  cerebral  cortex  and 
DHA  concentrations  at  birth  in  both  tissues  are  equivalent  (Figs  3.11&3.45). 
The  lowest  cerebellar  grey  DHA  compositions  were  encountered  in  the  infants 
fed  the  CGOST  formula  with  low  (<0.4%)  cc-linolenic  acid  content. 
Cerebellar  grey  matter  DRA  concentrations  show  a  gradual  decline  with  age  in 
breast-fed  infants  (Fig  3.45)  which  is  in  contrast  to  those  of  cerebral  grey 
matter  (Fig  3.11)  but  apart  from  the  CGOST  group,  no  overt  increase  in  DPA 
(C22:  5n-6)  is  apparent  in  the  remaining  infants  (Fig  3.44),  although  it  was 
noted  that  the  highest  DPA  concentration  belonged  to  the  19  week  old, 
CGOST  fed,  preterm  (34  wk  gestation)  infant.  As  increased  DPA 
concentrations  are  a  general  indication  of  DHA  deficiency  it  would  seem  that 
only  by  provision  of  "inadequate"  amounts  of  dietary  a-linolenic  acid  (CGOST 
group)  will  a  subsequent  deficit  in  cerebellar  grey  DHA  arise.  Although,  as 
discussed,  premature  infants  do  not  appear  to  be  specifically  vulnerable  to 
reduced  cerebellar  DHA  incorporation,  in  two  term-bom  unrelated  twins  (6.5 
and  7  wk  old),  disproportionately  low  DHA  concentrations  were  found  (Fig 
3.45),  however  this  might  have  been  a  feature  of  shared  maternal  DHA  supply 
in  utero. 
The  study  findings  with  respect  to  feeding  groups  must  be  somewhat  tempered 
because  of  the  lower  mean  birth  weights  of  the  SMA  (2.99  kg)  and  CGOST 
fed  (2.94  kg)  than  those  infants  breast  fed  (3.36  kg).  In  contrast  the  small 
107 C&G  fed  group  (n=4),  despite  a  mean  birth  weight  of  2.98  kg  similar  to  the 
other  formula  groups,  given  a  diet  containing  cc-linolenic  acid  at  2.2%  of  total 
fatty  acids,  was  able  to  maintain  cerebellar  cortex  DHA  concentrations  that 
were  50%  greater  than  that  of  the  age-equivalent  CGOST  group. 
Whether  with  the  extreme  dietary  "deprivation"  of  LCPUFA  (as  witnessed 
particularly  in  the  CGOST  group)  and  resultant  structural  alteration  in 
cerebellar  grey  matter  composition  a  functional  deficit  could  be  induced  is 
unknown.  It  is  interesting  to  speculate  however  that  inattention  in  school,  the 
so-called  attention  deficit  hyperactivity  disorder  has  risen  remorselessly  in 
particular  in  American  male  students  in  conjunction  with  an  increase  in 
formula  feeding  of  diets  both  devoid  of  long  chain  polyunsaturated  fatty  acids 
and  very  long  chain  fatty  acids  both  essential  to  white  matter  development. 
Stevens  el  aL(1995)  have  measured  the  red  cell  membrane  fatty  acids  in  boys 
with  this  disorder  and  found  significantly  lower  concentrations  of  both  AA  and 
DHA  when  compared  to  a  group  with  milder  symptoms.  Perhaps  the  first 
choice  treatment  Ritalin,  which  has  paradoxically  a  neuroexcitatory  function, 
is  in  some  way  correcting  for  the  dietary  induced,  biochemical  alterations  in 
cerebellar  structure.  In  addition  as  previously  stated,  an  "epidemic"  in 
uncoordinated,  dyspraxic  individuals  has  been  identified  in  upwards  of  6%  of 
school-age  children  (Brenner  et  aL,  1967).  However  higher  incidences  of  up  to 
14%  were  associated  with  children  of  low  birth  weight  (<2.5  kg)  (Lesny, 
1980). 
Fine  motor  co-ordination  defects  would  appear  to  be  at  the  heart  of  this 
problem,  and  although  far  from  being  life-threatening,  nevertheless  such 
symptoms  can  have  a  destructive  effect  on  quality  of  life.  Animal  studies  can 
provide  useful  information  on  dietary  deprivation  and  resultant  cerebellar- 
related  function.  However,  because  of  our  ultimate  complexity,  the  human 
species  might  be  uniquely  susceptible  to  cerebellar  membrane  structural 
108 alterations,  particularly  during  the  neonatal  period  when  there  is  maximal 
growth  and  cell  division.  It  cannot  be  advisable  to  introduce  mind-altering 
chemicals  to  young  and  developing  brains  in  order  to  maintain  "control"  in  the 
early  learning  environment.  Clearly  no  conclusions  can  be  drawn  about 
neurological  outcome  from  our  groups.  However,  a  retrospective  study  of 
infants  exclusively  fed  the  CGOST  formula  in  infancy  with  particular 
reference  to  subsequent  development  of  mild  to  moderate  dyspraxia  may  be 
informative. 
4.2.4.  HPTLC  of  Cerebral  White  and  Cerebellar  White  Matter 
HPT'LC  was  used  to  analyse  cerebral  and  cerebellar  white  tissues  previously 
assessed  for  fatty  acid  content  to  find  a  possible  explanation  for  the  fatty  acid 
results  from  those  specimens  designated  ?  locus  and  considered  to  be  outliers 
and  also  to  provide  more  information  on  cerebral  and  cerebellar  lipid  species 
and  their  relative  variation  in  infancy. 
On  visual  inspection  of  the  HPTLC  plates,  it  was  apparent  that  bands 
corresponding  to  cerebrosides  and  sulphatides  were  absent  or  very  faint  in 
parietal  cerebral  white  matter  tissue  extracts  of  infants  less  than  8  weeks  old. 
in  contrast  the  cerebellar  white  tissue  extracts  for  the  same  infants  had  strong 
bands  for  both  compounds.  In  spite  of  their  associated  infant  ages  (age  range  4 
-II  weeks),  the  five  tissue  extracts  defined  as  outliers  in  the  cerebral  white 
matter  had  well  defined  bands  of  both  cerebrosides  and  sulphatides. 
Researchers  who  have  examined  neonatal  brains  using  Magnetic  Resonance 
Imaging  with  the  purpose  of  studying  white  matter  maturation  have  identified 
significant  myelination  (grade  3)  by  birth  in  cerebellar  white  matter  but  not 
before  3-6  months  in  cerebral  central  white  matter  (Barkovich  el  aL,  1988). 
Others  who  studied  infants  bom  between  29  and  42  weeks  gestation  also  noted 
109 cerebellar  white  matter  myelination  in  advance  of  cerebral  myelination 
(McArdle  el  aL,  1987). 
Kinney  et  aL  (1994)  performed  HPTLC  in  the  separation  of  I  ýpid  classes  using 
white  matter  tissue  from  various  areas  of  the  brain  in  infants  ranging  in  age 
from  birth  to  two  years.  Previous  work  by  the  same  group  (Brody  et  aL,  1987; 
Kinney  et  aL,  1988)  had  examined  the  development  of  myelination  in  62 
different  white  matter  sites  of  the  brain.  These  histological  analyses  revealed 
that  myelination  occurred  at  different  stages  of  infant  development  and  at 
different  rates  that  were  dependent  on  the  white  matter  location.  Site  specific 
biochemical  analyses  added  further  confirmation.  The  lipids  known  to  be  rich 
in  myelin  such  as  cerebrosides,  sulphatides  and  sphingomyelin  were  present  in 
strong  bands  from  birth  in  areas  histologically  identified  as  "early  myelinators" 
whereas  these  compounds  appeared  at  a  later  age  in  areas  such  as  the  frontal 
pole,  defined  as  a  "late  myelinator". 
In  an  earlier  investigation,  Svennerholm  and  Vanier  (1972)  quoted  values 
for  galactocerebrosides  rising  from  virtually  undetectable  at  birth  (0.5)  to  20 
umol/g  wet  weight  at  8  months,  and  similarly  for  sulphatides  rising  to  5 
umol/g.  They  reported  a  two-fold  increase  in  cerebral  white  matter 
phospholipids  in  the  first  eight  months  of  life  with  the  percentages  of  the 
individual  phospholipids  in  good  agreement  with  the  results  of  the  HPTLC 
analyses  presented  in  this  thesis  (Fig  3.46). 
Martinez  (1982)  measured  galactolipids  in  the  cerebrum  and  cerebellum  of  14 
well-nourished  infants  from  26  weeks  gestation  to  15  months  of  age  and 
included  in  the  study  a  group  of  10  undernourished  infants  who  died  between 
27  weeks  gestation  and  4  months  of  life.  She  found  that  the  concentration  of 
galactocerebrosides  was  much  higher  in  the  immature  cerebellum  than  in  the 
immature  cerebrum.  At  term  galactolipids  in  the  cerebellum  were  five  times 
110 greater  than  in  the  cerebrum.  She  also  found  that  children  undernourished 
postnatally  (n=4)  had  lower  cerebral  galactolipids  than  the  well  nourished 
population  whereas  there  was  no  difference  in  the  cerebellar  concentrations  of 
the  two  groups. 
Although  exclusion  of  results  is  not  ideal,  in  view  of  the  data  presented  in  the 
aforementioned  papers,  it  would  seem  that  the  results  obtained  for  these  few 
specimens,  if  from  the  parietal  central  region,  would  not  be  compatible  with 
tissue  derived  from  a  normally  developing  brain. 
In  consideration  of  the  lipid  species  populated  by  the  rising  lignoceric  and 
nervonic  acids,  the  increase  in  nervonic  acid  concentrations  in  cerebral  white 
matter  (Fig  3.50)  correlated  with  the  rising  percentage  of  both  cerebrosides 
and  sulphatides  (Fig  3.46).  In  addition  the  very  low  levels  of  both  glycolipids 
in  the  first  few  weeks  of  life  coincided  with  the  absence  of  both  lignoceric  and 
nervonic  acids  in  early  life.  In  contrast,  sphingomyelin  was  present  at  5%  of 
total  phospholipids  from  birth  (Fig  3.48)  and  although  this  ratio  increased  to 
approximately  10%  by  6  months  there  was  not  a  dramatic  rise  in  comparison  to 
the  other  myelin  lipids.  Cerebellar  white  matter  displayed  earlier  indication  of 
myelination  in  relation  to  cerebral  white  in  terms  of  sphingomyelin  where  the 
ratio  to  total  phospholipids  at  birth  was  10%  increasing  to  15%. 
There  are  few  publications  quoting  lignoceric  and  nervonic  acid 
concentrations  of  myelin  lipids  in  early  infancy.  O'Brien  and  Sampson  (1965) 
measured  the  fatty  acid  content  of  the  lipids  of  grey  and  white  matter  from  the 
frontal  lobes  of  5  subjects.  They  quoted  values  for  an  infant  aged  10  months 
for  cerebrosides,  sulphatides  and  sphingomyelin.  The  nervonic  acid 
concentrations  were  17.5%  and  28.3%  for  cerebroside  and  sulphatide 
respectively  as  compared  to  10.8%  for  sphingomyelin.  Another  group  of 
researchers  analysed  the  fatty  acid  composition  of  cerebrosides  and  sulphatides 
III in  neonatal  and  infant  brains  (Svennerholm  and  Stallberg-Stenhagen,  1968). 
Some  of  the  data  was  however  from  whole  brain  tissue  because  of  the 
difficulty  of  separating  grey  and  white  in  very  young  infants.  Nervonic  acid 
content  was  in  excess  of  20%  in  both  cerebrosides  and  sulphatides  in  the  two 
white  matter  tissues  which  were  analysed.  Rao  (1976)  reported  the  fatty  acid 
composition  of  cerebrosides  from  total  cerebrum  and  cerebellum  in  fetal  brains 
from  20  week  gestation  to  full  term.  Comparison  of  data  is  difficult  since  the 
author  is  quoting  tissue  not  separated  into  grey  and  white  matter.  It  seems 
surprising,  however,  that  the  concentration  of  nervonic  acid  is  lower  in  the 
cerebellum  when  compared  to  the  cerebrum  whereas  lignoceric  acid  shows  the 
opposite  effect.  This  observation  on  lignoceric  acid  was  in  general  agreement 
with  the  results  in  this  thesis.  It  is  also  interesting  to  note  that  the  C22 
saturated  and  monounsaturated  fatty  acids  are  considerably  higher  in  cerebellar 
tissue. 
As  a  consequence  of  the  results  reported  for  this  part  of  the  study  it  would  be 
interesting  to  analyse  the  fatty  acid  composition  of  these  myelin  lipids  in 
relation  to  age  and  diet  as  there  is  a  dearth  of  information  of  this  type  in  the 
literature.  This  would  aid  in  assessment  of  the  importance  of  nervonic  acid 
which  is  present  in  small  amounts  in  breast  milk  but  not  in  formula  milks. 
4.2.5.  Cerebral  Parietal  White  Matter 
Although  not  exclusively,  the  deposition  of  cerebral  white  matter  and  myelin  in 
the  immediate  postnatal  period  involves  phospholipid  and  cerebroside 
(including  sulphatide)  synthesis  respectively.  Accreted  mainly  by  the 
oligodendrocytes,  these  lipids  are  populated  by  an  array  of  specific  fatty  acids, 
whose  incorporation  is  apparently  controlled  by  a  precise  series  of  reactions. 
These  occur  mainly  in  the  first  year  of  life  and  as  the  fatty  acid  compositions 
adopted,  thereafter  remain  unaltered,  (Dobbing  and  Sands,  1973; 
112 Svennerholm,  1968;  Svennerholm  and  Sttillberg-Stenhagen,  1968)  any 
disruption  to  the  process  may  have  far-reaching  consequences. 
As  white  matter  deposition  proceeds,  with  the  exception  of  docosatetraenoic 
acid  (C22:  4n-6),  a  relative  general  reduction  in  LCPUFA  is  the  common 
feature.  From  the  results  (Figs  3.57  &  3.60)  it  can  be  seen  that  the 
compositions  of  cerebral  parietal  white  matter  AA  and  DHA  nevertheless 
remain  constant  for  the  first  two  months  in  the  human  milk  fed  infants.  In 
contrast  the  DHA  concentration  in  the  term  SMA  group  is  not  sustained 
beyond  about  five  weeks.  However,  the  decline  appears  to  be  balanced  by  an 
increase  in  AA,  an  effect  similar  to  that  found  in  the  cerebral  cortex.  This 
decline  in  initial  DHA  content  is  more  pronounced  in  the  premature  SMA  fed 
infants,  but  again,  possibly  in  compensation,  the  highest  AA  concentration  is 
present  in  the  17  week  old  infant.  What  the  consequences  may  be  of  this 
decline  in  DHA  in  the  formula  fed  groups  relative  to  the  breast  fed  and 
resultant  postponement  in  the  reduction  of  AA,  is  not  known  but  it  may  be 
reassuring  that  these  between  group  differences  appear  to  be  corrected  within 
the  first  year  of  life  without  recourse  to  increased  insertion  of 
docosapentaenoic  acid  (C22:  5n-6),  which  usually  indicates  a  DHA  deficiency 
state.  The  proportion  of  DHA  declined  with  increasing  age  in  all  groups, 
although  more  rapidly  in  the  CGOST  group.  Inspection  of  the  results  also 
revealed  that  the  7  week  old,  partially  breast  fed  premature  infant  could 
maintain  a  significantly  greater  DHA  concentration  than  exclusively  formula 
fed  contemporaries  and  comparable  with  that  of  the  term  born  fully  breast  fed 
infant  (Fig  3.60).  This  has  probably  arisen  as  premature  infants  will  have 
negligible  fatty  acids  stored  at  birth  (Farquharson  et  aL,  1993)  and  in  spite  of 
the  provision  of  adequate  cE-linolenic  essential  fatty  acid  precursor,  we  now 
know  that,  even  in  term  born  infants,  hepatic  synthesis  of  DHA  in  the  first 
postnatal  months  is  minimal  (Farquharson  el  aL,  1995).  On  closer  inspection 
of  the  divergent  DHA  compositions  of  the  two  18  week  old  SMA  fed  infants 
113 (6.4%  and  4.0%)  these  were  found  to  correlate  with  their  birth  weights  of 
3.63kg  and  2.21kg  respectively  and  probably  indicate  greater  subcutaneous 
tissue  reserves  of  DHA  in  the  former. 
In  the  white  matter,  metabolism  of  LCPUFA  is  predominantly  confined  to  the 
non-choline  containing  phospholipids,  phosphatidylethanolamine, 
phosphatidylserine  and  phosphatidylinositol.  Possible  implications  of  altered 
fatty  acid  compositions  in  PE  and  PS  have  been  considered  in  respect  of 
neurological  function  in  the  infant  cerebral  cortex.  Although  the  between 
group  differences  in  white  matter  appear  to  be  eliminated  more  rapidly  than  in 
the  cortical  grey  matter,  nevertheless  white  matter  neural  structures  tend  to 
display  a  certain  permanence  and  rigidity  not  present  in  the  plasticity  of  the 
grey  matter  and  therefore  may  be  more  affected  by  early  deviations  from  the 
normal  pattern  of  fatty  acid  deposition. 
In  early  infancy  the  initial  differentiation  between  cerebral  grey  and  white 
matter  is  further  complicated  by  division  of  the  white  matter  into  myelinated 
and  unmyelinated  fibres.  The  great  difficulties  experienced  in  providing  an 
early  diagnosis  in  the  leukodystrophies,  in  spite  of  the  use  of  the  most  modem 
diagnostic  imaging  technology,  may  be  related  to  the  aforementioned 
gestational  age  and  dietary  dependent  variations  in  the  deposition  of  the 
component  fatty  acids.  As  there  appeared  to  have  been  "developmental  delay" 
in  the  processes  involved  in  white  matter  formation  in  the  formula  fed  infants, 
investigation  of  the  very  long  chain  fatty  acids  (VLCFA)  would  be  expected  to 
indicate  whether  the  effect  translated  to  myelination.  As  these  VLCFA  have  a 
high  "insulating  capacity"  and  are  hydrophobic  it  was  not  surprising  that  their 
incorporation  into  myelin  was  delayed  until  the  cerebral  water  content  reached 
a  minimum  (75-80%)  an  observation  supported  by  animal  studies  (Uzman  and 
Rumley,  1958).  A  direct  insight  into  this  is  provided  by  the  fatty  acids, 
lignoceric  and  nervonic  both  of  which  predominate  in  the  cerebrosides.  These 
114 VLCFA  increased  logarithmically  in  the  total  lipid  fraction  of  the  breast  fed 
group  parietal  white  matter  at  the  end  of  the  second  month,  but  not  until  the 
end  of  the  third  month  in  the  CGOST  and  SMA  groups  (Figs  3.61  &  3.62).  A 
subsequent  further  delay  may  also  be  evident  in  the  premature  SMA-fed 
infants.  This  may  have  been  as  a  consequence  of  the  differences  in  white 
matter  LCPUFA  discussed  previously  but  other  explanations  are  possible. 
From  previous  research  no  evidence  of  significant  hepatic  synthesis  of  these 
VLCFA  has  been  found  (Farquharson  et  aL  1995)  and  in  addition  although 
trace  quantities  (0.05-0.1%)  of  lignoceric  acid  were  identified  in  the  formula 
milk,  nervonic  acid  was  undetected  (<0.05%).  This  contrasted  with  mature 
human  milks  which  contained  similar  levels  of  lignoceric  but  nervonic  acid  at 
<0.05-0.3%  (median  0.15%)  of  total  fatty  acids.  This  dietary  supply  may  have 
enabled  the  earlier  incorporation  of  nervonic  acid  into  the  myelin  in  those 
breast  fed,  circumventing  the  need  for  microsomal  synthesis  by  chain 
elongation  of  its  long-chain  precursors.  This  enzymatic  sequence,  as  it  was  not 
evident  in  the  liver,  may  also  have  been  competitively  inhibited  by  the 
presence  of  "excess"  long-chain  saturated  fatty  acids,  such  as  arachidic  (C20:  0) 
and  behenic  (C22:  0),  found  in  significant  quantities  (>0.2%)  in  the  SMA 
formula  (Wilson  and  Sargent,  1993).  It  may  be  confirmatory  that  the  partially 
breast  fed,  18  week  old  term  infant  seemed  capable  of  maintaining  a  lignoceric 
acid  concentration  similar  to  that  of  breast  fed  infants  (Fig  3.61),  whereas 
nervonic  acid  correlated  more  closely  with  the  formula  fed  infants  (Fig  3.62). 
The  presence  of  immature  enzyme  systems  in  the  premature  infants  may 
explain  the  further  delay  in  their  accretion  of  the  VLCFA.  This  delay, 
however,  may  not  be  inappropriate  in  the  preterm  infant  in  whom  myelination 
may  correlate  with  postconceptual  rather  than  chronological  age. 
An  indication  that  mechanisms  involved  in  LCPUFA  and  VLCFA  metabolism 
may  be  working  independently  may  also  be  demonstrated  in  the  results  of  the 
CGOST  group.  With  the  CGOST  feeding  regimen  not  only  being  devoid  of 
115 LCPUFA  but  containing  very  low  levels  of  a-linolenic  acid,  cerebral  parietal 
white  DHA  concentrations  are  in  general  very  similar  to  those  pertaining  in  the 
SMA  preterm  group  (Fig  3.60).  This  may  be  confirmed  by  the  resultant  higher 
concentrations  of  DPA  in  both  the  CGOST  and  SMA  preterm  groups 
(Fig  3.59). 
However  analysis  of  the  VLCFA  results  appears  to  confirm  a  trend  whereby 
infants  within  the  CGOST  group  have  generally  lignoceric  and  nervonic  acid 
concentrations  which  are  intermediary  between  the  breast  fed  and  term  SMA 
group.  A  possible  explanation  may  be  in  the  formulation  of  both  C&G  and 
Farley's  milks  which  constitute  the  CGOST  group.  These  contain  significantly 
higher  concentrations  of  both  nervonic  acids  immediate  monoenoic  precursors, 
eicosenoic  and  erucic  acid  (Table  3.12)  and  may  push  the  momentum  of  chain 
elongation  reactions  towards  nervonic  acid  synthesis  when  compared  with  the 
SMA  group  as  previously  discussed.  This  effect  also  appears  to  translate  to  the 
long-chain  monounsaturated  fatty  acids  where  C  16:  1  and  C  18:  1  concentrations 
in  the  CGOST  group  are  also  quite  dissimilar  from  those  of  the  SMA  preterm 
group  (Figs  3.53  &  3.55). 
As  previously  stated,  because  of  the  dynamics  of  white  matter  and  myelin 
deposition  in  early  life  it  was  essential  that  specimens  were  taken  at  necropsy 
from  precise  loci.  For  a  period  of  4  months  results  were  obtained  from  5 
specimens  in  which  the  fatty  acid  concentrations  (in  those  that  varied  with 
age)  were  found  to  be  extreme  outliers.  Further  investigation  revealed  that 
these  probably  had  been  obtained  from  a  more  posterior  cerebral  site.  This 
may  have  been  confirmed  by  the  HPTLC/densitometry  of  the  phospholipids 
and  cerebrosides. 
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In  contrast  to  cerebral  white  matter,  cerebellar  white  matter  occupies  a 
relatively  restricted  area.  It  is  composed  of  several  central  isolated  nuclei.  The 
largest  of  these,  the  dentate  nucleus  is  sited  in  the  neocerebellum,  whose 
efferent  impulses  alight,  via  the  thalamus,  at  the  cerebral  motor  cortex.  In 
conjunction  with  the  less  prominent  white  matter  fastigial  nuclei,  their  axonal 
impulses  ultimately  serve  to  control  both  balance  and  eye  movement. 
Davison  and  Dobbing  (1966)  examined  the  brain-growth  spurt  in  different 
species  and  demonstrated  that  development  of  the  cerebellum  proceeded  with  a 
similar  sequence  of  events  but  at  rates  that  were  species  specific.  The  rat  is 
often  used  as  an  animal  model  to  study  the  development  of  the  human 
cerebellum  as  both  species  have  an  immature  cerebellum  at  birth  and 
morphogenesis  mainly  occurs  during  postnatal  life.  This  "growth  spurt" 
includes  the  period  of  rapid  myelination  and  it  has  been  suggested  that  this  is  a 
critical  period  in  terms  of  nutrition  (Budowski  et  aL,  1987).  In  rats  post  natal 
growth  is  retarded  by  imposing  a  nutritional  deficit  exclusively  after  birth  and 
during  the  suckling  period.  Alterations  in  the  brain  growth  are  exacted  by 
either  introducing  more  pups  per  dam  to  suckle  or  by  removing  the  pups  from 
the  mother  for  several  hours  each  day.  The  cerebellum  of  animals  fed  in  this 
manner  has  disproportionately  fewer  cells,  especially  granular  neurons  and 
glial  cells  (Dobbing  and  Sands,  1971)  and  the  brain  lipids,  especially  those 
characteristic  of  myelin,  are  permanently  reduced  (Dobbing,  1968). 
As  a  result  of  the  above  findings,  researchers  tested  the  hypothesis  that 
nutritional  deprivation  in  early  postnatal  life  may  affect  motor  co-ordination. 
(Lynch  et  aL,  1975;  Jordan  et  aL,  1979).  They  found  that  growth  restricted 
animals  performed  worse  in  specific  tests  of  co-ordination  when  compared 
with  control  animals.  Balazs  et  aL  (1986)  noted  retarded  development  of 
spontaneous  motor  activity  and  a  variety  of  motor  reflexes  in  undernourished 
117 rats.  Other  groups  have  shown  that  cell  numbers  of  neurons  and 
oligodendrocytes  are  not  restored  by  nutritional  rehabilitation  (Clos  el  al., 
1982)  and  that  myelin  thickness  is  also  not  restored  (Wiggins,  1982). 
There  is  a  dearth  of  literature  on  cerebellar  white  matter  lipid  fatty  acid 
composition  in  either  animal  or  human  nervous  tissue.  Martinez  (1982) 
however  presented  a  study  comparing  cerebral  and  cerebellar  myelin  lipids  in 
undernourished  infants  with  those  fed  a  normal  diet.  She  found  significantly 
reduced  levels  of  galactolipids  in  the  cerebrum  of  the  malnourished  infants  but 
no  difference  in  the  cerebellum  of  these  subjects.  In  contrast  the  phospholipids 
and  cholesterol  in  both  forebrain  and  cerebellum  were  indistinguishable  from 
normal  values.  Plasmalogens  were  decreased  in  both  loci  but  not  so  markedly 
in  the  cerebellum.  These  data  do  not  agree  with  the  findings  of  Chase  et  al. 
(1972)  who  examined  the  cerebellum  of  a  group  of  small  for  gestational  age 
(SGA)  infants  and  compared  them  with  a  group  of  appropriate  for  gestational 
age  (AGA)  infants  all  of  whom  died  shortly  after  birth.  The  cerebellar  tissue  of 
the  SGA  infants  was  found  not  only  to  be  reduced  in  cell  size,  but  there  was 
also  a  significant  reduction  in  cerebrosides  and  sulphatides  but  no  difference  in 
phospholipids  and  cholesterol  when  compared  to  the  AGA  group.  This  study 
may  differ  in  its  findings  because  it  is  affected  primarily  by  intrauterine 
undemutrition  whereas  that  of  Martinez  involved  postnatal  undemutrition. 
When  the  results  obtained  by  Martinez  (1982)  are  related  to  the  results  of  the 
present  study,  they  can  provide  an  explanation  for  the  lack  of  differences 
observed  in  nervonic  acid  in  relation  to  diet  in  cerebellar  white  matter  as 
compared  to  the  cerebral  white  matter  where  there  was  a  deficit  in  nervonic 
acid  in  both  the  formula  fed  infants  and  the  preterm  infants.  Lignoceric  acid  in 
the  cerebellum  showed  the  opposite  effect  to  that  in  the  cerebrum,  SMA-fed 
infants  having  significantly  higher  concentrations  than  the  breast-fed  group.  A 
similar  trend  was  also  noted  in  the  CGOST-fed  infants  although  no  statistical 
118 analysis  was  performed  due  to  lack  of  age-matching  of  individuals.  Both 
lignoceric  and  nervonic  acids  are  however  present  at  about  1%  of  total  lipids 
at  birth  in  contrast  to  the  cerebral  parietal  white  matter  in  which  both  these 
fatty  acids  were  undetected.  These  findings  may  imply  that  myelination  is 
further  advanced  in  the  cerebellum  than  cerebrum  at  birth,  which  is  in 
agreement  with  Kinney  el  aL  (1994)  who  showed  in  their  study  of  autopsied 
brains  that  cerebellum  matured  ahead  of  cerebral  parietal  white  matter. 
The  study  results  for  cerebellar  white  matter  DHA  show  significantly  lower 
concentrations  in  the  SMA-formula  fed  infants  when  compared  to  an  age- 
matched  breast-fed  group.  This  finding,  similar  to  that  of  the  cerebellar  cortex, 
is  surprising  when  the  cerebellum  requires  only  one  tenth  of  the  supply  of 
DHA  needed  to  sustain  the  cerebrum  but  might  indicate  a  higher  turnover  in 
infant  cerebellar  polyunsaturated  fatty  acids.  It  is  however  unknown  whether 
the  dietary  induced  differences  in  DHA  are  sufficiently  large  to  influence  the 
predominantly  neuro-inhibitory  characteristics  of  the  cerebellum. 
4.3.1.  Infant  feeding  and  developmental  outcome 
This  thesis  has  examined  the  fatty  acid  composition  of  neural  membranes  with 
special  reference  to  diet.  This  section  summarises  recent  publications  relating 
the  effects  of  early  feeding  to  the  development  of  the  retina  and  cerebrum  as 
estimated  by  visual  and  developmental  studies. 
Most  of  the  studies  have  examined  the  hypothesis  that  breast  feeding  gives 
infants  developmental  advantages  over  formula  feeding.  Some  workers  have 
looked  at  infants  and  toddlers  (<  2  years)  while  other  groups  have  concentrated 
on  older  children.  Studies  can  be  further  subdivided  into  those  which  have 
examined  preterm  children  and  those  which  concentrate  on  term-bom  infants. 
119 Five  studies  of  term-bom  infants  measured  cognitive  development  by  the 
Bayley's  scale  of  mental  developmental  index  (MDI)  up  to  24  months.  These 
studies  compared  breast-fed  with  forinula-fed  individuals  and  also  considered 
the  duration  of  breast-feeding.  Temboury  et  aL  (1994)  examined  229  infants 
bom  in  Madrid  and  found  bottle  fed  babies  had  lower  MDI  scores  between  18 
and  29  months  when  compared  to  breast-fed  infants.  Two  American  groups 
classified  breast-fed  infants  according  to  length  of  breast  feeding.  Morrow- 
Tlacak  et  aL  (1988)  subdivided  the  breast-fed  group  into  <4  months  or  >4 
months.  They  examined  229  infants  and  found  a  significant  difference 
between  bottle-fed  children,  children  breast-fed  <4  months  and  those  fed  >4 
months  both  at  12  and  24  months.  Further  regression  analysis  indicated  breast 
feeding  duration  was  significantly  correlated  with  improved  MDI  scores  at  12 
and  24  months  allowing  for  confounding  variables.  Rogan  and  Gladen  (1993) 
examined  600  subjects  up  to  24  months  and  observed  a  difference  of  +6.7 
points  on  MDI  when  comparing  very  long  (>20  weeks)  with  short  term  (<4 
weeks)  breast-feeding  and  +5.6  points  when  comparing  very  long  with  formula 
feeding.  Young  et  al  (1982)  performed  a  retrospective  study  on  1000  infants 
ftom  Tunis  birth  records  and  classified  the  subjects  according  to  length  of 
breast  feeding.  Artificial  feeding  was  defined  as  <2  months  breast  feeding, 
mixed  feeding  as  breast  fed  for  2  months  followed  by  cows  milk  and  breast-fed 
as  exclusive  breast  feeding  for  >7  months.  They  found  significantly  higher 
MDI  scores  for  breast  feeding  over  artificial  and  mixed  at  12  and  24  months 
allowing  for  confounding  variables.  The  fifth  study  was  performed  with  846 
first-born  singletons  ftom  Dundee  and  measured  both  motor  and  mental 
development  at  18  months  (Florey  et  aL  1995).  Group  mean  difference  for  the 
MDI  scores  were  8  points  higher  in  the  breast-fed  group  but  no  mean 
differences  were  found  for  psychomotor  development  index  (PDI)  scores. 
Studies  on  older  children  included  one  published  as  early  as  1929  by  Hoefer 
and  Hardy  where  their  383  subjects  were  aged  7-13  years.  The  groups  were 
120 categorised  as  artificially  fed  or  according  to  the  length  of  breast  feeding  and 
assessed  for  intelligence  quotient  (IQ),  educational  quotient  (EQ)  and 
performance  quotient  (PQ)  scores.  Of  two  publications  from  a  group  in  New 
Zealand,  the  first  examined  a  large  number  (n>1000)  of  children  at  3,5  and  7 
years  using  IQ  and  language  comprehension  (LC)  tests  and  compared  bottle 
feeding,  breast  feeding  <4  months  and  breast-feeding  >4  months.  (Fergusson 
et  al.,  1982).  ne  follow-on  study  (Horwood  and  Fergusson,  1998)  reported  a 
range  of  measures  of  cognitive  and  academic  outcomes  for  the  same  children 
between  the  ages  of  8  and  18  years.  After  correction  for  confounding  variables, 
the  authors  concluded  that  breast  feeding  was  associated  with  small  but 
detectable  increases  in  child  cognitive  ability  and  academic  achievement.  They 
also  noted  that  these  effects  were  relatively  long-lasting  extending  throughout 
childhood  into  young  adulthood.  Rogan  and  Gladen  (1993)  produced  a  follow- 
up  to  their  infant  study  where  they  used  McCarthy  Scale  scores  as  a  measure 
of  cognitive  development  at  3,4  and  5  years.  Their  results  showed  a  trend  for 
higher  scores  in  the  breast  feeding  groups  at  all  ages.  A  study  in  the  U.  K. 
compared  the  performance  of  exclusively  breast-fed  with  exclusively  bottle  fed 
children  N000  in  each  group)  at  8  and  15  years  (Rodgers,  1978).  They  found 
significant  differences  at  age  8  on  picture  intelligence  and  at  age  15  on 
sentence  completion,  non-verbal  ability  and  maths  tests. 
A  similar  study  by  Pollock  (1994)  followed  children  born  in  the  United 
Kingdom  during  seven  days  in  April  1970.  The  cohort  was  divided  into  those 
mothers  who  had  exclusively  breast-fed  for  at  least  three  months  and  those 
who  had  exclusively  bottle-fed  over  the  same  period.  Children  were  assessed  at 
five  and  ten  years  for  several  medical,  physical  and  intellectual  characteristics. 
This  study  differed  from  the  others  already  discussed  in  that  control  for  those 
confounders  focused  on  differences  between  the  two  groups  and  not  on  factors 
which  necessarily  contributed  to  the  outcome  being  assessed.  This  was  to 
ensure  that  results  were  not  attributable  to  differences  between  the  social  and 
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differences  were  observed  between  infant  feeding  methods  for  any  medical 
outcomes  or  physical  characteristics  at  five  or  ten  years.  At  five  years  only  one 
measurement  of  development  achieved  significance,  namely  the  English 
Picture  Vocabulary  Test  in  which  the  breast-fed  children  had  higher  scores.  By 
ten  years  of  age,  exclusively  breast-fed  children  scored  above  average  on  the 
pictorial  language  test  and  also  had  higher  scores  on  the  British  Ability  Scales 
for  Word  Definitions,  Similarities  and  Matrices.  The  study  concluded  that 
intellectual  attainment  was  superior  among  children  that  were  exclusively 
breast-fed  for  at  least  three  months.  Pollock  hypothesised  that  it  was  unlikely 
that  the  intellectual  difference  was  due  to  small  differences  in  the  protein, 
carbohydrate  or  total  fat  content  of  human  or  formula  milk,  but  was  more  likely 
to  be  due  to  suboptimal  levels  of  specific  micronutrients  in  formula  milk  at  a 
critical  period  of  neural  tissue  growth  and  differentiation. 
All  the  aforementioned  studies  have  been  on  term  children.  Lucas  has 
published  several  studies  on  preterm  children.  His  first  main  study  was  to 
follow-up  300  children  from  5  different  centres  who  were  categorised 
according  to  whether  they  had  received  their  own  mother's  milk  (Lucas  et  al. 
1994).  Using  the  Weschler  Intelligence  Scales  for  Children  (WISC-R)  test  at 
7.5  years  the  authors  found  a  10-point  higher  IQ  in  the  breast  fed  group. 
Adjustment  for  mother's  education,  social  class  and  sex  reduced  the  difference 
to  8.3  points.  These  infants  received  their  mothers'  milk  via  nasogastric  tube 
and  therefore  any  advantage  conferred  by  the  act  of  breast-feeding  was 
cancelled  out.  The  next  study  involved  pretenn  infants  whose  mothers  had 
chosen  not  to  breast  feed.  In  one  trial  infants  fed  on  standard  term  formula  for 
an  average  of  4  weeks  had  a  15  point  deficit  in  PDI  at  18  months  compared  to 
those  fed  a  nutrient-enriched  preterm.  formula.  In  another  trial  a  group  of 
infants  fed  donor  breast  milk  had  scores  similar  to  those  fed  the  preterm 
formula.  Lucas  suggested  that  the  donor  breast  milk  was  similar  to  the  term 
122 formula  in  that  it  did  not  provide  adequate  nutrition  for  the  needs  of  the 
preterm  infant.  The  author  also  compared  the  group  fed  expressed  breast  milk 
with  those  fed  standard  term  formula.  The  children  fed  the  expressed  breast 
milk  had  a  significant  9  point  advantage  in  PDI  at  18  months  over  those  fed 
standard  term  formula  (Lucas  et  al.,  1990). 
The  effect  of  dietary  essential  fatty  acid  supply  on  retinal  development  in  the 
human  infant  has  been  examined  by  several  authors  (Carlson  el  aLP  1996;  Innis 
et  al.,  1994;  Jorgensen  el  aL,  1996;  Auestad  et  aL  1996).  Development  of  the 
retina  and  visual  systernwas  assessed  by  measurement  of  visual  acuity,  which 
is  a  non-invasive  test  readily  applied  to  non-verbal  individuals.  The  above 
studies  all  concentrated  on  term  born  infants.  Innis  and  Jorgensen  merely 
compared  breast  fed  versus  standard  formula  fed  infants  and  their  visual 
acuity.  Innis  found  no  difference  in  visual  acuity  at  either  14  days  or  3  months 
whereas  Jorgensen  found  the  visual  acuity  of  the  breast  fed  infants 
significantly  greater  than  that  of  the  formula  fed  group.  This  was  paralleled  by 
a  decrease  in  red  cell  membrane  DRA  in  formula  fed  infants.  This  finding  was 
similar  to  that  observed  by  other  groups.  Auestad  et  aL  (1996)  evaluated  the 
addition  of  DHA  and  AA  or  DHA  alone  to  term  formula  and  assessed  both 
growth  and  visual  function.  They  found  no  differences  in  growth  or  visual 
function  during  the  12  month  period.  This  study  had  involved  197  infants.  In 
1996,  Carlson  had  performed  a  similar  experiment  on  58  infants  in  USA.  She 
found  a  transient  improvement  in  visual  acuity  in  the  supplemented  group  over 
the  standard  formula  but  it  was  not  evident  after  2  months.  Makrides  et  aL 
1995)  reported  a  small  trial  comparing  a  group  of  term  infants  fed  standard 
formula  with  a  group  receiving  a  formula  supplemented  with  fish  oil  as  a 
source  of  DHA  and  gamma-linolenic  acid  as  a  precursor  of  AA.  The 
supplemented  group  had  higher  visual  acuity,  as  measured  by  visual  evoked 
potentials,  than  the  group  fed  standard  formula  at  4  and  7  months.  A  reference 
breast-fed  group  performed  similarly  to  the  supplemented  infants. 
123 Preterm  infants  have  also  been  given  supplemented  formula  and  visual  acuity 
measured  comparing  with  both  breast-fed  infants  and  those  given  standard 
preterm  formula.  These  studies  have  differed  in  the  source  of  LCPUFA  and 
the  amount  added.  Carlson  et  al.  (1992)  added  fish  oil  to  standard  preterm 
formula  and  found  that  the  supplemented  group  had  significantly  lower  weight, 
length  and  head  circumference  at  12  months.  The  supplemented  group  were 
also  lower  at  12  months  in  both  MDI  and  PDI  and  there  was  no  difference  in 
visual  acuity  between  groups.  The  negative  findings  were  presumably  due  to 
the  high  amount  of  EPA  in  the  fish  oil  preparation.  In  a  second  trial  (Carlson  et 
al.,  1994)  the  infants  were  only  given  the  supplemented  formula  for  two 
months  and  the  dietary  EPA  concentration  was  lower  at  0.06%.  Visual  acuity 
was  higher  in  the  supplemented  group  at  2  months  but  no  different  at 
subsequent  testing  up  to  12  months.  The  supplemented  group  was  however 
still  reduced  in  weight  and  head  circumference  at  6  and  9  months.  Presumably 
this  is  due  to  the  competitive  inhibition  of  the  n-6  pathway  by  the  added  DHA 
and  EPA. 
The  above  work  can  be  broadly  divided  into  two  categories.  In  the  first, 
researchers  have  tried  to  show  that  breast  fed  infants  have  an  advantage  in 
neurological  outcome  as  compared  to  formula  fed  infants.  It  is  very  difficult  to 
compare  the  publications,  although  those  assessing  cognitive  function  in 
childhood  include  a  majority  which  show  mild  to  moderate  benefits  in  the 
breast  fed  population.  1"he  inconsistency  in  the  outcome  between  the  various 
studies  could  relate  to  population  differences  and  variation  in  the  number  of 
confounding  variables  applied.  Many  of  the  publications  do  not  give  details  of 
formula  feeding  and  has  been  mentioned  in  this  thesis  there  is  a  wide  variation 
between  formulas  in  both  alpha-linolenic  acid  concentrations  and  linoleic:  cc- 
linolenic  acid  ratios. 
124 In  the  second  category,  researchers  have  started  to  compare  standard  formulas 
with  supplemented  formulas.  Here  again  it  is  difficult  to  compare  results  as 
there  have  been  large  variations  in  supplementation,  ranging  from  different 
sources  of  LCPUFA  to  the  amounts  of  DHA  and/or  AA  added,  not  to  mention 
again  the  difference  in  the  standard  formula  to  which  these  LCPUFA  are  being 
added. 
4.3.2.  The  preterm  infant 
'Me  preterm  infant  is  defined  as  having  been  born.  at  a  gestation  of  less  than  37 
weeks.  Such  infants  are  therefore  bom  with  only  limited  transfer  of  AA  and 
DHA  from  the  placenta.  The  amount  of  subcutaneous  tissue  will  also  be  less 
in  a  premature  infant,  resulting  in  lower  stores  of  fatty  acids  at  birth.  A  baby 
bom  several  weeks  prematurely  will  be  fed  parenteral  nutrition,  expressed 
breast  milk  or  supplemented  formula  milk,  none  of  which  will  match  the 
amount  of  AA  and  DHA  supplied  by  the  placenta  had  the  infant  still  been  in 
utero.  This  deficit  in  AA  and  DHA  which  occurs  in  the  first  few  weeks  of  the 
preterm  infant's  life  coincides  with  the  most  rapid  period  of  brain  growth. 
The  incidence  of  neurodevelopmental  disorders  is  greater  in  both  preterm 
infants  and  low  birth  weight  for  gestational  age  infants.  A  birthweight  of  2.5 
kg  or  less  in  a  term-bom  infant  is  associated  with  a  greater  chance  of  a  central 
nervous  system  defect.  Of  the  four  infants  in  this  study  from  twin  pregnancies 
two  could  be  classified  as  intrauterine  growth  retarded.  Here  also  the  infants 
are  under  stress  at  birth  having  shared  placental  supplies  of  LCPUFA  during 
pregnancy.  All  four  infants  however  were  in  the  same  feeding  group  and  it  was 
not  possible  to  assess  the  effect  of  diet  in  such  individuals. 
Manufacturers  of  milks  have  accepted  as  a  result  of  research  that  addition  of 
AA  and  DHA  is  recommended  for  the  preterm  infant  and  all  specially 
formulated  milks  for  this  group  now  contain  these  LCPUFA.  Future  research 
125 should  include  where  possible  analysis  of  nervous  tissue  from  infants  fed  these 
new  formula  milks.  In  addition  further  visual  and  long  term  developmental 
studies  should  be  instigated. 
4.4  Conclusions 
Controversy  still  remains  in  relation  to  formula  milks  for  term-born  infants. 
This  is  most  probably  due  to  visual  and  developmental  studies  producing 
contradictory  results  between  those  who  found  significant  Oifferences  between 
breast  feeding  and  formula  feeding  and  those  who  found  no  differences.  From 
the  results  presented  in  this  thesis,  it  would  appear  beneficial  to  add  AA  and 
DHA  to  term  formulae  in  order  to  eliminate  structural  differences  in  nervous 
tissue.  The  other  interesting  finding  of  lower  nervonic  acid  in  cerebral  parietal 
white  matter  of  formula  fed  infants  leads  to  the  suggestion  that  this  fatty  acid, 
which  is  present  in  breast  milk,  should  also  be  added  to  infant  formula  milks. 
The  ratio  of  n-6  to  n-3  fatty  acids  in  milks  is  still  the  subject  of  much  debate. 
Certainly  from  the  few  infants  in  this  study  who  received  the  new  C&G 
formulation,  it  would  appear  that  their  levels  of  LCPUFA  in  nervous  tissue 
were  closer  to  that  of  the  breast  fed  infants  but  further  work  is  necessary  to 
confirm  this  finding.  Evidence  exists  that  the  new-born  infant  is  capable  of 
desaturating  and  elongating  linoleic  and  cc-linolenic  acids  to  their  longer  chain 
homologues,  but  whether  the  rate  is  sufficient  to  supply  the  requirements  of  the 
rapidly  growing  neural  network  is  still  not  proven.  An  additional  dietary  supply 
of  LCPUFA  may  still  be  essential. 
As  stated  further  dietary  related,  long-term  developmental  studies  are  required 
in  humans.  Is  it  possible  that  people  have  become  more  aware  of  disorders 
such  as  dyslexia,  attention  deficit  hyperactivity  disorder  and  behavioural 
problems  in  the  last  20  to  30  years  or  may  it  be  that  there  is  a  true  increase  of 
these  disorders  as  a  result  of  the  decrease  in  the  percentage  of  mothers  breast 
126 feeding?  In  the  adult  population,  the  incidence  of  multiple  sclerosis  is  much 
lower  in  countries  such  as  Japanwhere  the  population  are  predominantly  fish 
caters  and  a  large  proportion  of  mothers  breast  feed  providing  not  only  dietary 
AA  and  DHA  but  also  nervonic  acid  essential  for  myelination.  Alzheimer's 
disease,  which  is  showing  an  increasing  prevalence  with  an  ageing 
population,  whilst  perhaps  not  directly  caused  by  deficits  of  LCPUFA  and 
VLCFA  in  the  brain,  disruption  of  their  supply  may  be  a  contributory  factor. 
It  would  therefore  seem  prudent  to  attempt  to  improve  rates  of  long-term  breast 
feeding  and  for  those  mothers  who  are  unable  or  do  not  wish  to  breast-feed,  to 
provide  a  substitute  formulawhich  contains  all  prominent  neural  fatty  acids  in 
a  preformed  state,  in  similar  proportions  to  that  found  in  the  milks  of  well 
nourished  mothers.  In  conjunction  with  optimal  dietary  advice  to  mothers 
during  pregnancy  in  an  attempt  to  improve  uptake  of  essential  fatty  acids  by 
the  fetus  and  possibly  reduce  the  occurrence  of  both  intrauterine  growth 
retardation  and  premature  delivery,  it  would  then  be  practical  to  invoke  non- 
invasive  longitudinal  studies  to  answer  the  question,  whether  introduction  of 
formula  milks  devoid  of  the  fatty  acids  discussed,  has  been  detrimental  to  the 
neurodevelopment  of  previous  and  present  generations. 
127 %,  J[2j  REFERENCES ]References 
Abbasi,  KA  (1989)  Influence  of  diet  on  lipids  and  their  fatty  acids  in 
developing  human  brain.  Ph.  D.  Thesis,  Glasgow  University. 
Abe,  T.  &  Norton,  W.  T.  (1974)  The  characterisation  of  sphingolipids  from 
neurons  and  astroglia  of  immature  rat  brain.  Joumal  of  Neurochemistry  23, 
1025-1036. 
, 
Acheson,  E.  D.  (1972)  The  epidemiology  of  multiple  sclerosis.  In  Multiple 
Sclerosis:  A  Reappraisal.  ed.  McAlpine,  D.,  Lumsden,  C.  E.  &  Acheson,  E.  D. 
pp.  3-80.  Edinburgh:  Churchill  Livingstone. 
Aggett,  P.  J.,  Haschke,  F.,  Heine,  W.,  Hernell,  0.,  Koletzko,  B.,  Launiala,  K., 
17Zey,  J.,  Rubino,  A.,  Sch6ch,  G.,  Senterre,  I&  Tormo,  R.  (1991)  Comment  on 
the  content  and  composition  of  lipids  in  infant  formulas.  ESPGAN  committee 
c)n  nutritionAcla  Pediaftica  Scandinavica  80,887-896. 
Anderson,  GJ,  Connor,  W.  E.  &  Corliss,  J.  D.  (1990)  Docosahexaenoic  acid  is 
the  preferred  dietary  n-3  fatty  acid  for  the  development  of  the  brain  and  retina. 
pediatric  Research  27,89-97. 
A.  nding,  PLH,  &  Hwang,  D.  H.  (1986)  Effects  of  dietary  linolenate  on  the  fatty 
acid  composition  of  brain  lipids  in  rats.  Lipids  21,697-70  1. 
Amsell,  G.  B.  &  Metcalfe,  F.  F.  (1971)  Studies  on  CDP-ethanolamine-1,2- 
(liglyceride  ethanolamine  phosphotransferase  of  rat  brain.  Joumal  of 
lVeurochemistry  18,647-665. 
Araki,  T.,  Kato,  H.,  Hara,  H.  &  Kogure,  K.  (1992)  Postischemic  binding  of 
(3kýphorbol  12,13  dibutyrate  and  CH)inositol  1,4,5-trisphosphate  in  the  gerbil 
brain:  an  autoradiographic  study.  Neuroscience  46,973-980. 
Arbuckle,  L.  D.  &  Innis,  S.  M.  (1992)  Docosahexaenoic  acid  in  developing 
brain  and  retina  of  piglets  fed  high  or  low  a-linolenate  formula  with  and 
without  fish  oil.  Lipids  27,89-93. 
, 
Auestad,  N.,  Montalto,  M.  B.,  Hall,  PLT.,  Fitzgerald,  K.  M.,  Wheeler,  R.  E., 
Connor,  W.  E.,  Neuringer,  M.,  Connor,  S.  L.,  Taylor,  J.  A.  &  Hartmann,  E.  E. 
(1997)  Visual  acuity,  erythrocyte  fatty  acid  composition,  and  growth  in  term 
infants  fed  formulas  with  long  chain  polyunsaturated  fatty  acids  for  one  year. 
pediatric  Research  4  1,1  -10. 
128 ]3alazs,  PL,  Jordan,  T.,  Lewis,  P.  D.  &  Patel,  A.  J.  (1986)  Undernutrition  and 
brain  development.  In  Human  Groivth  Volume  3,  ed.  Falkner,  F.  &  Tanner, 
J.  M.  2nd  edn.  pp.  415-473.  New  York:  Plenum  Publishing. 
13allabriga,  A-  &  Martinez,  M.  (1978)  A  chemical  study  on  the  development  of 
the  human  forebrain  and  cerebellum  during  the  brain  "growth  spurC'  period.  IL 
Phosphoglyceride  fatty  acids.  Brain  Research  159,363-370. 
Barkovich,  A-J.,  Kjos,  B.  O.,  Jackson,  D.  E.  Jr.  &  Norman,  D.  (1988)  Normal 
rnatumtion  of  the  neonatal  and  infant  bmin:  MR  Imaging  at  1.5  T.  Radiology 
166,173-180. 
13embdck,  S.,  Blackberg,  L.  &  Hemell,  0.  (1990)  The  complete  digestion  of 
human  milk  triacylglycerol  in  vitro  requires  gastric  lipase,  pancreatic  colipase- 
dependent  lipase,  and  bile  salt-stimulated  lipase.  Journal  of  Clinical 
-investigation 
85,1221-12276. 
]3itman,  J.,  Wood,  L.,  Hamosh,  M.,  Hamosh,  P.  &  Mehta,  N.  R-  (1983) 
Comparison  of  the  lipid  composition  of  breast  milk  from  mothers  of  term  and 
preterm  infants.  American  Journal  ofClinical  Nutrition  38,300-312. 
][3ligh,  E.  G.  &  Dyer,  WJ.  (1959)  A  rapid  method  of  total  lipid  extraction  and 
purification.  Canadian  Journal  ofBiochemistry  and  Physiology  37,911-917. 
j3jerve,  K-S.,  Fischer,  S.  &  Alme,  K  (1987)  Alpha-linolenic  acid  deficiency  in 
rnan:  effect  of  ethyl  linolenate,  on  plasma  and  erythrocyte  fatty  acid 
composition  and  biosynthcsis  of  prostanoids.  Amefican  Journal  of  Clinical 
jVutrilion  46,570-576. 
131or,  W.  R.  (1943)  Chemistry:  Descriptive  and  Analytical.  In  Biochemistry  of 
the  Fatty  .  4cids  and  their  Compounds,  the  Lipids.  ed.  Blor,  W.  R.  pp.  1-57. 
New  York:  Reinhold  Publishing  Company. 
jE3ourre,  J.  M.,  Pascal,  G.,  Durand,  G.,  Masson,  M.,  Dumont  0.  &  Piciotti,  M. 
(1994)  Alterations  in  the  fatty  acid  composition  of  rat  brain  cells  (neurons, 
astrocytes,  and  oligodendrocytes)  and  of  subcellular  fractions  (myelin  and 
: Synaptosomes)  induced  by  a  diet  devoid  of  n-3  fatty  acids.  Joumal  of 
jVeurochemistry  43,342-348. 
]3ourre,  J.  M.,  Francois,  M.,  Youyou,  A.,  Dumont,  0.,  Piciotti,  M.,,  Pascal,  G.  & 
f)urand,  G.  (1989)  Ile  cffects  of  dietary  cE-linolenic  acid  on  the  composition 
of  nerve  membranes,  enzymatic  activity,  amplitude  of  electrophysiological 
parameters,  resistance  to  poisons  and  performance  of  learning  tasks  in  rats. 
Journal  qfNulrifion  119,1880-1892. 
129 Brenner,  M.  W.,  Gillman,  S.,  Zangwill,  O.  L.  &  Farrell,  M.  (1967)  Visuo-motor 
disability  in  schoolchildren.  British  Medical  Journal  4,259-262. 
Brenner,  R-R.  &  Peluffo,  R.  O.  (1969)  Regulation  of  unsaturated  fatty  acids 
biosynthesis:  Effect  of  maturated  fatty  acid  of  18  carbons  on  the  microsomal 
desaturation  of  linoleic  acid  into  linolenic  acid.  Biochimica  et  Biophisica  Acta 
176,471-479. 
Brenner,  R.  R.  (1989)  Factors  influencing  fatty  acid  chain  elongation.  In  The 
Role  ofFats  in  Human  Nutrition  2d  Edn.  Eds.  Vergroessen,  A.  J.  &  Crawford, 
M.  A.  pp.  45-79.  London:  Academic  Press. 
Brody,  B.  A.,  Kinney,  H.  C.,  Kloman,  A.  S.  &  Gilles,  F.  H.  (1987)  Sequence  of 
central  nervous  system  myelination  in  human  infancy.  1.  An  autopsy  study  of 
myelination.  Journal  of  Neuropathology  and  Experimental  Neurology  46, 
283-301. 
Budowski,  P.,  Leighfield,  M.  J.  &  Crawford,  M.  A.  (1987)  Nutritional 
encephalomalacia  in  the  chick:  an  exposure  of  the  vulnerable  period  for 
cerebellar  development  and  the  possible  need  for  both  co6-  and  0)3-fatty  acids. 
British  Journal  offutrition  58,511-520. 
Burr,  G.  O.  &  Burr,  M.  M.  (1929)  A  new  deficiency  disease  produced  by  the 
rigid  exclusion  of  fat  from  the  diet.  Journal  ofBiological  Chendstry  82,345- 
367. 
Butte,  N.  F.,  Wong,  W.  W.,  Ferlic,  L.,  Smith,  E.  O.,  Klein,  P.  D.  &  Garza,  C. 
(1990)  Energy  expenditure  and  deposition  of  breast-fed  and  formula-fed 
infants  during  early  infancy.  Pediatric  Research  28,631-640. 
Caldwell,  M.  D.,  Jonsson,  H.  T.  &  Otherson,  H.  B.  (1972)  Essential  fatty  acid 
deficiency  in  an  infant  receiving  prolonged  parenteral  alimentation.  Journal  of 
Pediatrics  81,894-898. 
Campbell,  F.  M.,  Gordon,  M.  J.  &  Dutta-Roy,  A.  K.  (1998)  Placental  membrane 
fatty  acid-binding  protein  preferentially  binds  arachidonic  and 
docosahexaenoic  acids.  Life  Sciences  63,235-240. 
Carlson,  S.  E.,  Carver,  J.  D.  &  House,  S.  G.  (1986a)  High  fat  diets  varying  in 
ratios  of  polyunsaturated  to  saturated  fatty  acid  and  linoleic  to  linolenic  acid:  a 
comparison  of  rat  neural  and  red  cell  membrane  phospholipids.  Journal  of 
Nutrition  116,718-725. 
130 Carlson,  S.  E.,  Rhodes,  P.  G.  &  Ferguson,  M.  G.  (1986b)  Docosahexaenoic  acid 
status  of  pretenn  infants  at  birth  and  following  feeding  with  human  milk 
formula.  American  Joumal  of0inical  Nutrition  44,798  -804. 
Carlson,  S.  E.,  Cooke,  RU,  Rhodes,  P.  G.,  Peeples,  J.  M.,  Werkman,  S.  H.  & 
Tolley,  E.  A.  (1991)  Long-term  feeding  of  formulas  high  in  linolenic  acid  and 
marine  oil  to  very  low  birth  weight  infants:  phospholipid  fatty  acids.  Pediatric 
Research  30,404-412. 
Carlson,  S.  E.,  Cooke,  R-J.,  Rhodes,  P.  G.,  Peeples,  J.  M.  &  Werkman,  S.  H. 
(1992)  Effect  of  vegetable  and  marine  oils  in  preterm  infant  formulas  on  blood 
arachidonic  and  docosahexaenoic  acids.  Journal  of  Pediatrics  120,  S159- 
S167. 
Carlson,  S.  E.,  Werkman,  S.  H.,  Peeples,  J.  M.,  Cooke,  R.  J.  &  Tolley,  E.  A. 
(1993)  Arachidonic  acid  status  correlates  with  first  year  growth  in  pretenn 
infants.  Proceedings  of  the  NationalAcademy  of  Science  USA  90,1073-1077. 
Carlson,  S.  E.,  Werkman,  S.  H.,  Peeples,  J.  M.  &  Wilson  W.  M.  (1994)  Long 
chain  fatty  acids  and  early  visual  and  cognitive  development  of  preterm 
infants.  European  Journal  ofClinical  Nutrition  48  (Suppl.  2),  S27-S30. 
Carlson,  S.  E.,  Ford,  AI,  Werkman,  S.  H.,  Peeples,  J.  M.  &  Koo,  W.  W.  K. 
(1996)  Visual  acuity  and  fatty  acid  status  of  term  infants  fed  human  milk  and 
formulas  with  and  without  docosahexaenoate  and  arachidonate  from  egg  yolk 
lecithin.  Pediatric  Research  39,882-888. 
Carnielli,  V.  P.,  Wattimena,  D.  J.,  Luijendijk,  I.  H.,  Boerlage,  A.  Degenhart,  H.  J. 
&  Sauer,  P.  J.  (1996)  The  very  low  birth  weight  premature  infant  is  capable  of 
synthesizing  arachidonic  and  docosahexaenoic  acids  from  linoleic  and 
linolenic  acids.  Pediatric  Research  40,169-174. 
Chase,  H.  P.,  Welch,  N.  N.,  Dabiere,  C.  S.,  Vasan,  N.  S.  &  Butterfield,  L.  J. 
(1972)  Alterations  in  human  brain  biochemistry  following  intrauterine  growth 
retardation.  Pediatrics  50,403  -411. 
Chen,  I.  S.,  Hotta,  S.  S.,  Ikeda,  L,  Cassidy,  M.  M.,  Sheppard,  A.  J.  &  Vahouny, 
G.  V.  (1987)  Digestion,  absorption  and  effects  on  cholesterol  absorption  of 
menhaden  oil,  fish  oil  concentrate  and  com  oil  by  rats.  Journal  of  Nutrition 
117,1676-1680. 
Chen,  Q.,  Blackberg,  L.,  Nilsson,  A.,  Stemby,  B.  &  Hernell,  0.  (1994) 
Digestion  of  triacylglycerols  containing  long-chain  polyenoic  fatty  acids  in 
vitro  by  colipase-dependent  pancreatic  lipase  and  human  milk  bile  salt- 
stimulated  lipase.  Biochimica  etBiophysicaActa  1210,239-243. 
131 Christie,  W.  W.  (1986)  Separation  of  lipid  classes  by  high-perfon-nance  liquid 
chromatography  with  the  "mass  detector".  Journal  of  Chromatography  361, 
396-399. 
Clandinin,  M.  T.,  Chappell,  J.  E.,  Leong,  S.,  Heim,  T.,  Swyer,  P.  R.  &  Chancel 
G.  W.  (1980)  Intrauterine  fatty  acid  accretion  rates  in  human  brain: 
implications  for  fatty  acid  requirements.  Early  Human  Development  4,121- 
129. 
Clandinin,  M.  T.,  Chappell,  J.  E.,  Heim,  T.,  Swyer,  P.  R.  &  Chance,  G.  W. 
(1981)  Fatty  acid  utilization  in  perinatal  de  novo  synthesis  of  tissues.  Early 
Human  Development  5,3  55-3  66. 
Clark,  K.  J.,  Makrides,  M.,  Neumann,  M.  A.  &  Gibson,  R.  A.  (1992) 
Determination  of  the  optimal  ratio  of  linoleic  acid  to  alpha-linolenic  acid  in 
infant  formulas.  Journal  ofPediatrics120,  Sl5l-Sl58. 
Clausen,  J.  &  Moller,  1  (1967)  Allergic  encephalomyelitis  induced  by  brain 
antigen  after  deficiency  in  polyunsaturated  fatty  acids  during  myelination.  Acta 
Neurological  Scandinavia  43,3  75-3  8  8. 
Clos,  J.,  Legrand,  J.,  Limozin,  N.,  Dalmasso,  C.  &  Laurent,  G.  (1982)  Effects 
of  abnormal  thyroid  state  and  undernutrition  on  carbonic  anhydrase  and 
oligodendroglia  development  in  the  rat  cerebellum.  Developmental 
Neuroscience  5,243-25  1. 
Connor,  W.  E.,  Neuringer,  M.  &  Lin,  D.  S.  (1990)  Dietary  effects  on  brain  fatty 
acid  composition:  the  reversibility  of  n-3  fatty  acid  deficiency  and  turnover  of 
docosahexaenoic  acid  in  the  brain,  erythrocytes,  and  plasma  of  rhesus 
monkeys.  Journal  oftipid  Research  31,237-247. 
Cook,  A.  M.,  Low,  E.  &  Ishijimi,  M.  (1972)  Effect  of  phosphatidyl  serine 
decarboxylase  on  neural  excitation.  Nature:  New  Biology  239,150-15  1. 
Crawford,  M.  A.,,  Hassam,  A.  G.,  Williams,  G.  &  Whitehouse,,  W.  L.  (1976) 
Essential  fatty  acids  and  fetal  brain  growth.  Lancet  i,  452-453. 
Crawford,  M.  A.,  Costeloe,  K.,  Ghebremeskel,  K.,  Phylactos,  A.,  Skirvin,  L.  & 
Stacey,  F.  (1997)  Are  deficits  of  arachidonic  and  docosahexaenoic  acids 
responsible  for  the  neural  and  vascular  complications  of  preterin  babies? 
Ametican  Joumal  of0inical  Nutfition  66  (Suppl),  1032-104  1. 
Cullis,  P.  R.  &  De  Kruijff,  B.  (1979)  Lipid  polymorphism  and  the  functional 
roles  of  lipids  in  biological  membranes.  Biochimica  et  Biophysica  Acta  559, 
399-420. 
132 Cunnane,  S.  C.,  Harbige,  L.  S.  &  Crawford,  M.  A.  (1993)  The  importance  of 
energy  and  nutrient  supply  in  human  brain  evolution.  Nutfition  and  Health  9, 
219-235. 
Cuzner,  M.  L.  &  Davison,  AN  (1968)  The  lipid  composition  of  rat  brain 
myelin  and  subcellular  fractions  during  development.  Biochemistry  Journal 
106,29-34. 
Davison,  AN  &  Dobbing,  J.  (1966)  Myelination  as  a  vulnerable  period  in 
brain  development.  British  Medical  Bulletin  22,40-44. 
Dickerson,  J.  W.  T.  &  Dobbing,  J.  (1966)  Prenatal  and  postnatal  growth  and 
development  of  the  central  nervous  system  of  the  pig.  Proceedings  of  the 
Royal  Society  166,3  84-3  95. 
Dobbing,  J.  (1968)  Effects  of  experimental  undernutrition  on  development  of 
the  nervous  system.  In  Malnutrition,  Leaming  and  Behaviour.  ed.  Scrimshaw 
N.  S.  &  Gordon  J.  E.  pp.  181-202.  Cambridge,  Massachusetts:  MIT  Press. 
Dobbing,  J.,  Hopewell,  J.  W.  &  Lynch,  A.  (1971)  Vulnerability  of  developing 
brain:  VIE[.  Permanent  deficit  of  neurons  in  cerebral  and  cerebellar  cortex 
following  earlymild  undernutrition.  ExperimentalNeurology32,439-447. 
Dobbing,  J.  &  Sands,  J.  (1973)  Quantitative  growth  and  development  of 
human  brain.  Archives  ofDisease  in  Childhood  48,757-767. 
Edmond,  J.,  Korsak,  kA.,  Morrow,  J.  W.,  Torok-Both,  G.  &  Catlin,,  D.  H. 
(1991)  Dietary  cholesterol  and  the  origin  of  cholesterol  in  the  brain  of 
developing  rats.  Joumal  offulfition  121,1323-1330. 
El  Boustani,  S.,  Colette,  C.,  Monnier,  L.,  Descomps,  B.,  Crastes  de  Paulet,  A. 
&  Mendy,  F.  (1987)  Enteral  absorption  in  man  of  eicosapentaenoic  acid  in 
different  chemical  forms.  Lipids  22,711-714. 
Farquharson,  J.,  Cockburn,  F.,  Patrick,  W.  A.,  Jamieson,  E.  C.  &  Logan,  R.  W. 
(1993)  Effect  of  diet  on  infant  subcutaneous  tissue  triglyceride  fatty  acids. 
Archives  ofDisease  in  Childhood  69,589-593. 
Farquharson,  J.,  Jamieson,  E.  C.,  Logan,  R.  W.,  Patrick,  W.  J.  A.,  Howatson, 
A.  G.  &  Cockburn,  F.  (1995)  Age-  and  dietary-related  distributions  of  hepatic 
arachidonic  and  docosahexaenoic  acid  in  early  infancy.  Pediatric  Research  38, 
361-365. 
133 Feldman,  M.,  Van  Aerde,  J.  E.  &  Clandinin,  M.  T.  (1992)  Lipid  accretion  in  the 
fetus  and  newborn.  In  Fetal  and  Neonatal  Physiology,  ed.  Polin,  R.  A.  &  Fox, 
W.  W.  pp.  299-314.  Toronto:  W.  B.  Saunders. 
Fenske,  D.  B.,  Jarrell,  H.  C.,  Guo,  Y.  &  Hui,  S.  W.  (1990)  Effect  of  unsaturated 
phosphatidylethanolamine  on  the  chain  order  profile  of  bilayers  at  the  onset  of 
the  hexagonal  phase  transition.  A2H  NMR  study.  Biochemistry  29,11222. 
11229. 
Ferguson,  A.  E.,  Tappin,  D.  M.,  Girdwood,  R.  W.  A.,  Kennedy,  R.  &  Cockburn, 
F.  (1994)  Breast  feeding  in  Scotland.  British  Medical  Journal  308,824-825. 
Fergusson,  D.  M.,  Beautrais,  A.  L.  &  Silva,  P.  A.  (1982)  Breast-feeding  and 
cognitive  development  in  the  first  seven  years  of  life.  Social  Science  and 
Medicine  16,1705-1708. 
Fildes,  V.  (1990)  Breast-feeding  practices  during  industrialization  1800-1919. 
In  Infant  and  child  nutrition  worldWde.  Issues  and  perspectives  ed.  Faulkner, 
F,  pp.  1-2  1.  Boston:  CRC  Press. 
Fisher,  S.  K-  &  Agranofý  B.  W.  (1987)  Receptor  activation  and  inositol  lipid 
hydrolysis  in  neural  tissues.  Joumal  ofNeurochemistry  48(4),  999-1017. 
Florey,  C.  D.,  Leech,  A.  M.  &  Blackhall,  A.  (1995)  Infant  feeding  and  mental 
and  motor  development  at  18  months  of  age  in  first  bom  singletons. 
International  Journal  ofEpidemioloV  24,  S21-S26. 
Folch,  J.,  Lees,  M.  &  Sloane  Stanley,  G.  H.  (1957)  A  simple  method  for  the 
isolation  and  purification  of  total  lipids  from  animal  tissues.  Journal  of 
Biological  Chemistry  226,497-509. 
Forsy,  the,  I.  D.  &  Clements,  J.  D.  (1990)  Presynaptic  glutamate  receptors 
depress  excitatory  monosynaptic  transmission  between  mouse  hippocampal 
neurones.  Joumal  ofPhysiology  429,1-16. 
Fox,  P.  T.,  Raichle,  M.  E.  &  Thach,  W.  T.  (1985)  Functional  mapping  of  the 
human  cerebellum  with  positron  emission  tomography.  Proceedings  of  the 
National  Academy  ofScience  USA  82,7462-7466. 
Galli,  C.,  White,  H.  B.  Jr.  &  Paoletti,  R.  (1970)  Brain  lipid  modifications 
induced  by  essential  fatty  acid  deficiency  in  growing  male  and  female  rats. 
Joumal  ofNeurochemisoy  17,347-355. 
134 Galli,  C.,  Trzeciak,  H.  I.  &  Paoletti,  R.  (1971)  Effects  of  dietary  fatty  acids  on 
the  fatty  acid  composition  of  brain  ethanolamine  phosphoglyceride:  reciprocal 
replacement  of  n-6  and  n-3  polyunsaturated  fatty  acids.  Biochimica  el 
Biophysica  Acta  248,449454. 
Garg,  M.  L.,  Keelan,  M.,  Thomson,  A.  B.  R.  &  Clandinin,  M.  T.  (1988)  Fatty 
acid  desaturation  in  the  intestinal  mucosa.  Biochimica  et  Biophysica  Acta  958, 
139-141. 
Gerst],  B.,  Tavaststjerna,  M.  G.,  Hayman,  R.  B.,  Eng,  L.  F.  &  Smith,  J.  K.  (1965) 
Alterations  in  myelin  fatty  acids  and  plasmalogens  in  multiple  sclerosis.  Annals 
New  York  Academy  ofSciences  122,405-41  S. 
Gibson,  R.  A.  &  Kneebone,  G.  M.  (1981)  Fatty  acid  composition  of  human 
colostrurn  and  mature  breast  milk.  American  Journal  of  Clinical  Nutrition  34, 
252-257. 
Green,  P.  &  Yavin,  E.  (1993)  Elongation,  desaturation,  and  esterification  of 
essential  fatty  acids  by  fetal  rat  brain  in  vivo.  Journal  of  Lipid  Research  34, 
2099-2107. 
Hamosh,  M.  &  Bums,  W.  A.  (1977)  Lipolytic  activity  of  human  lingual  glands 
(Ebner).  Laboratory  Investigations  37,603-608. 
Hansen,  A.  E.,  Wiese,  H.  F.,  Boelsche,  AN,  Haggard,  MR,  Adam,  D.  J.  D.  & 
Davis,  H.  (1963)  Clinical  and  chemical  study  of  428  infants  fed  on  milk 
mixtures  varying  in  kind  and  amount  of  fat.  Pediatrics  31,171-192. 
Hara,  A.  &  Radin,  N.  S.  (1972)  Lipid  extraction  of  tissues  with  a  low  toxicity 
solvent.  Analytical  Chemistry  90,420-426. 
Harzer,  G.,  Haug,  M.,  Dietrich,  1.  &  Gentner,  P.  R.  (1983)  Changing  patterns  of 
human  milk  lipids  in  the  course  of  the  lactation  and  during  the  day.  American 
Journal  ofClinical  Nutrition  37,612-62  1. 
Hassam,  A.  G.,  Sinclair,  A.  J.  &  Crawford,  M.  A.  (1975)  The  incorporation  of 
orally  fed  radioactive  y-linolenic  acid  and  linoleic  acid  into  the  liver  and  brain 
lipids  of  suckling  rats.  Lipids  10,417-420. 
Hay,  W.  W.  Jr.  (1991)  The  placenta.  Not  just  a  conduit  for  matemal  fuels. 
Diabetes  40  (Suppl.  2),  44-50. 
135 Heinig,  M.  J.,  Nommsen,  L.  A.,  Peerson,  J.  M.,  Lonnerdal,  B.  &  Dewey,  K.  G. 
(1993)  Energy  and  protein  intakes  of  breast-fed  and  formula-fed  infants  during 
the  first  year  of  life  and  their  association  with  growth  velocity:  the  DARLING 
Study.  American  Journal  ofClinical  Nutrition  58,152-16  1. 
Henzi,  V.  &  MacDennott,  A.  B.  (1992)  Characteristics  and  function  of  Ca(2+)- 
and  inositol  1,4,5-trisphosphate-releasable  stores  of  Ca(2+)  in  neurons. 
Neuroscience  46(2),  251-273. 
Hitchcock,  C.  &  Nichols,  B.  W.  (1971)  The  lipid  and  fatty  acid  composition  of 
specific  tissues.  In  Plant  Lipid  Biochemistry,  ed.  Sutcliffe,  IF  &  Mahlberg,  P. 
pp.  59-80.  London:  Academic  Press. 
Hoefer,  C.  &  Hardy,  M.  C.  (1929)  Later  development  of  breast-fed  and 
artificially  fed  infants.  Journal  of  the  American  MedicalAssociation  92,615- 
619. 
Holman,  R-T.,  Johnson,  S.  B.  &  Hatch,  T.  F.  (1982)  A  case  of  human  linolenic 
acid  deficiency  involving  neurological  abnormalities.  American  Journal  of 
Clinical  Nutrition  35,617-623. 
Horwood,  L.  J.  &  Fergusson,  D.  M.  (1998)  Breastfeeding  and  later  cognitive 
and  academic  outcomes.  Pediatrics  101,99  (6). 
Hundrieser,  K.  &  Clark,  R.  M.  (1988)  A  method  for  separation  and 
quantification  of  phospholipid  classes  in  human  milk.  Journal  of  Dairy 
Science  71,61-67. 
Innis,  S.  M.  (1992)  Human  milk  and  fonnula  fatty  acids.  Joumal  ofPediatrics 
120,  S56-S61. 
Innis,  S.  M.,  Nelson,  C.  M.,  Rioux,  M.  F.  &  King,  D.  J.  (1994)  Development  of 
visual  acuity  in  relation  to  plasma  and  erythrocyte  (o-6  and  w-3  fatty  acids  in 
healthy  term  gestation  infants.  American  Journal  ofClinical  Nutrition  60,347- 
352. 
Jensen,  C.  L.,  Prager,  T.  C.,  Fraley,  J.  K.,  Chen,  H.,  Anderson,  R.  E.  &  Heird, 
W.  C.  (1997)  Effect  of  dietary  linoleic/alpha-linolenic  acid  ratio  on  growth  and 
visual  function  of  tenn  infants.  Joumal  ofPediatrics  131,200-209. 
Jensen,  RG.,  Ferris,  A.  M.  &  Lammi-Keefe,  C.  J.  (1992)  Lipids  in  human  milk 
and  infant  formulas.  Annual  Reviews  in  Nutrition  12,417-44  1. 
136 Jordan,  T.  C.,  Howells,  K.  F.  &  Piggott,  S.  M.  (1979)  Effects  of  early 
undernutrition  on  motor  coordination  in  the  adult  rat.  Behavioral  and  Neural 
Biology  25,126-132. 
Jorgensen,  M.  H.,  Hernell,  0.,  Lund,  P.,  Holmer,  G.  &  Michaelsen,  K.  F.  (1996) 
Visual  acuity  and  erythrocyte  docosahexaenoic  acid  status  in  breast-fed  and 
formula-fed  term  infants  during  the  first  four  months  of  life.  Lipids  31,99-105. 
Keen,  D.  V.  &  Pearse,  R-G.  (1985)  Birthweight  between  14  and  42  weeks' 
gestation.  Archives  ofDiseases  in  Childhood  60,440-446. 
Kinney,  H.  C.,  Brody,  B.  A.,  Kloman,  A.  S.  &  Gilles,  F.  H.  (1988)  Sequence  of 
central  nervous  system  myelination  in  human  infancy.  11.  Patterns  of 
myelination  in  autopsied  infants.  Journal  of  Neuropathology  and 
Experimental  Neurology  47,217-234. 
Kinney,  H.  C.,  Karthigasan,  J.,  Borenshteyn,  N.  I.,  Flax,  J.  D.  &  Kirschner,  D.  A. 
(1994)  Myelination  in  the  developing  human  brain:  Biochemical  correlates. 
Neurochemical  Research  19,983-996. 
Kneebone,  G.  M.,  Kneebone,  R-  &  Gibson,  R-A.  (1985)  Fatty  acid  composition 
of  breast  milk  from  three  racial  groups  from  Penang,  Malaysia.  American 
Journal  ofClinical  Nutrition  41,765-769. 
Kolb,  B.  &  Whishaw,  I.  Q.  (1985)  Memory.  In  Fundamentals  of  Human 
Neuropsychology.  2nd.  edition.  pp  475-512  W.  H.  Freeman 
Koletzko,  B.,  Schmidt  E.,  Bremer,  H.  J.,  Haug,  M.  &  Harzer,  G.  (1989)  Effects 
of  dietary  long-chain  polyunsaturated  fatty  acids  on  the  essential  fatty  acid 
status  of  premature  infants.  European  Journal  ofPediatrics  148,669-675. 
Koletzko,  B.  (1992)  Trans  fatty  acids  may  impair  biosynthesis  of  long-chain 
polyunsaturates  and  growth  in  man..  Acta  Pediatrica  81,302-306. 
Koletzko,  B.,  Thiet,  I.  &  Abiodun,  P.  O.  (1992)  The  fatty  acid  composition  of 
human  milk  in  Europe  and  Africa.  Joumal  qfPediatfics  120,  S87-92. 
Kuhn,  D.  C.  &  Crawford,  M.  (1986)  Placental  essential  fatty  acid  transport  and 
prostaglandin  synthesis.  Progress  in  Lipid  Research  25,345-353. 
Lamptey,  M.  S.  &  Walker,  B.  L.  (1975)  A  possible  essential  role  for  dietary 
linolenic  acid  in  the  development  of  the  young  rat.  Journal  of  Nutrition  106, 
86-93. 
137 Lawson,  L.  D.  &  Hughes,  B.  G.  (1988)  Human  absorption  of  fish  oil  fatty  acids 
as  triacylglycerols,  free  acids,  or  ethyl  esters.  Biochemical  and  Biophysical 
Research  Communications  152,328-335. 
Leiner,  H.  C.,  Leiner,  A.  L.  &  Dow,  R-S.  (1991)  The  human  cerebro-cerebellar 
system:  its  computing,  cognitive,  and  language  skills.  Behavioural  Brain 
Research  44,113-128. 
Lesny,  I.  A.  (1980)  Developmental  dyspraxia-dysgnosia  as  a  cause  of 
congenital  children's  clumsiness.  Brain  Development  2,69-7  1. 
Lindquist,  B.,  Ballabriga,  A.,  Hadorn,  B.,  Lloyd,  J.,  Nordio,  S.,  Plenert,  W., 
Rey,  J.,  Schmidt,  E.,  Wolff,  0.  &  Visakorpi,  J.  K.  (1982)  Uniqueness  of  human 
milk.  ESPGAN  committee  on  nutrition.  Acta  Pediatrica  Scandinavica  302, 
S4-S24. 
Lucas,  A.  &  Davies,  P.  S.  W.  (1990a)  Physiologic  energy  content  of  human 
milk.  In  Breasffieeding,  Nutrition,  Infection  and  Infant  Growth  in  Developed 
and  Emerging  Countries,  ed.  Atkinson,  S.  A.,  Hanson,  L.  A.  &  Chandra,  R.  K. 
pp.  337-357.  St.  JohWs,  Newfoundland,  Canada.:  ARTS  Biomedical 
Publishers. 
Lucas,  A.,  Morley,  R,  Cole,  T.  J.,  Gore,  S.  M.,  Lucas,  F.  J.,  Crowle,  F.,  Fearse, 
R.,  Boon,  A.  J.  &  Powell,  R-  (1990b)  Early  diet  in  preterm  babies  and 
developmental  status  at  18  months.  Lancet  335,1477-148  1. 
Lucas,  A.,  Morley,  R-,  Cole,  T.  J.  &  Gore,  S.  M.  (1994)  A  randomiscd 
multicentre  study  of  human  milk  versus  formula  and  later  development  in 
prcterm  infants.  Archives  ofDisease  in  Childhood  70,  F  14  1  -F  146. 
Lutze,  B.  S.  &  Braughler,  J.  M.  (1990)  An  improved  method  for  the 
identification  and  quantitation  of  biological  lipids  by  HPLC  using  laser  light- 
scattering  detction.  Journal  ofLipid  Research  31,2127-213  0. 
Lynch,  A.,  Smart,  J.  L.  &  Dobbing,  1  (1975)  Motor  co-ordination  and 
cerebellar  size  in  adult  rats  undernourished  in  early  life.  Brain  Research  83, 
249-259. 
McArdle,  C.  B.,  Richardson,  CI,  Nicholas,  D.  A.,  Mirfakhraee,  M.,  Hayden, 
C.  K  &  Amparo,  E.  G.  (1987)  Developmental  features  of  the  neonatal  brain: 
MR  imaging.  Radiology  162,223-229. 
McMurray,  W.  C.  (1983)  Lipids.  In  Essentials  of  human  metabolism,  pp.  160- 
205.  Philadelphia:  Harper  and  Row. 
138 Makrides,  M.,  Simmer,  K.,  Goggin,  M.  &  Gibson,  R.  A.  (1993)  Erythrocyte 
docosahexaenoic  acid  correlates  with  the  visual  response  of  healthy,  term 
infants.  Pediatric  Research  33,425-427. 
Makrides,  M.,  Neumann,  M.  A.,  Byard,  R-W.,  Simmer,  K.  &  Gibson,  R.  A. 
(1994)  Fatty  acid  composition  of  brain,  retina,  and  erythrocytes  in  breast-  and 
formula-fed  infants.  American  Joumal  ofClinical  Nutrition  60,189-194. 
Mann,  H.  B.  &  Whitney,  DR  (1947)  On  a  test  of  whether  one  of  two  random 
variables  is  stochastically  larger  than  the  other.  Annales  of  Mathematical 
Statistics  18,50-60. 
Martin,  J.  C.,  Bougnoux,  P.,  Antoine,  J.  M.,  Lanson,  M.  &  Couet,  J.  C.  (1993) 
Triacylglycerol  structure  of  human  colostrum  and  mature  milk.  Lipids  28,637- 
643. 
Martinez,  M.,  Conde,  C.  &  Ballabriga,  A.  (1974)  Some  chemical  aspects  of 
human  brain  development.  11.  Phosphoglyceride  fatty  acids.  Pediatric 
Research  8,93-102. 
Martine4  M.  (1982)  Myelin  lipids  in  the  developing  cerebrum,  cerebellum, 
and  brain  stem  of  normal  and  undernourished  children.  Journal  of 
Neurochemistry  39,1684  -  1692. 
Martinez,  M.  (1989)  Dietary  polyunsaturated  fatty  acids  in  relation  to  neural 
development  in  humans.  In  Dietary  w3  and  o)6  Fatty  Acids,  ed.  Galli,  C.  & 
Simopoulos,  A.  P.  pp.  123-133.  New  York:  Plenum  Press. 
Martinez,  M.  (1992a)  Abnormal  profiles  of  polyunsaturated  fatty  acids  in  the 
brain,  liver,  kidney  and  retina  of  patients  with  peroxisomal  disorders.  Brain 
Research  583,171-182. 
Martinez,  M.  (1992b)  Tissue  levels  of  polyunsaturated  fatty  acids  during  early 
human  development.  Joumal  ofPediatrics  120,  SI  29-S  13  8. 
Mead,  J.  F.  &  Slaton,  W.  H.  (1956)  Metabolism  of  essential  fatty  acids  111. 
Isolation  of  5,8,11-Eicosatrienoic  acid  from  fat  deficient  mts.  Journal  of 
Biological  Chemistry  219,705-709. 
Mead,  J.  F.  &  Dhopeshwarkar,  G.  A.  (1971)  Types  of  fatty  acids  in  brain  lipids, 
their  derivation  and  function.  In  Lipids,  Malnutrition  and  the  Developing 
Brain.  Ciba  Foundation  Symposium  pp.  59-72.  Amsterdam:  Elsevier. 
139 Menkes,  J.  H.,  Alter,  M.,  Steigleder,  G.  K.,  Weakley,  D.  R.  &  Sung,  J.  H.  (1962) 
A  sex-linked  recessive  disorder  with  retardation  of  growth,  peculiar  hair,  and 
focal  cerebral  and  cerebellar  degeneration.  Pediatrics  29,764-779. 
Menon,  N.  K.  &  Dhopeshwarkar,  G.  A.  (1982)  Essential  fatty  acid  deficiency 
and  brain  development.  Progress  in  LipidResearch  21,309-326. 
Metcalfe,  L.  D.,  Schmitz,  A.  A.  &  Pelka,  J.  R.  (1966)  Rapid  preparation  of  fatty 
acid  esters  from  lipids  for  gas  chromatographic  analysis.  Analytical  Chemistry 
38,514-515. 
Mohrhauer,  H.  &  Holman,  R.  T.  (1963)  Alteration  of  the  fatty  acid  composition 
of  brain  lipids  by  varying  levels  of  dietary  essential  fatty  acids.  Joumal  of 
Neurochemistry  10,523-530. 
Moore,  S.  A.,  Hurt,  E.,  Yoder,  E.,  Sprecher,  H.  &  Spector,  A.  A.  (1995) 
Docosahexaenoic  acid  synthesis  in  human  skin  fibroblasts  involves 
peroxisomal  retroconversion  of  tetracosahexaenoic  acid.  Journal  of  Lipid 
Research  36,2433-2443. 
Morrison,  W.  B.  &  Smith,  L.  M.  (1964)  Preparation  of  fatty  acids  methyl  esters 
and  dimethylacetals  from  lipids  with  boron  tluoride-methanol.  Journal  ofLipid 
Research  5,600-608. 
Morrow-7nucak,  M.,  Haude,  R.  H.  &  ErnhaM  C.  B.  (1988)  Breastfeeding  and 
cognitive  development  in  the  first  2  years  of  life.  Social  Science  and  Medicine 
26,635-639. 
Nawy,  S.  &  Jahr,  C.  E.  (1990)  Suppression  by  glutamate  of  cGMP-activated 
conductance  in  retinal  bipolar  cells.  Nature  346,269-27  1. 
Neuringer,  M.,  Connor,  W.  E.,  Van  Petten,  C.  &  Barstad,  L.  (1984)  Dietary 
omega-3  fatty  acid  deficiency  and  visual  loss  in  infant  rhesus  monkeys. 
Journal  ofClinical  Investigation  73,272-276. 
Neuringer,  M.,  Connor,  W.  E.,  Lin,  D.  S.,  Barstad,  L.  &  Luck,  S.  (1986) 
Biochemical  and  functional  effects  of  prenatal  and  postnatal  (03  fatty  acid 
deficiency  on  retina  and  brain  in  rhesus  monkeys.  Proceedings  of  the  National 
Academy  ofScience  USA  83,4021-4025. 
Mrien,  J.  S.  &  Sampson,  E.  L.  (1965)  Fatty  acid  and  fatty  aldehyde 
composition  of  the  major  brain  lipids  in  normal  human  gray  matter,  white 
matter,  and  myelin.  Journal  oftipid  Research  6,545-55  1. 
140 Olegard,  F.  &  Svermerholm,  L.  (1971)  Effects  of  diet  on  fatty  acid 
composition  of  plasma  and  red  cell  phosphoglycerides  in  three-month-old 
infants..  Acta  Pediatrica  Scandinavia  60,505-511. 
Olsen,  R-E.  &  Henderson,  R-J.  (1989)  The  rapid  analysis  of  neutral  and  polar 
marine  lipids  using  double-development  HPTLC  and  scanning  densitometry. 
Journal  ofExperimental  Marine  Biology  and  Ecology  129,189-197. 
Pawlosky,  R.  J.,  Ward,  G.  &  Salem,  N.  Jr.  (1996)  Essential  fatty  acid  uptake 
and  metabolism  in  the  developing  rodent  brain.  Lipids  31  (Suppl),  103-107. 
Poisson,  J.  -P.,  Dupuy,  R--P.,  Sarda,  P.,  Descomps,  B.,  Narce,  M.,  Rieu,  D.  & 
Crastes  de  Paulet,  A.  (1993)  Evidence  that  liver  microsomes  of  human 
neonates  desaturate  essential  fatty  acids.  Biochimica  et  Biophysica  A  cla  1167, 
109-113. 
Pollock,  JI  (1994)  Long  tenn  associations  with  infant  feeding  in  a  clinically 
advantaged  population  of  babies.  Developmental  Medicine  and  Child 
Neurology  36,429-440. 
Ponder,  D.  L.,  Innis,  S.  M.,  Benson,  J.  D.  &  Siegman,  J.  S.  (1992) 
Docosahexaenoic  acid  status  of  term  infants  fed  breast  milk  or  infant  formula 
containing  soy  oil  or  com  oil.  Pediatric  Research  32,683-688. 
Porcellati,  G.,  Arienti,  G.,  Pirotta,  M.  &  Giorgini,  D.  (1971)  Base-exchange 
reactions  for  the  synthesis  of  phospholipids  in  nervous  tissue:  the  incorporation 
of  serine  and  ethanolamine  into  the  phospholipids  of  isolated  brain 
microsomes.  Journal  ofNeurochemistry  18,1395-1417. 
Putnam,  J.  C.,  Carlson,  S.  E.,  DeVoe,  P.  W.  &  Barness,  L.  A.  (1982)  The  effect 
of  variations  in  dietary  fatty  acids  on  the  fatty  acid  composition  of  erythrocyte 
phosphatidy1choline  and  phosphatidylethanolamine  in  human  infants. 
,  fterican  Journal  ofClinical  Nutrition  36,106-114. 
Rao,  P.  S.  (1976)  Fatty  acids  of  cerebrosides  in  different  regions  of  the 
developing  foetal  brain.  Lipids  12,335-339. 
Rivers,  J.  P.  W.,  Sinclair,  A.  J.  &  Crawford,  M.  A.  (1975)  Inability  of  the  cat  to 
desaturate  essential  fatty  acids.  Nature  258,171-173. 
Robertson,  A.  F.  &  Sprecher,  H.  (1968)  A  review  of  human  placental  lipid 
metabolism  and  transport.  Acta  Pediatrica  Scandinavica  183,  S2-S  18. 
141 Rodgers,  B.  (1978)  Feeding  in  infancy  and  later  ability  and  attainment:  a 
longitudinal  study.  Developmental  Medicine  and  Child  Neurology  20,421- 
426. 
Rogan,  W.  J.  &  Gladen,  B.  C.  (1993)  Breast-feeding  and  cognitive 
development.  Early  Human  Development  31,181-193. 
Rouser,  G.,  Kritchevsky,  G.  &  Yamamoto,  A.  (1967) 
. 
In  Lipid 
chromatographic  analysis  Volume  1,  ed.  Marinetti,  G.  V.  pp.  99-162.  London: 
Edward  Arnold  Ltd. 
Rouser,  G.,  Yamamoto,  A.  &  Kritchevsky,  G.  (1971)  Cellular  membranes. 
Structure  and  regulation  of  lipid  class  composition  species  differences, 
changes  with  age,  and  variations  in  some  pathological  states.  Archives  in 
Internal  Medicine  127,1105-112  1. 
Salem,  N.  Jr.,  Kim,  H-Y.  &  Yergey,  J.  A.  (1986)  Docosahexaenoic  acid: 
Membrane  function  and  metabolism.  In  Health  Effects  of  Polyunsaturated 
Fatty,  4cids  in  Seafoods,  ed.  Simopoulos,  A.  P.,  Kifer,  R.  R.  &  Martin,  R.  pp. 
263-317.  New  York:  Academic  Press. 
Salem,  N.  Jr.,  Shingu,  T.,  Kim,  H-Y.,  Hullin,  F.,  Bougnoux,  P.  &  Karanian, 
J.  W.  (1988)  Specialization  in  membrane  structure  and  metabolism  with  respect 
s  em  to  polyunsaturated  lipids.  In  Biological  Membranes:  Aberration  inM  brane 
Structure  and  Function,  ed.  Karnovsky,  M.  &  Leaf,  A.  pp.  319-333.  New 
York:  Alan  R-  Liss. 
Sanders,  T.  A.  B.  &  Naismith,  D.  J.  (1979)  A  comparison  of  the  influence  of 
breast-feeding  and  bottle-feeding  on  the  fatty  acid  composition  of  the 
erythrocytes.  British  Joumal  offutrition  41,619-623. 
Sauerwald,  T.  U.,  Hachey,  D.  L.,  Jensen,  C.  L.,  Chen,  H.,  Anderson,  R.  E.  & 
Heird,  W.  C.  (1997)  Intermediates  in  endogenous  synthesis  of  C22:  6  W  and 
C20:  4  w6  by  term  and  preterm  infants.  Pediatric  Research  41,183-187. 
Sinclair,  A.  J.  (1975)  Incorporation  of  radioactive  polyunsaturated  fatty  acids 
into  liver  and  brain  of  developing  rat.  Lipids  10,175-184. 
Slaughter,  M.  M.  &  Miller,  RF.  (1981)  2-Amino-4-phosphonobutyric  acid:  a 
new  pharmacological  tool  for  retinal  research.  Science  211,182-185. 
Stevens,  L.  J.,  Zentall,  S.  S.,  Deck,  U.,  Abate,  M.  L.,  Watkins,  B.  A.,  Lipp,  S.  R. 
&  Burgess,  J.  R-  (1995)  Essential  fatty  acid  metabolism  in  boys  with  attention- 
deficit  hyperactivity  disorder.  4merican  Journal  of  Clinical  Nutrition  62,76  1- 
768. 
142 Stubbs,  C.  D.  &  Smith,  A.  D.  (1984)  The  modification  of  mammalian 
membrane  polyunsaturated  fatty  acid  composition  in  relation  to  membrane 
fluidity  and  function.  Biochimica  et  Biophysica  Acta  779,89-137. 
Sun,  G.  Y.  (1972)  Effects  of  a  fatty  acid  deficiency  on  lipids  of  whole  brain, 
microsomes,  and  myelin  in  the  rat.  Journal  oftipid  Research  13,56-62. 
Svennerholm,  L.  (1968)  Distribution  and  fatty  acid  composition  of 
phosphoglycerides  in  normal  human  brain.  Journal  of  Lipid  Research  9,570- 
579. 
Svennerholm,  L.  &  Stallberg-Stenhagen,  S.  (1968)  Changes  in  the  fatty  acid 
composition  of  cerebrosides  and  sulfatides  of  human  nervous  tissue  with  age. 
Journal  ofLipid  Research  9,215-225. 
Svennerholm,  L.  &  Vanier,  M.  T.  (1972)  The  distribution  of  lipids  in  the 
human  nervous  system.  H  Lipid  composition  of  human  fetal  and  infant  brain. 
Brain  Research  47,457468. 
Svennerholm,  L.  &  Vanier,  M.  (1973)  The  distribution  of  lipids  in  the  human 
nervous  system.  III.  Fatty  acid  composition  of  phosphoglycerides  of  human 
fetal  and  infant  brain.  Brain  Research  50,341-35  1. 
Svennerholm,  L.,  Hagberg,  M.  B.,  Haltia,  M.,  Sourander,  P.  &  Vanier,  M.  T. 
(1975)  Polyunsaturated  fatty  acid  lipidosis.  Acta  Pediatfica  Scandinavica  64, 
489-496. 
Temboury,  M.  C.,  Otero,  A.,  Polanco,  1.  &  Arribes,  E.  (1994)  Influence  of 
breast-feeding  on  the  infanfs  intellectual  development.  Journal  of  Pediatric 
Gastoenterology  andNutrition  18,32-36. 
Thomson,  ARIZ-,  Keelan,  M.,  Garg,  M.  L.  &  Clandinin,  M.  T.  (1989)  Intestinal 
aspects  of  lipid  absorption:  In  review.  Canadian  Journal  of  Physiology  and 
Pharmacology  67,179-19  1. 
Tomarelli,  R.  M.,  Meyer,  B.  J.,  Weaber,  J.  R.  &  Bernhart,  F.  W. (1968)  Effect  of 
positional  distribution  on  the  absorption  of  the  fatty  acids  of  human  milk  and 
infant  formula.  Journal  ofNuirition  95,583-590. 
Tsao,  F.  H.  C.  (1982)  The  effect  of  humidity  on  the  determination  of 
lecithin/sphingomyelin  ratio  and  phosphatidyl  glycerol  by  thin-layer 
chromatography.  Clinica  ChimicaActa  122,75-78. 
Turpeinen,  0.  (1938)  Further  studies  on  the  unsaturated  fatty  acids  essential  in 
nutrition.  Journal  offutrition  15,3  51-3  66. 
143 Uzman,  L.  L.  &  Rumley,  M.  K.  (1958)  Changes  in  the  composition  of  the 
developing  mouse  brain  during  early  myelination.  Joumal  of  Neurochemistry 
3,170-184. 
Vitiello,  F.  &  Zanetta.,  J.  P.  (1978)  Thin-layer  chromatography  of 
phospholipids.  Joumal  ofChromatography  166,63  7-640. 
Voss,  A.,  Reinhart,  M.,  Sankarappa,  S.  &  Sprecher,  H.  (199  1)  The  metabolism 
of  7,10,13,16,19-docosapentaenoic  acid  to  4,7,10,13,16,19-docoahexaenoic 
acid  in  rat  liver  is  independent  of  a  4-desaturase.  Joumal  of  Biological 
Chemisay  266,19995-20000. 
Watkins,  J.  B.  (1975)  Mechanisms  of  fat  absorption  and  the  development  of 
gastrointestinal  function.  Pediatric  Clinics  offorth  America  22,721-730. 
Ways,  P.  &  Hanahan,  D.  J.  (1964)  Characterization  and  quantification  of  red 
cell  lipids  in  normal  man.  Joumal  ofLipidResearch  5,318-328. 
White,  H.  B.  Jr.,  Turner,  M.  D.,  Turner,  A.  C.  &  Miller,  R.  C.  (1973)  Blood  lipid 
alterations  in  infants  receiving  intavenous  fat-free  alimentation.  Joumal  of 
pediaftics  83,305-313. 
Wiggins,  R-C.  (1982)  Myelin  development  and  nutritional  insufficiency.  Brain 
Research  Reviews  4,151-175. 
Wilcoxon,  F.  (1945)  Individual  comparisons  by  ranking  methods.  Biometrics 
Bulletin  1,80-83. 
Wilson,  R.  &  Sargent,  J.  R-  (1993)  Lipid  and  fatty  acid  composition  of  brain 
tissue  from  adrenoleukodystrophy  patients.  Journal  of  Neurochemistry  61, 
290-297. 
Yamamoto,  N.,  Hashimoto,  A.,  Takemoto,  Y.,  Okuyama,  H.,  Nomura,  M., 
Kitajima,  R-,  Togashi,  T.  &  Tamai,  Y.  (1988)  Effect  of  the  dietary  cc- 
linolenate/linoleate  balance  on  lipid  compositions  and  learning  ability  of  rats. 
II.  Discrimination  process,  and  glycolipid  compositions.  Journal  of  Lipid 
Research  29,1013-1021. 
Yavin,  E.  &  Zeigler,  B.  P.  (1977)  Regulation  of  phospholipid  metabolism  in 
differentiating  cells  from  rat  brain  cerebral  hemispheres  in  culture.  Journal  of 
Biological  Chemistry  252,260-267. 
Young,  H.  B.,  Buckley,  A.  E.,  Harnza,  B.  &  Mandarano,  C.  (1982)  Milk  and 
lactation:  some  social  and  developmental  correlates  among  1000  infants. 
Pediaftics  69,169-175. 
144 APPENDIX Publications 
Farquharson,  J.,  Cockburn,  F.,  Patrick,  W.  A.,  Jamieson,  E.  C.  &  Logan,  R.  W. 
(1992)  Infant  cerebral  cortex  phospholipid  fatty  acid  composition  and  diet. 
Lancet  340,810-813. 
Jamieson,  E.  C.,  Abbasi,  K.  A.,  Cockburn,  F.,  Farquharson,  J.,  Logan,  R.  W.  & 
Patrick,  W.  J.  A.  (1994)  Effect  of  diet  on  term  infant  cerebral  cortex  fatty  acid 
composition.  In  Fatty  Acids  and  Lipids:  Biological  Aspects.  ed.  Galli,  C., 
Simopoulos,  A.  P.  &  Tremoli,  E.  pp.  139-141.  Basel,  Switzerland:  Karger. 
Farquharson,  J.,  Jamieson,  E.  C.,  Abbasi,  K.  A.,  Patrick,  W.  J.  A.,  Logan,  R.  W.  & 
Cockburn,  F.  (1995)  Effect  of  diet  on  the  fatty  acid  composition  of  the  major 
phospholipids  of  infant  cerebral  cortex.  Archives  of  Disease  in  Childhood  72, 
198-203. 
Farquharson,  J.,  Jamieson,  E.  C.,  Logan,  R.  W.  Patrick,  W.  J.  A.,  Howatson,  A.  G. 
&  Cockburn,  F.  (1996)  Docosahexaenoic  acid  and  nervonic  acids  in  term  and 
preterm  infant  cerebral  white  matter.  Prenatal  and  Neonatal  Medicine  1,234- 
240. rr/pM 
rqo.  402/94 
EXTERNAL  APPEARANCE 
A  well  nourished  well  cared  for  male  infant,  weighing  6126g, 
measuring  CH  63cm,  CR  42.5cm,  OFC  42.5cm,  foot  8.5cm,  with 
two  small  superficial  abrasions,  1-2mm  and  3-4mm  lateral  to 
and  below  the  outer  angle  of  the  left  eye,  an  oblique  curved 
elliptical  pressure  mark  2x  1cm  consisting  of  a  central 
area  of  pallor  and  a  surrounding  hyperaemic  zone  over  the 
upper  outer  aspect  of  the  left  cheek  bone,  greenish 
postmortem  discolouration  of  the  anterior  abdominal  wall, 
postmortem  lividity  on  the  back  of  the  body  and  head,  and  no 
signs  of  non-accidental  injuries. 
INTERNAL  EXAMINATION 
There  were  no  development  anomalies. 
Head: 
The  skull  and  meninges  were  normal.  The  brain  was  soft  and 
showed  slight  generalised  swelling  with  some  flattening  of 
the  gyri.  The  pituitary  was  normal. 
Neck  and  Thorax: 
The  pharynx  and  oesophagus  were  normal. 
The  thymus  was  normal.  The  pleural  sacs  were  normal,  apart 
from  a  few  fine  petechial  haemorrhages  in  the  visceral 
pleurae  in  the  posterior  aspect  of  both  lungs.  The 
pericardium  was  normal. 
The  epiglottis,  larynx,  trachea  and  main  bronchi  were 
normal.  The  lungs  showed  some  lobular  collapse  of  a  minor 
nature.  There  was  no  apparent  consolidation  or  evidence 
of  gastric  aspirate  in  the  main  and  peripheral  airways. 
The  heart  had  a  probe  patent  foramen  ovale  of  no  clinical 
significance.  The  great  vessels  were  normal.  The  ductus 
arteriosus  was  closed.  The  carotid  bodies  were  not 
enlarged. 
Abdomen: 
The  peritoneal  sac  was  normal. 
showed  some  gaseous  distension 
The  stomach  contained  a  small 
mesenteric  lymph  nodes  were  not 
The  liver,  biliary  tract,  pancr, 
The  adrenal  glands,  kidneys  and 
The  gastrointestinal  tract 
but  was  otherwise  normal. 
amount  of  milky  feed.  The 
unduly  prominent. 
eas  and  spleen  were  normal. 
urinary  tract  were  normal. 
The  testes  were  normal  and  situated  in  the  scrotum. 
The  hypogastric  ligaments  were  normal. 
WEIGHTS: 
Brain  779g,  thymus  34.4g,  right  lung  70.0g,  left  lung  47.3g, 
liver  261.5g,  spleen  21.0g,  adrenals  3.4g,  right  kidney 
27.0g,  left  kidney  27.2g. 
Written  24.10.94 
Typed  27.10.94 FEEDING  REGIME 
34  How  did  you  start  with  feeding  when  baby  was  born? 
Breast 
.......  1 
Bottle  ....... 
C2ý) 
35  Were  you  still  breastfeeding  when  baby  died?  Yes/Noýý 
36  If  no,  when  did  breast-feeding  stop  completely?  (weeks) 
37  Reason  for  stopping  - 
You  had  a  problem  YeslNo&N 
The  baby  had  a  problem  Yes/No/(O 
You  went  back  to  work  YeslNoAg 
Babyfs  age  Yes/No/10 
other  (specify) 
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with  other  milk?  Yes/Nc(/NA) 
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as 
-  -1'ý 
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If  yes,  at  what  age  (weeks)  did  you  start?  FID 
40  If  you  bottleýed,  was  the  formula  you  first  used 
one  out  of  Group  1  or  Group  2? 
Group  1-  SMA  Goldcap  t, 
ý 
Cow  and  Gate  Premium 
Aptamil 
Ostermilk 
Group  2-  SMA  Whitecap 
Cow  and  Gate  Plus 
Milumil,  30 
Ostermilk  2  El 
ý41 
How  many  times  did  you  change  from  one 
i  ce/More/NA  group  to  the  other  NeverýýTw 
ý42  At  what  age  was  the  first  change  (weeks)? 
'43 
Reason  for  this  change? 
'3 
44  Which  Group  did  you  change  to?  El 
45  At  what  age  was  the  second  change  (weeks)? 
I  I? 
46  Reason  for  this  change? 
F  -I 
2 
47  Which  Group  did  you  change  to?  Li 
48  When  did  baby  start  on  solid  food?  (weeks) 
Lk-0 
49  Was  baby  ever  given  other  fluids? 
L4.2 
50  At  what  age  (weeks)  did  you  start  baby  on 
Weeks 
Full  strength  cow's  milk 
Semi-skimmed  cow's  milk 
Skimmed  cow's  milk 
Lell 
UHT  full  fat  FTý 
UHT  semi-skimmed 
Progress 
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